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Photodynamic therapy is an emerging treatment modality for cancer as it is a non-
invasive, inexpensive and able to produce targeted effect. It is based on the dynamic 
interaction of light, oxygen and a fluorescence molecule (photosensitizer) to induce 
oxidative damage in cancerous cells. Chlorin e6 (Ce6), introduced in the early 90‟s has 
widely been used as photosensitizer of interest. However, the photodynamic efficacy of 
Ce6 is largely limited by its tendency to form aggregates.  In addition, strong 
hydrophobicity of Ce6 adversely affects its bioavailability.   
In this study, it was hypothesized that aggregation of Ce6 could be prevented by using 
suitable pharmaceutical adjuvants, which would render Ce6 aggregates into its 
monomeric form. Furthermore, it was anticipated that these adjuvants could also be used 
as drug carrier for Ce6 if appropriately formulated. Their dual characteristics would 
therefore satisfy the necessity of a disaggregating agent and a drug carrier together.  
The study was divided into two parts, comprising photophysical investigation and 
pharmaceutical applications. In the first part, the influence of physicochemical factors 
such as pH and Ce6 concentration on the aggregate formation were extensively studied. 
The findings suggested that Ce6 preferentially exist as aggregates in the acidic to near 
neutral pH conditions as exhibited by broadened absorption spectra, reduced fluorescence 
intensity and lower quantum yield in the afore-mentioned pH conditions. In these pH 
conditions, Ce6 had a higher octanol/water partition coefficient value with lower aqueous 
solubility, suggesting aggregation was promoted by hydrophobic force. Novel 
chemometric quantification was applied employing Parallel Factor (PARAFAC) 
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algorithm to determine the fraction of different species of Ce6 (aggregate or monomer) at 
varying pH conditions. The results obtained were in good agreement with the 
spectroscopic findings, confirming significant influence of pH on Ce6 aggregation and 
photophysical properties.  
The disaggregation potential of polyvinylpyrrolidone (PVP) and sucrose esters (SE) was 
investigated. Disaggregation efficiency of PVP and SE gradually increased on decreasing 
the PVP molecular weight and increasing the alkyl chain of SE respectively. Using 
thermodynamic studies, the disaggregation effect was found to be mediated by 
hydrophobic interactions. Simulations at molecular level showed that Ce6 monomers 
could be entangled at different locations of the PVP macromolecules or incorporated into 
the hydrophobic core of SE.  
In the second part, selected formulations were evaluated. A modified hot-melt 
emulsification method was used to prepare Ce6-SE nanosuspension, where Ce6 was 
encapsulated as amorphous form in the SE matrix resulting in enhanced in vitro 
dissolution. Encapsulating Ce6-PVP complex in alginate nanoparticles further enhanced 
the mucoadhesivity of the formulation. These formulations were optimized using 
appropriate statistical designs. The photodynamic efficacy of these formulations was 
evaluated using extent of singlet oxygen generation, cellular uptake and phototoxicity to 
oral squamous carcinoma cells as determining parameters. The optimized formulations 
were found to exhibit superior photodynamic activity against oral squamous carcinoma 
cells in comparison with aggregate-rich solution form of Ce6.  
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Cancer is one of the potentially fatal diseases responsible for the rising death toll in many 
countries nowadays. Apart from surgical intervention, photodynamic therapy (PDT) is 
one of the emerging treatments of interest for premalignant and malignant conditions. 
This mode of treatment is based on dynamic interaction of light, oxygen and a 
photoactive drug to induce oxidative damage in target tissues [1-3]. In the last decade, 
this treatment modality had gained increased attention as it is mostly non-invasive and 
potentially devoid of the toxic adverse effects associated with chemotherapy [4]. The 
molecular and pharmacological basis for photodynamic therapy was established in the 
early 1990‟s [5]. For PDT, the patient is usually administered the photoactive drug either 
intravenously or topically (for superficial tumours) and exposed to light of higher 
wavelengths (usually red light) for a period of time. The photons from light activate the 
drug molecules and subsequently produce highly reactive oxygen radicals, which are 
thought to be the main mediator of cellular death induced by PDT [6].  PDT is now well-
established as an acceptable option in lung, esophagus, bladder, skin or head and neck 
cancers [7,8]. In addition, employing such photoactive compounds (known as 
photosensitizers) as probes greatly enhance the detection of small or poorly differentiated 
neoplastic tissues based on fluorescence light emission after accumulation of the 
photoactive compounds in the affected tissues. Interestingly, one of the prominent 
advantages of using this treatment modality is the selective destruction of tumour cells 
with minimal involvement of surrounding healthy tissues.  This is achieved by a
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combination of specific photosensitizer properties affecting cellular accumulation and 
control of the light geometry and illumination parameters of the photodynamic source 
[9].  
1.2. Photosensitizers in the treatment of cancer 
Many photosensitizers have been extracted from natural sources or synthesized and 
evaluated for their biological activities. Over time, several new generations of 
photosensitizers have been introduced and evaluated [10]. The earliest application of 
PDT in the treatment of a cancerous disease can be traced back to 4000 years ago when 
the ancient Egyptians used a combination of plant extracts (containing photoactive 
psoralens) and sunlight to treat vitiligo [11]. Contemporary research in PDT began 
around the late 19
th
 century with the discovery by Finsen that the skin disease, Lupus 
vulgaris could be treated using ultraviolet (uv) light [12.]. In 1903, Trappeiner used eosin 
and light to treat skin disease [13]. PDT research underwent a new phase by the 
venturous experiments of Meyer-Betz in 1913 when he injected himself with 200 mg of 
hematoporphyrin (Hp) and found no ill effects until he was exposed to sunlight, 
whereupon he suffered extreme swelling and photosensitivity over several months [14]. 
In the early 1950‟s, Schwartz discovered that it was not the monomeric hematoporphyrin 
but an oligomeric mixture that actuated long term phototoxic effect in the Meyer-Betz‟s 
experiment [15]. Schwartz synthesized a new Hp derivative (HpD) containing enriched 
oligomer fractions by treating Hp with sulfuric acid in acetic acid and then followed by 
treatment with alkali. By 1960, the combination of HpD and selective light irradiation 
marked the start of the usage of PDT in the treatment of cancerous diseases [16-18]. 
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1.2.1. Different classes of photosensitizers 
Photosensitizers can be characterized by their chemical structures and origins.  They are 
generally divided into three categories, namely first generation photosensitizers, second 
generation photosensitizers and dyes, according to their history of synthesis and use 
(Figure 1). Hematoporphyrin derivative (HpD), a first generation photosensitizer, was 
introduced by Schwartz and it was marketed as Photofrin
® 
after purification for the 
treatment of lung cancer [19-20]. Porphyrins are heteroaromatic compounds 
characterized by a tetrapyrrolic structure that consists of four pentagonal pyrroles linked 
by four methylene bridges [Figure 1]. Porphyrins are considered to be stable although 
they can be oxidized or reduced. They are characterized by an absorption spectrum with a 
specific band around 400 nm (Soret band) and four further specific bands in the region 
500-650 nm [21]. Photofrin
® 
was marketed as the first generation photosensitizer by 
Axcan Pharma, USA in 1982 and subsequently approved for clinical use by the 
regulatory agencies of other countries [22]. However, Photofrin
® 
posed several 
deficiencies, including poor tumour selectivity, weak absorption in the near infrared 
region and induction of long-lasting retinal and skin photosensitizing effects [23-25]. 
The second generation photosensitizers were developed by further modification of HpD 
or the porphyrin macrocycle for better photodynamic efficacy. Further emphasis was put 
forth in modification of porphyrin nucleus to induce specificity, such as to remain 
preferentially inactivated in absence of light. Low cytotoxicity in absence of laser 
irradiation (dark toxicity) was observed in these photosensitizers. Examples include 5-
amino levulinic acid (ALA) and chlorin/purpurin derivatives. ALA is a prodrug, 




Figure 1:  Different categories of photosensitizers. 
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molecule and does not penetrate intact skin, cell membrane or biological barriers easily. 
Although lacking in the ability to produce high fluorescence intensity at 630 nm, ALA 
has been efficiently used in dermatology for the treatment of neoplastic skin carcinoma 
[26-27].  
Another group of promising second generation photosensitizers is the chlorin derivatives 
which are produced from chlorophyll by chemical synthesis. Unlike porphyrins, chlorins 
strongly absorb in the red region (between 640 and 700 nm), possess high fluorescence 
half-life and are devoid of the afore-mentioned disadvantages of first generation 
photosensitizers [28-29]. Chlorin derivatives are localized in the cellular lysozomes and 
exert cytotoxic effects after light irradiation.  
Purpurins are benzoporphyrin-based derivatives, either free-base or complexed with a 
metal (silver, nickel, tin, zinc, etc.). They show a strong light absorption in the red region 
but only the metallic purpurins of tin or zinc are useful for PDT [30]. One of the highly 
effective purpurins representative of this class is purlytin (Fig. 1), which is a tin ethyl 
etiopurpurin dichloride (SnET2), used for several ophthalmological, oncological and 
urological indications [31]. An effective benzoporphyrin derivative, Verteporphin or 
Visudyne
®
, has been approved by the Food and Drug Administration of the United States 
(US FDA) particularly for ophthalmologic applications, and age-related macular 
degeneration (AMD).  The intracellular localization of this photosensitizer at the tumour 
site was reported to be rapid immediately after injection, which showed potent 
cytotoxicity following light irradiation at 690 nm [32].  
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Other notable second generation photosensitizers include tetrahydroxyphenylchlorin 
(THPC), pthalocyanines and texaphyrins derivatives, which are characterized by strong 
absorption in the red region and approved for photodiagnosis and treatment of 
proliferative diseases and infections [33, 34].  
Some dyes are useful photosensitizers. They include anthraquinones and 
perylenequinones, hypericin, xanthenes, fluorescein, rhodamines and cyanines. Some of 
these compounds have been approved by US FDA and other drug regulatory agencies for 
the treatment of malignant carcinomas [35]. 
1.2.2. Mechanism of photosensitization  
The mechanism of light absorption and energy transfer in the event of photodynamic 
therapy is illustrated by a modified Jabolonski diagram in Figure 2 [36]. The 
photosensitizer absorbs energy from light and is excited from its ground state (S0) into an 
excited singlet state (S1). The excited molecule can return to S0 by non-radiative decay or 
fluorescence. Alternatively, the excited molecule can undergo inter-system crossing to an 
excited triplet state (T1). The photosensitizer in the excited triplet state can undergo two 
types of reactions (Figure 2). In the Type 1 reaction, it can react directly with a substrate, 
such as the cell membrane or a molecule, and transfer a proton or an electron to form a 
radical anion or radical cation, respectively. These radicals may further react with oxygen 
to produce reactive oxygen species. In the Type 2 reaction, the photosensitizer in the 
triplet state can transfer its energy directly to molecular oxygen (
3
O2) to form excited 
state singlet oxygen (
1
O2). Both Type 1 and Type 2 reactions usually occur spontaneously 




Figure 2: Graphical illustration of photophysical and photochemical pathways of PDT. 
well as the concentrations of substrate and oxygen available. The free radicals or singlet 
oxygen generated are highly active oxidizing agents, which cause damage to DNA base-
pair, or modification of various functional proteins in the cell organelles through 
oxidation. The free radicals could also result in cell death by direct oxidative attack on 
protein biomolecules, leading to inhibition of protein synthesis. The lifetime of singlet 
oxygen in cellular systems ranges from 100 ns to 250 ns and its diffusion range is limited 
to approximately 45 nm. Therefore, only molecules and structures that are proximal to 
the area of its generation (areas of photosensitizer localization) are directly affected by 
PDT [37-40]. 
1.2.3. Chemical and photophysical properties of photosensitizers  
Considering the afore-mentioned principles of photoexcitation for PDT, a photosensitizer 





 Strong absorption in the higher wavelength of visible light spectral region (> 650 
nm) 
 High quantum yield of the triplet formation with a triplet energy greater than 94 





 High singlet oxygen quantum yield 
 Low dark toxicity and selective cytotoxic effect in the presence of light 
 High absorption band or molar extinction coefficient (> 20,000-30,000M−1 cm−1) 
to minimize the dose of photosensitizer needed to achieve the desired effect 
 Rapid clearance from the body to ensure low systemic toxicity 
 Selective accumulation in the tumour tissues compared to healthy tissues 
 Adequate lipophilicity to efficiently permeate into the affected cell 
 Facile synthesis from readily available starting compounds that are inexpensive 
1.2.4.  Factors affecting photosensitization 
The therapeutic efficacy of PDT depends on several factors, which when collectively 
triggered, produce the optimal outcome. The sensitizing efficiency has often been 
reported to be affected by physico-chemical factors, resulting in deviation from the 
desired behaviour of an ideal photosensitizer. The various factors that affect the 
sensitizing efficiency are discussed below. 
1.2.4.1. Aggregation of photosensitizers 
The self-association of hydrophobic or amphiphilic photosensitizers in solution is 
frequently encountered owing to the strong intermolecular van der Waals-like attractive 
forces between the relatively large molecules. Aggregation is characterized by the 
reduction in fluorescence emission along with compromised photophysical properties for 
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porphyrins, chlorins, cyanines and various other dyes [44].  The aggregates in solution 
exhibit distinct changes in the absorption band as compared to the monomeric species. 
From the spectral shifts, various aggregation patterns of the compounds in different 
media have been proposed. Bathochromically-shifted J‐bands and hypsochromically-
shifted H‐bands of the aggregates have been explained in terms of molecular exciton 
coupling theory. For bathochromatic shifts, spectral bands migrate to lower frequencies 
(longer wavelengths) and are informally referred to as red shifts. In contrast, 
hypsochromic shift refers to the migration of a spectral band to a higher frequency 
(shorter wavelength) and is commonly known as a blue shift [45]. Extensive studies on J‐ 
and H‐aggregates have revealed that these aggregates exist as one‐dimensional 
assemblies in solution. Based on these proposals, various arrangements such as 
brickwork, ladder or staircase type of association are possible (Figure 3) [46]. These 
aggregates are typically composed of parallel photosensitizer molecules stacked plane‐to-
plane or end‐to‐end and form two‐dimensional crystals. The presence of aggregates can 
be identified by bi-exponential or tri-exponential fluorescence decays, exhibiting very 
short decay component, usually smaller than 50 ps. In addition, the fluorescence intensity 
and the singlet oxygen quantum yield of an aggregated species are significantly lower 
than those of the corresponding monomer. This observation is attributed to the 
association of photosensitizer molecules, where the relaxation energy is released by non-
radiative way without attaining the triplet state, thereby resulting in reduced singlet 
oxygen generation [47-50]. Consequently, the fluorescence life-time of aggregated 
species is shorter and thereby reduces the transition from singlet (S1) to triplet (T1) state, 
which is an essential step in the photochemical pathway of PDT modality. Therefore, the 
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aggregated species is not advantageous for PDT action and the understanding of how to 
avoid aggregation of photosensitizer molecules is important.  
 
Figure 3: Schematic representation of different arrangements of fluorophores during 
aggregation. 
1.2.4.2. Interaction with solvents 
The surrounding solvent molecules can affect fluorescence emission and self-association 
of dye molecules. In fact, a high degree of sensitivity in fluorescence is primarily due to 
interactions occurring in the local environment during the excited state lifetime, when the 
fluorophore is considered as an entirely different entity due to some of its unique 
properties. In solution, solvent molecules surrounding the ground state fluorophore have 
dipole moments that can interact with the dipole moment of the fluorophore to build an 
ordered distribution of solvent molecules around the fluorophore [51]. Due to energy 
level difference between the ground and excited states, the dipole moment of the 
fluorophore changes, which subsequently induces a rearrangement in dipole moment of 
surrounding solvent molecules to maintain the ordered distribution (Figure 4). Upon 
excitation of a fluorophore, the molecule achieves a higher electronic energy level in a far 
shorter timeframe. This is a couple of folds shorter than the time required for the 
fluorophore and solvent molecules to re-orient themselves within the ideal solute-solvent 
(a) Ladder-type (a) Staircase-type (a) Brickwork-type a e (b) Staircase-type c  r
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interactive environment. Once the fluorophore is excited to higher vibrational levels of 
the first excited singlet state (S1), excess vibrational energy is rapidly lost to surrounding 
solvent molecules as the fluorophore slowly relaxes to the lowest vibrational energy 
level. Solvent molecules assist in stabilizing and further lowering the energy level of the 
excited state by re-orienting around the excited fluorophore. This induces reduction in the 
energy separation between the ground and excited states and results in a red shift of the 
fluorescence emission. Increasing the solvent polarity produces a correspondingly larger 
 
Figure 4: Schematic representation of solvent-induced photophysical transformations of 
fluorophores. 
reduction in the energy level of the excited state while decreasing the solvent polarity 
reduces the solvent effect on the excited state energy level. In addition, specific solvent-
solute interactions, such as H-bonding between a polar solvent and polar fluorophore in 
the excited state, produce strong absorption bands and high fluorescence intensities. This 
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enhanced fluorescence activity in the excited state. However, weak non-covalent 
interactions persist between non-polar solvents and fluorophore, resulting in weak 
fluorescence emission, indicating increased propensity for the formation of aggregates 
[52-55].  
1.2.4.3. Quenching Phenomenon 
Quenching refers to the reduction in fluorescence intensity of a photosensitizer due to the 
presence of an external agent. This results in concomitant decrease in fluorescence 
quantum yield and attenuates the sensitizing efficacy during PDT. There are two 
quenching conditions characterized by the mechanisms of interaction between quencher 
and fluorophore: static and dynamic quenching.  Static quenching refers to the formation 
of a non-fluorescence photosensitizer-quencher complex. In dynamic or collisional 
quenching, the quencher in the excited state diffuses towards the fluorophore and upon 
contact with the fluorophore, returns to the ground state without emission of a photon, 
thereby diminishing the fluorescence intensity [56]. Fluorescence quenching has been 
utilized mainly for the determination of protein folding sequence, conformational 
changes of amino acid residues or oxygen diffusion through membranes [57]. It has been 
reported that effective use of biodegradable quenchers for photosensitizer delivery results 
in enhanced sensitizing efficacy.  The biodegradable quencher selectively delivers the 
drug at the site of action and it is then gradually eliminated from the target site. Thus, if 
the quencher is used as a photoactive drug carrier, a profound increase in fluorescence 
activity could be observed through gradual degradation of the carrier at the target site. 
Whereas, fluorescence intensity is attenuated at the non-target site due to the quenching 
action resulting in preserving the PDT activity [58-60].  
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1.2.4.4. Light dosimetry 
Light is either scattered or absorbed when it enters the tissue and the extent of both 
processes depends on tissue type and light wavelength.  In PDT, it is important to be able 
to predict the spatial distribution of light in the target tissue because the biological tissue 
is inhomogeneous and the presence of microscopic inhomogenities, such as 
macromolecules, cell organelles and interstitial layers, makes it turbid. Multiple 
scattering within a turbid medium leads to spreading or attenuation of a light beam and 
loss of directionality [61]. Scattering is generally the most important factor in limiting 
light penetration into most tissues and is measured by µs (which for soft tissues is in the 
range 100-1000 cm
−1
). Absorption is usually of less importance and measured by µa 
(values in the range of 0.1-5 cm
−1
 for most tissues at green and longer wavelengths). The 
average penetration depth is about 1-3 mm at 630 nm, the wavelength used for clinical 
applications of photosensitizers. The penetration depth is approximately twice that at 
700-850 nm. This observation led to the development of novel naphthylocyanines and 
bacteriochlorins, which possess excellent penetration power in the near infra-red (NIR) 
region [62-64]. Reduction of unwanted tissue damage and minimization of the absorption 
by endogenous chromophores are important considerations in the design of lasers to 
possess narrow bandwidth with well-controlled and focused light output. Table 1 lists the 
various types of light sources for PDT. In particular, xenon and tungsten lamps are often 
used when a broader spectrum of light is required for the photosensitizer. These are 
relatively inexpensive and easier to handle as compared to lasers, which require 
adjustments using optical filters for the desirable emission [65]. The amount of light dose 
emitted from the laser is an essential factor in modulating photodynamic efficiency.  
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 laser 488, 514.5/No 500-1000 
 Metal vapor laser UV or visible/Yes Up to several thousand 
 Dye laser Depending on dye/Yes 10-500 
 Diode laser 600-950/Yes Up to 700 
 Titanium-sapphire 670-1100/Yes Up to several thousand 
Non-laser Halogen bulb >  400/ Yes Up to 250 
 Xenon lamp 
UV-IR full 
spectrum/Yes  




Up to 250 
The effective light dose becomes further complicated depending on the tumour size and 
shape. Generally, a threshold photodynamic response is considered to be the function of 
the following parameters [66]: 
                                                                                                                   
where 
R is the threshold concentration of the oxidizing radicals to elicit the PDT effect, 





ks is the backscatter factor due to reflected light from the underlying tissue,  
T is the exposure time of light, 
ε is the extinction coefficient of photosensitive drug, 
D is the concentration of the photosensitive drug, 
Φ is the quantum yield of the singlet oxygen radical and 
f is the fraction of the generated oxidizing  radicals which attack the sensitive cellular 
sites.  
In principle, the light dosimetry quantity is determined by the amount of light delivered 
(E) and the exposure time (T). Therefore, the amount of light dose (L) given is: 
  
 
        
                                                                                                              
Considering that ks, ε, and D are constant for a particular photosensitizer, L is 
proportional to     R /   f, which is also known as the threshold dose for that particular 
photosensitizer. For PDT studies in vitro, the commonly used light dose (L) is in the 
range of 0.1–10 J cm-2, whereas, it could be as high as 1–600 J cm-2 for in vivo studies 
[67]. 
1.2.5.   Advantages and disadvantages of PDT 
The prominent advantages of PDT can be summarized as follows: 
 PDT is recommended when surgery is contraindicated because of the tumour 
spread and other complications due to associated diseases.  
 PDT produces a targeted effect. The red light selectively damages the tumour 
whereas surrounding tissues are less affected.  
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  As PDT is used for localized treatment of malignant carcinomas, the patient will 
not be subjected to an unwanted systemic effect. Therefore, the typical side 
effects of conventional chemotherapy such as nausea, vomiting, stomatitis, loss of 
hair and inhibition of hematopoiesis could be avoided. 
 PDT is cost-effective. It is also a tolerable, localized and inexpensive technique, 
which can be used to treat a variety of malignant tumours (primary, relapsing and 
metastatic). 
 Besides cancerous tissues, many skin conditions such as acne, Bowen‟s disease 
and sebaceous hyperplasia can be treated by PDT. It was recently reported that the 
photosensitizer, Photofrin
®
, is active against HIV as is it able to significantly 
reduce the intracellular and extracellular concentrations of HIV virus in vitro [68]. 
Apart from the non-invasive and cost-effective advantages, PDT also poses some 
limitations and these include the following. 
 PDT is ideally recommended for the treatment of superficial tumours. As the 
depth of penetrating laser light is few millimeters, PDT has little effect on deep-
seated tissue tumours.  
 Another disadvantage is that following PDT treatment, the patient remains 
photosensitive and may suffer from severe swelling, skin rashes and dark 
pigmentation if exposed to light. For example, the light sensitivity of Photofrin
®
 
can last as long as two months [69].  
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 Another minor side effect is the inconvenience experienced by the patient as the 
time gap between photosensitizer administration and light irradiation, which could 
be extended to as long as 12-14 hr for ALA [70]. 
1.2.6. Challenges in PDT 
Despite the various advantages of PDT, it is still regarded as a second line treatment in 
cancer therapy. Over the years, researchers have reported various limitations of PDT with 
regard to its in vivo efficacy. Most of the organic photosensitizers are hydrophobic and 
penetrate the cell membrane readily. However, the poor water solubility of the 
photosensitizers makes them unsuitable for systemic administration. In addition, the 
efficacy of a photosensitizer is largely attributed to its monomeric form, while the self-
association of the monomers results in drastic reduction of photodynamic efficacy. 
Furthermore, during the transport of photosensitizers, physiological barriers and 
nonspecific uptake can affect their access to the target sites. Moreover, PDT outcome 
becomes clinically questionable by non-selective biodistribution of a photosensitizer, 
which necessitates the administration of higher doses of the photosensitizer with the 
consequence of increased incidence of side effects [71-74]. These limitations can be 
mitigated by synthesizing new photosensitizers or exploring a carrier to selectively target 
at the site of action. However, synthesis involves complicated steps as well as regulatory 
approval of the new drug substance. Therefore, fabrication of a delivery device with 
multi-functional capabilities will be an optimum choice to selectively target the 
photosensitizer and increase its therapeutic efficacy. 
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1.2.7. Nanoparticles as delivery platform for PDT 
Nanoparticles are specially engineered materials, generally in the 1-100 nm dimension 
range. They have unique physicochemical properties, such as small size, large surface 
area to mass ratio and high reactivity, which are used to overcome various limitations of 
conventional therapeutic agents [75]. Moreover, nanoparticles-based delivery systems 
have been extensively utilized to improve the solubility of poorly water-soluble drugs, 
prolong the circulation half-life of the drug in the blood, minimize degradation of the 
drug after administration, decrease its side effects and increase its bioavailability [76]. 
Nanoparticles have been reported to preferentially accumulate at the tumour sites rather 
than healthy tissues due to enhanced permeability and retention (EPR) effect. This is 
based on the fact that the vasculature in pathological areas is „„leaky‟‟, unlike in normal 
healthy tissues. The pore sizes in normal tumours usually vary from 100 to 780 nm, 
which allows the spontaneous accumulation of size-specific nanoparticles in the 
interstitial tumour tissues [77-78].  A large number of drug-loaded therapeutic 
nanoassemblies are now available. These include polymeric nanoparticles, liposomes, 
niosomes, solid lipid nanoparticles, nanocrystals, micelles, dendrimers, 
superparamagnetic iron oxide nanoparticles and carbon nanoplatforms. The use of PDT-
based nanotherapeutics has also been explored [79-90]. Apart from the external factors 
such as hydrophobic properties of the photosensitizer, variations in light dosimetry and 
aggregation-related issues, effective delivery to the target site is equally crucial for 
improving therapeutic outcomes in PDT. In this context, nanoparticles with adjuvants can 
increase the solubility of hydrophobic photosensitizers and offer the benefits of 
hydrophilicity and proper size to accumulate in the tumour tissue via the EPR effect. In 
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addition, increase in hydrophilicity could also reduce the likelihood of aggregation by the 
photosensitizer in the physiological media. A summarized overview of various 
nanotherapeutic delivery systems for efficient delivery of photosensitizers (Table 2) will 
be discussed with emphasis on the salient features of each of the delivery systems. 
1.2.7.1. Polymeric nanoparticles  
Both biodegradable and non-biodegradable polymers have been used for drug delivery 
applications in PDT. A large variety of polymers are available for product design to meet 
the requirements for high drug loading capacity, controlled release, and targeted delivery. 
Nanospheres (polymeric matrix systems) or nanocapsules (aqueous or oily cores 
surrounded by a polymeric membrane) are the two distinctive polymeric nanoparticle 
structures that can be prepared by different methods for the delivery of photosensitizers 
[91]. The photosensitizer can be either adsorbed on the surface or entrapped in polymeric 
nanoparticles. Verteporfin and benzoporphyrin-loaded poly-lactic-coglycolide-based 
biodegradable nanoparticles showed excellent photocytotoxity against EMT-6 mammary 
tumour cells in comparison with the free drug [92]. Bourdon et al. (2000) investigated the 
photosensitizing efficiency of m-HTPC in surface-modified PLA-PEG nanocapsules with 
the aim to achieve long in vivo circulation time. These nanocapsules showed significantly 
lower accumulation in macrophage-like J774 cells, indicating potential to be long 
circulating carriers with limited uptake by reticulo-endothelial cells (RES) [93]. Konan et 
al. (2003) studied sub-200 nm PLGA nanoparticles of hydrophobic photosensitizer meso-
tetra(p-hydroxyphenyl) porphyrin (m- THPP) by emulsion-solvent diffusion technique 
and the uniform-sized nanoparticles had average drug loading and high phototoxicity 
against EMT-6 mammary tumour cells [94]. 
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Table 2: Types of nanoparticle-based PDT system 
Delivery system  Size Shape Photosensitizers used  
Polymer-based 
nanoparticles 





Polymeric micelles 10-100 nm  Spherical PpIX, mTHPP, Si(sol)2Pc 
Liposomes  
25 nm to 






, mTHPC,  
Dendrimers 










HPPH, mTHPC, PpIX 











< 200 nm Nanosphere HPPH, Photofrin
®
 
Others Variable Nanosphere 
Merocyanine 540. TiO2, 
fullerenes 
Hydrophilic polyacrylamide (PAA)-based non-biodegradable polymers have also been 
employed to encapsulate photosensitizers and they offer unique advantages like minimal 
protein adsorption, low aggregation and good biocompatibility. Tang et al. (2008) 
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demonstrated the photo-induced cytotoxicity of methylene blue (MB)-loaded PAA 
nanoparticles to tumour cells, where the drug carrier prevented diaphorase enzyme-
mediated reduction of MB, thus preserving the active form of MB [95]. 
Polymeric nanoparticles such as chitosan nanocarriers have shown numerous advantages, 
such as high drug-loading efficiency and rapid cellular uptake of protoporphyrin IX [96]. 
Pullulan-based nanogels have been successfully employed in the treatment of articular 
joints using chlorin photosensitizers. Selective delivery to macrophages was evident in 
arheumatoid arthritis mouse model [97]. 
Polymer-photosensitizer conjugates of hydrophilic polymers provide an alternative 
pathway for PDT applications. Improved efficacy of poly-L-lysine-chlorin e6 conjugates 
was demonstrated with the addition of PEG, where higher phototoxicity to ovarian cancer 
cells and less damage to macrophage cells were observed [98]. Water-soluble PEG-zinc 
protoporphyrin conjugates have been studied in vitro and showed potential phototoxic 
effects after laser irradiation [99]. 
1.2.7.2. Polymeric micelles 
Polymeric micelles are composed of amphiphilic block copolymers with hydrophobic 
interior cores suitable to house a wide variety of poorly water-soluble photosensitizers 
[81, 82, 100]. These micelles have the potential for targeted PDT drug delivery and were 
shown to be useful in recent studies with various hydrophobic photosensitizers. Roby et 
al.  (2006) reported the efficiency of PEG-phosphatidyl ethanolamine (PE)-based 
micellar carrier for the delivery of meso-tetraphenylporphine (mTPP) [101]. The TPP-
containing PEG-PE micelles showed significant improvement of photocytotoxicity in 
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vivo compared to free TPP against cancer cells. Rijcken et al. (2007) showed the 
improved sensitizing ability of hydrophobic solketal-substituted phthalocyanine when it 
was encapsulated in thermosensitive poly(ethyleneglycol)-block-poly(N-(2-
hydroxypropyl) methacrylamide-dilactate) micelles [102]. These micelles with an 
average size of 75 nm were able to deliver monomeric form of the photosensitizer, when 
the substituted-pthalocyanine was used at low concentrations (≤ 0.05 µM). Other diblock 
copolymer-based micelles such as poly-(ethyleneoxide-b-ω-caprolactone) (PEO–PCL) 
were reported to possess great potential to deliver hydrophobic photosensitizers. Li et al. 
(2007) demonstrated high loading efficiency of PpIX (82.4%) with narrow size 
distribution (52.2 nm) when incorporated in PEO-PCL micelles [103]. Compared to the 
free PpIX, the PpIX in micelles showed a higher cellular uptake as well as higher PDT 
effect upon irradiation in RIF-1 cells. Nishiyama et al. (2009) reported the efficacy of 
ionic dendritic photosensitizer-incorporated polyion complex micelles. By means of 
electrostatic interaction, the charged block copolymer PEG-poly(L-lysine) block 
copolymers (PEG-b-PLL) and anionic dendrimer phthalocyanine (DPc) formed micelles 
[104]. The PDT effect of the DPcZn was double compared to the free DPc for the same 
irradiation time. The DPc-loaded micelles showed a higher anti-proliferative activity than 




Liposomes are self-assembled spherical structures composed of one or more lipid 
bilayers with aqueous cores [84,85]. The main components are biocompatible 
phospholipids and cholesterol. Liposomal structures can accommodate both hydrophobic 
and hydrophilic photosensitizers [85]. Several studies have reported successful 
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application of liposomes for PDT drug delivery. One of the earliest reported liposome 
applications was to improve the solubility of verteporfin, and the liposomal formulation 
was approved for use in clinical trials for choroidal neovascularization associated with 
AMD [105-106]. Dipalmitoyldiphosphatidylcholine (DPPC) liposome encapsulating 
Photofrin
®
 demonstrated enhanced drug uptake and tumour destruction compared to 
Photofrin
®
 in dextrose solution [107]. Intravenous injection of m-THPC encapsulated in 
DPPC liposomes exhibited highest m-THPC tumour-to-muscle accumulation at 6 hr post-
injection. Several factors, such as half-life, stability in the presence of plasma 
lipoproteins, opsonization followed by clearance from the blood stream by mono-nuclear 
phagocyte system, affect the therapeutic effects of liposomes in vitro. More recently, a 
number of liposomal formulations have been developed to improve the plasma stability 
and circulation lifetime of bioactives. Incorporation of PEG and glycolipids showed 
stealth characteristics by avoiding fast detection by the immune system, thereby 
prolonging the circulation time of the photosensitizer [108]. Improved skin penetration 
for ALA was obtained when ALA was entrapped in liposomes comprising 
PE/cholesterol/sodium stearate in the molecular ratio 2:1:2.5 [109]. Incorporation of ALA 
hexyl esters in the afore-mentioned liposomes also showed similar effects with increased 
stability [110]. 
1.2.7.4. Quantum dots 
Quantum dots (QD) are single crystals of semiconductor with size range of a few 
nanometers to less than 10 nm [89]. The light absorption ability of the QDs can be varied 
from ultraviolet (UV) to the IR region by changing their size and composition [111]. 
These nanomaterials of constant composition possess high photoluminescence quantum 
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yield, photostability and molar extinction coefficient. They are relatively simple and 
inexpensive to synthesize and are non-cytotoxic in the absence of light but have the 
potential to induce cytotoxicity under UV irradiation. Another useful advantage is their 
ability to resist metabolic degradation [112]. Currently, surface coating of QDs makes 
them water-soluble, biocompatible and target specific for efficient delivery of various 
therapeutic and diagnostic agents [113-114].  Samia et al. (2003) first demonstrated the 
possibility of using QDs as a photosensitizer for PDT during the study of a QD system 
composed of cadmium, selenium and pthalocyanine (Cd-Se-Pc) [115]. Phthalocyanine 
molecules attached on QDs can be indirectly excited via QDs at 488 nm and emit at 680 
nm with 77% fourier resonance energy transfer (FRET) efficiency, implying potential 
application of QDs for NIR sensitization. More recently, Tsay et al. (2007) produced 
stable and multifunctional peptide-coated QD-photosensitizer conjugates with singlet 
oxygen generation yield as high as 31 % [116]. They also conjugated RB and chlorin e6 
in peptide-coated CdSe/CdS/Zn QDs with high singlet oxygen generation efficiency. The 
results showed that singlet oxygen could be produced via energy transfer from 
nanocrystal donors to the photosensitizer acceptor by FRET mechanism.  
1.2.7.5. Dendrimers 
Dendrimers are monodispersed spherical or globular macromolecular structures with 
repeated branches [87]. Their highly branched symmetric architecture, consisting of a 
multivalent functional surface, interior shell and a core, offers three unique approaches 
for PDT drug delivery. Kojima et al. (2007) studied the PEG-attached poly(amidoamine) 
dendrimers and the PEG-attached poly(propylene imine) (PPI) dendrimers for 
hydrophilic rose bengal and hydrophobic PpIX photosensitizers for PDT drug delivery 
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[117]. Stabilization of the photosensitizer inside the dendrimer core was achieved through 
interaction of the acidic moieties of both molecules with the inner tertiary amino group in 
the dendrimers. Based on confocal fluorescence imaging, the complex of PpIX with 
PEG–PPI dendrimers could be delivered to mitochondria more efficiently compared to 
the free PpIX. More recently, Ideta et al. (2009) reported the feasibility of using 
dendrimer porphyrins (DPs) with different charges on the periphery [118]. The study 
showed the occurrence of charge dependent interaction with the cells, where positively 
charged DPs showed better PDT effect.  
1.2.7.6. Gold nanoparticles 
Gold nanoparticles have emerged as a useful therapeutic carrier for the transport of 
peptides, proteins as well as nucleic acids for gene therapy [119-120]. This system has 
been recently explored for PDT drug delivery through covalent and non-covalent 
approaches. Hone et al. (2002) had produced phthalocyanine-stabilized gold 
nanoparticles through strong covalent attachment by Au-S bond [121]. Although the 
formulation showed high singlet oxygen generation, it was insoluble in water and 
exhibited dark toxicity in HeLa cells to some extent. Therefore, a non-covalent approach 
through electrostatic or hydrophobic interactions with gold nanoparticles provides a 
promising delivery strategy as it maintains the active form of the drug. Recently, Oo et al. 
(2008) demonstrated PDT efficacy of electrostatically-conjugated ALA to positively 
charged Au nanoparticles by selective destruction and inhibition of the proliferation of 
fibrosarcoma cells through high singlet oxygen generation [122]. Using Au nanoparticles 
for hydrophobic photosensitizers, Oo et al. developed a non-covalent approach to entrap 
the hydrophobic pthalocyanine (Pc) in Au nanoparticles. Pthalocyanine was found 
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attached to the Au nanoparticle surface through a nitrogen-gold bond via the terminal 
amine group of the drug. In vitro studies indicated an excellent biocompatibility and good 
PDT effect of the Au-Pc conjugates in HeLa cells.  
1.2.7.7. Other nanoassemblies 
Apart from the afore-mentioned nanotherapeutic drug carriers, photosensitizer-loaded 
ceramic nanoparticles, magnetic nanoparticles and fullerene-based nanoparticles have 
also been explored as drug delivery systems for PDT.  
Silica-based mesoporous nanoparticles were prepared in order to achieve high drug 
loading and stability against degradation. Photosensitizers can be either encapsulated in 
the mesoporous matrix or directly linked to the nanoparticle surface through covalent 
bonds [123]. In 1993, Prasad et al. first reported the efficiency of mesoporous 
nanoparticles of the hydrophobic drug pyrophorbide. These nanoparticles had average 
size of 30 nm and showed high singlet generation, increased stability and phototoxicity 
against tumour cells [124, 125].  
Magnetic nanoparticles offer a myriad of applications in the field of magnetic resonance 
imaging, hyperthermia therapy, drug delivery and disease diagnosis [126-128]. 
Superparamagnetic iron oxides (> 50 nm) and ultrasmall supermagnetic iron oxides (< 50 
nm) have been reported to possess biocompatibility and usefulness for drug delivery. Gu 
et al. demonstrated the efficacy of iron oxide nanoparticles by anchoring porphyrin 
covalently on the nanoparticle surface for PDT and hyperthermia therapy [129]. In vitro 
studies demonstrated that the conjugates could be taken up by HeLa cells and showed 
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considerable PDT effect. Combination of magnetic carriers and polymeric micelles or 
chitosan-based hydrophilic conjugates showed marked increase in PDT efficacy.  
Fullerenes (C60 and C70) have high triplet yield and thus can efficiently transfer energy to 
surrounding molecules such as oxygen and form reactive oxygen species [130]. 
Andrievsky et al. (2009) reported the photo-activity of water-soluble fullerene carboxylic 
acid, which showed strong activity against HeLa cells with selective DNA cleaving 
ability under irradiation [131]. 
1.2.7.8. Marketed formulations and current developments 
Many drug delivery systems have been investigated with the aim of achieving high PDT 
efficacy, increased drug stability and least toxicity. A few of these delivery systems have 
been approved by the drug regulatory agencies for clinical use. ALA was formulated for 
oral, topical and intravenous administration, which proved to be highly efficacious 
against skin malignancies and squamous cell tumours. This prodrug is enzymatically 
converted to protoporphyrin IX, thus eliciting its photodynamic effect [132]. Verteporfin 
(Photofrin
®
), which was approved by FDA in 2000, is a liposome-based system 
recommended for AMD complications. Verteporfin, which was recently used to treat 
choroidal neovascularization, showed beneficial effects [133]. Foscan
® 
was approved in 
EU in 2001 for the treatment of head and neck cancers. The product contains 1-4 mg/mL 
of temporfin in an injectable dosage form [134]. In 2002, a 1:1 chlorin e6-
polyvinylpyrrolidone injectable formulation (known as Photolon
®
) was registered in 
Belarus. It was proven to be highly effective against basal cell skin cancer, breast cancer, 
Caposi‟s sarcoma, cervix and rectum cancer [135]. Tin ethyl etiopurpurin (SnET2) is a 
hydrophilic purpurin derivative, which is a degradation product of chlorophyll. It is often 
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formulated in an egg-based carrier and has shown promising PDT efficacy against 
cutaneous basal cell cancer, breast metastasis and Kaposi‟s sarcoma [136]. An aluminum 
pthalocyanine tetrasulfate has also offered excellent clinical response in naturally 
occurring veterinary tumors. Photosens
®
 (Sulfonated Aluminum Phtalocyanine) was 
approved in Russia in 2003. It showed enhanced PDT efficacy in the form of intravenous 
and aerosol formulation, particularly in the treatment of primary lung, recurrent lung, 
pharyngeal, laryngeal, and esophageal tumours [137]. Texaphyrin (Motexafin Lutetium 
or Lu-Tex) is a hydrophilic porphyrin and has been formulated for intravenous 
administration. It is an excellent singlet oxygen producer and was particularly effective 
against cutaneous metastasis for breast cancer and prostate cancer [138]. A formulation 
containing mTHPC loaded into DPPC liposomes (Foslip
®
) is currently undergoing phase 
III clinical trial and has shown promising efficiency, enhanced selectivity and reduced 
side effects [139]. HPPH, which showed improved efficacy against endobronchial lung 
cancer with minimal photosensitivity reactions, is also currently undergoing phase III 
clinical trial [140].  
1.2.8. Chlorins as promising photosensitizer 
Chlorins, which are the reduced form of porphyrins, provide better photophysical 
properties than porphyrin-based photosensitizers. The porphyrin core absorbs light of 
wavelengths that are too short for penetration to be effective in PDT modality. The 
reduction of a pyrrole double bond at the porphyrin periphery gives the chlorin core a 
high band I absorption at longer wavelengths of 650-670 nm than those of porphyrin 
band I [48]. In addition, chlorins maintain the proper photophysics needed for the 
production of singlet oxygen, namely high quantum yield, lifetime and energy                
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(≥ 94 kJ mol-1) of the triplet state. These three parameters are collectively known as 
quantum yield (ΦΔ) of singlet oxygen, which was experimentally found to be adequately 
high for chlorins. In the last decade, chlorins were actively investigated for their 
photodynamic efficacy in cancer treatment. [141]. Among the chlorins evaluated, the 
naturally occurring Ce6 is of particular interest [142]. Ce6 has shown improved efficacy, 
decreased side effects and faster clearance from the skin tissues. It also facilitates deeper 
light penetration leading to PDT-induced necrosis of the carcinoma cells. The widely-
used Ce6 derivatives are meso-tetrahydroxyphenyl chlorin (mTHPC) and monoaspartyl-
Ce6 (MACE), which were preclinically found to have optimum hydrophilic-lipophilic 
balance, thereby actuating efficient transport and permeation to the affected cells. 
1.2.9. Research gaps in photophysical aspects and formulation strategies for Ce6 
Various approaches were undertaken to improve tumour targeting and selectivity of 
chlorin-based photosensitizers, either by chemically altering the chlorin moiety or by 
incorporating a physical carrier to efficiently deliver the photosensitizer to the site of 
action. The common disadvantages of Ce6 include its poor solubility in neutral to acidic 
pH conditions, which accentuates the self-association of Ce6 molecules. These 
aggregates drastically reduce the sensitizing efficiency and therefore, Ce6 products 
susceptible to form aggregates are not considered ideal for PDT modality.  In fact, the 
aggregation factor is given much importance because of the characteristic physiology of 
the tumour microenvironment. In tumour tissue and its adjacent surroundings, the pH is 
generally reduced due to low oxygen content (hypoxia) of the affected cells [83, 121]. It 
has been reported that in most instances, the pH of the tumour cells lies between 5 to 6 
with high carbon dioxide content. Such neutral to acidic pH reduces Ce6 solubility and 
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enhances its propensity for self-association. Isakau et al. (2008) demonstrated the 
significant reduction of sensitizing ability of aggregated Ce6 molecules in relation to 
reduced quantum yield of singlet oxygen, which resulted in poor therapeutic efficacy 
after laser irradiation [135]. Chin et al. (2010) illustrated the poor activity of Ce6 
aggregates in human bladder carcionoma cell lines and chick chorio-allantoic membrane 
(CAM) model [143-145]. In the presence of the water-soluble polymer, 
polyvinylpyrrolidone (PVP), Ce6:PVP complex was formed and it exhibited manifold 
increase in sensitizing efficacy with respect to the corresponding aggregates. These 
findings necessitate the incorporation of a suitable adjuvant or modification of the chlorin 
nucleus to reduce the extent of aggregate formation. More recently, Xiao et al. (2012) 
devised chitosan-coated single-walled carbon nanotubes with conjugated Ce6, which 
exhibited high uptake by HeLa cells and low dark toxicity [146]. Lee et al. (2012) 
demonstrated the efficiency of multifunctional nanoparticles comprising poly(lactide-
coglycolide) (PLGA) coupled with Ce6, prepared by Steglitch esterification method. 
Incorporation of Fe3O4 in the nanoparticles enabled simultaneous imaging and 
phototherapy at the tumour site [147]. Park et al. (2011) reported the photodynamic 
efficacy of a water-soluble conjugate that comprised polyethyleneglycol (PEG), 
polyethyleneimine (PEI) and Ce6. Rapid internalization of these 100 nm particles with 
selective accumulation at the tumour site was observed [148]. High phototoxicity and 
enhanced uptake of Ce6 incorporated in chitosan nanogels was demonstrated in 
rheumatoid arthritis-induced mouse xenograft model by Schmitt et al. (2010) [149]. 
Taima et al. (2005) reported the synthesis of water-soluble esters of Ce6 through 
esterification with aminoalcohols. Absorption and circular dichroism spectra revealed 
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that the synthesized products were readily soluble as monomers [150]. Hydrophilic 
conjugates based on the glycosylation of chlorin nuclei were designed by Statio et al. 
(2005) and they showed a 3-fold increase in cellular uptake due to reduced aggregate 
formation [151]. Clearly, decreasing hydrophobicity of porphyrin nucleus by chemical 
conjugation or synthesis is one of more efficient ways to increase the therapeutic activity 
of Ce6 in PDT modality. However, these synthesis-based approaches are less preferred as 
they involve complicated steps with lack of reproducibility and the need for stringent new 
regulatory approvals. Similarly, physical carriers employed to deliver Ce6 such as 
polymeric nanoparticles, iron-oxide based magnetic nanoparticles, chitosan and PEI-
based hydrophilic conjugates possess their own limitations. Prolonged release from 
biodegradable polymer PLGA and chitosan could fluctuate the therapeutic efficacy in 
vivo. Furthermore, in actual PDT modality, the time gap between the dosage 
administration and laser irradiation should be accurately adjusted so as to avoid the 
inconvenience experienced by patients or human volunteers. Biodegradable synthetic 
polymers and other prolonged release polymers grossly fail these criteria. 
Polyethyleneimines are toxic to the cells and therefore, the anti-proliferative activity 
elicited by Ce6-PEI conjugates does not necessarily reflect the high therapeutic efficacy 
of the photosensitizer itself [148]. In addition, toxicities arising from inorganic-based 
nanoparticles (iron oxide, Cd-Se QDs, carbon nanotubes) are still a major concern and 
the more practical approach devoid of toxic side effects needs to be revisited. Moreover, 
due to the very small size of these nano-carriers (≤ 25 nm), they are often prone to be 
detected by RES and are subsequently eliminated from the blood stream, resulting in 
compromised photodynamic efficacy.  
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As mentioned earlier, understanding the evolution of aggregate formation and the various 
photophysical properties of the photosensitizer, which are affected by aggregation is 
important. Traditionally, the aggregation phenomenon is elucidated by differences in 
characteristic absorption and fluorescence spectral features along with parameters like 
quantum yield, fluorescence half-life and singlet oxygen generation efficiency. 
Disaggregation of Ce6 aggregates with the use of PVP was partially described by Isakau 
et al. in terms of fluorescence half-life and triplet-triplet absorption spectra [135]. 
Besides, surfactant-induced disaggregation of a chlorin analog, chlorin p6 (Cp6), has 
been reported by Dutta et al. (2006) [152]. No other studies on the disaggregation 
potential of pharmaceutical adjuvants for improved PDT efficacy of Ce6 have been 
reported. Apart from exploring suitable carriers for the delivery of Ce6 to the target site, 
investigation of agents with disaggregation ability is highly recommended because it 
could also improve drug delivery. The limited quantitative determination of aggregate to 
monomer conversion is in part due to the lack of proper computational tools. In fact, 
aggregate to monomer conversion of various photosensitizers has been illustrated only on 
the basis of qualitative estimation of spectral shifts. Likewise, disaggregation of 
porphyrin-based photosensitizers was demonstrated by red shifts in the fluorescence 
emission spectra. However, accurate quantitative determination of aggregate to monomer 
conversion is imperative as it reveals the relative disaggregation efficiencies of different 
disaggregating agents when they are incorporated in the formulations. This facilitates the 
selection of desired concentration of a disaggregating agent to be therapeutically optimal. 
Thus, a suitable computational tool to determine the underlying species of a fluorophore 
mixture (aggregate and monomer) is highly warranted.  
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The application of molecular simulation as a theoretical basis for explanation of drug-
polymer binding has gained tremendous interest in recent years. Molecular modeling 
methods are now routinely used to investigate the structure, dynamics, surface properties 
and thermodynamics of inorganic, biological and polymeric systems. The application of 
coarse grain simulations has also gained considerable interest with the availability of a 
larger time frame and a larger number of molecules to incorporate into the system [153-
155]. In many complex systems, such as dispersions of colloids and submicron drug 
carriers, the afore-mentioned simulation method has been found to be useful in such 
studies [156, 157]. Elucidation of aggregation-disaggregation of Ce6 by molecular 
simulation has yet been established. Therefore, such simulations as a visualization tool 
could greatly reinforce the understanding of the interactive system, comprising Ce6 and 
disaggregating agent, at the molecular level. 
Taking into consideration the significance of the afore-mentioned research gaps, a 
substantial research work on the selection of an effective disaggregating agents, which 
could be further used as drug carrier for Ce6 is still lacking. Since water is the most 
widely used vehicle in the preparation of pharmaceutical dosage forms, a good 
understanding of the aggregation phenomenon in aqueous medium is also necessary. An 
exploratory study on aggregation as a function of pH and concentration of Ce6 may 
elucidate the optimized conditions for delivery of monomer-rich Ce6 for better PDT 
efficacy. The photophysical changes accompanying aggregate to monomer conversion 
need to be generalized for identification of other disaggregating agents having similar 
potential. Such disaggregating agents could be used as effective drug carrier alone or in 





















2. HYPOTHESES AND OBJECTIVES 
Aggregation of chlorin e6 is a topic of interest. A good understanding of the factors that 
affect aggregate formation and use of disaggregating agents are pertinent for improved 
therapeutic efficacy of the anti-cancer drug. Conversion of aggregate to monomer and 
vice versa may be induced by variation in pH, solvent type and other accompanying 
adjuvants. A substantial reduction of therapeutic activity due to aggregate formation in a 
formulation could be precluded by suitable absorption and fluorescence-based 
characterization techniques. The exploration of commonly used pharmaceutical 
excipients as potential disaggregating agents could thus also be helpful as their non-toxic 
and compatible properties will not complicate the usability and application of the 
formulation. As mentioned previously, the interactive mechanism and changes in 
photophysical characteristics of Ce6-PVP marketed formulation have not been widely 
investigated in terms of simple spectroscopic parameters. The utilization of simple 
absorption and fluorescence spectroscopic techniques could efficiently detect the 
aggregation-disaggregation behaviour of Ce6 and facilitate the exploration of other 
potential disaggregating agents showing similar effects as polyvinylpyrrolidone. These 
technique will also enable a good understanding of the different predisposing factors and 
selection of suitable conditions to reduce the occurrence of aggregate formation. In recent 
years, sucrose-based esters have been extensively used in food industries for their low 
toxicity and biodegradability as solubilizers [158-160]. Studies had shown that 
nanosuspension preparation for enhancing drug dissolution through increasing specific 
surface area of particulates is one of the simplest approaches to overcome bioavailability 
related problems. It was thus anticipated that Ce6 could be formulated as monomers in 
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nanocarriers of sucrose ester matrix for rapid release as well as enhanced photodynamic 
activity.  
PDT is a direct and promising approach for cancer treatment with particular relevance to 
non-deeply seated tumours. Studies have shown high in vivo efficacy of chlorin- and 
porphyrin- based photosensitizers in the treatment of skin, neck and bladder cancers. 
These photosensitizers are more effective in the superficial surface layers where laser 
light can penetrate easily. As mentioned in the introduction part, the different formulation 
approaches considered for improved PDT efficacy of Ce6 possess limitations to different 
extents. Ce6 incorporated in polysaccharide-based chitosan nanogels showed improved 
phototoxicity in rheumatoid arthritis-induced mouse xenograft model [149]. However, 
the delayed release of Ce6 from chitosan-based carriers increased the time interruption 
between dosage administration and laser light irradiation, which could lead to patient 
non-compliance. Recently, anti-cancer drug-loaded alginate-based micro/nanospheres 
and hydrogel beads were shown to be promising in various forms of mucosal cancers 
[161-164]. These polysaccharide-based drug delivery systems have gained much 
attention because of their flexibility in achieving the desired drug release profile, cost 
effectiveness, broad range of physicochemical properties and high regulatory acceptance. 
Therefore, the mucoadhesive sodium alginate could be employed to encapsulate Ce6 for 
targeted delivery to the oral mucosal tumour cells. Unlike chitosan, sodium alginate is 
soluble above pH 4.0. Thus, the oral mucosal pH (pH ~ 6.4) would favour the fast release 
of Ce6 from the formulation to attain a high drug concentration for absorption. The 
incorporation of PVP with Ce6 in alginate may further enhance mucoadhesivity and Ce6 
dissolution in addition to its potential disaggregation effect. 
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Therefore, the main hypotheses of this project are: 
1. Aggregation of Ce6 can be prevented by utilization of pharmaceutical adjuvants 
such as PVP and sucrose esters.  
2. The PDT efficacy of Ce6 could be improved by incorporating the pharmaceutical 
adjuvants as disaggregating agents alone or in combination with alginate.  
3. Improved in vitro dissolution of Ce6 could be achieved by formulating Ce6 as 
nanoparticles with sucrose esters.  
4. Enhanced mucoadhesivity of Ce6 formulation could be achieved with alginate 
nanoparticles consisting of Ce6-PVP complex.  
To test the afore-mentioned hypotheses, studies were carried out to accomplish the 
following objectives: 
 Elucidation of various factors associated with aggregate formation of Ce6 and 
their effects on the characteristic features of aggregate-to-monomer conversion by 
spectroscopic techniques. 
 Study of photophysical characteristics of aggregate-to-monomer conversion of 
Ce6 in the presence of PVP and sucrose esters respectively by absorption and 
fluorescence-based techniques. 
 Determination of PDT response parameters of Ce6, such as singlet oxygen 
generation, cellular uptake and photo-toxicity to tumour cells, in the presence of 
PVP and sucrose esters respectively.  
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 Quantification of relative disaggregation efficiency of PVP and sucrose esters by 
employing suitable computational tool and optimization of their concentrations 
for in vitro studies.  
 Illustration of interactive mechanism between Ce6 and the disaggregating agents 
at the molecular level using molecular modeling and coarse grain simulation 
method.  
 Formulation preparation of Ce6-sucrose ester nanoparticles and alginate 
nanoparticles consisting of Ce6-PVP complex with the aim to increase in vitro 
dissolution and mucoadhesivity of Ce6.  
 Evaluation of the improved photodynamic efficacy of the formulations using oral 
mucosal carcinoma cells as tumour xenograft model.  
For ease of understanding the multi-disciplinary objectives of this research project, a 
schematic diagram of the different studies in relation to the thesis objectives is shown 
below: 
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Chlorin e6 (~ 98% purity, SPE Chemical Co. Ltd., Shanghai, China) was employed as the 
model drug. n-Octanol (AR grade, Sigma Aldrich, Singapore) was used in the partition 
coefficient experiments. The pharmaceutical adjuvants for disaggregation study consisted 
of polyvinylpyrrolidone of different molecular weights (PVP: K17, K25, K30; ISP 
Pharmaceuticals, NJ, USA) and sucrose esters of different alkyl chain lengths 
(laurate/myristate/palmitate; Compass Foods Pvt. Ltd., Singapore). Organic solvents (AR 
grade, Merck, Singapore) such as dichloromethane (DCM) and acetone (AC) were used 
in the preparations of the nanosuspensions. Sodium alginate (Sigma Aldrich, Singapore) 
and calcium chloride (Merck, Singapore) were employed in the production of alginate 
nanoparticles. Mucin type IS (Sigma Aldritch, Singapore) and periodic acid (MP 
Biomedicals Inc., Singapore) were used in the determination of in vitro mucoadhesivity 
of the alginate nanoparticles. Hydrochloric acid, potassium dihydrogen phosphate and 
sodium hydroxide (AR grade, Merck, Singapore) were used for the preparation of 
buffers.  
Human oral squamous carcinoma (OSC) cell line used to represent the in vitro tumour 
model was obtained from the American Type Culture Collection (Rockville, MD, USA). 
Dulbecco‟s modified eagle‟s media (DMEM) and fetal bovine serum albumin (FBS) with 
supplemented nutrients (HyClone Laboratories, Logan, UT, USA) were used as 
cultivation media for OSC cells. A trypsin-EDTA (PAA Laboratories GmbH, Somerset, 
UK) mixture was used to dislodge the OSC cells. While Penicillin-Streptomycin (PAN 
Biotech GmbH, Aidenbach, Germany) was used to prevent contamination of the cultured 
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cells. N-N'-dimethyl-p-nitrosoaniline (RNO) (MP Biomedicals Inc., Singapore) and 
histidine (Merck, Singapore) were used for the determination of singlet oxygen 
generation, while the anti-proliferative activity of different formulations were tested 
using MTT reagent (3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide) (MP 
Biomedicals Inc., Singapore). Intracellular distribution of Ce6 was evaluated with the use 
of the nucleus staining dye, DAPI (MP Biomedicals Inc., Singapore). 
3.B. Photophysical studies of Ce6 
3.B.1. Aggregation study of Ce6 in aqueous media 
3.B.1.1. Determination of Ce6 solubility at different pH 
Solubility of Ce6 was determined from acidic to alkaline pH conditions ranging from pH 
2 to pH 10 at pH interval of 2.  Buffers of different pH were prepared according to the 
USP procedure, using sodium hydroxide, potassium dihydrogen phosphate and 
phosphoric acid. Buffers of different pH and excess amounts of Ce6 were agitated in a 
shaker water-bath at 37°C for 24 hr. Ce6 concentration of the supernatant was determined 
by high performance liquid chromatography (HPLC) using C18 column (Thermo 
Electron corporation, NJ, USA) under the following conditions: mobile phase – 90 % 
methanol and 10 % PBS (phosphate buffer solution; acetic acid and potassium-di-
hydrogen phosphate, pH 4.0), detection wavelength – 405 nm, flow rate – 1 mL/min. 
Each determination was carried out in triplicate and the average Ce6 solubility at each pH 
reported. 
3.B.1.2. Determination of Ce6 partition coefficient at different pH 
The octanol/buffer partition coefficients of Ce6 were determined by the equilibration 
technique at 37°C at the pH conditions stated in section 3.B.1.1. Two mg of Ce6 was 
44 
 
added to 5 mL of 1:1 binary mixture of n-octanol and buffer prepared at different pH, and 
agitated with a vortex mixer for 5 min. The mixture was then centrifuged for 2 min at 
4000 rpm to separate the n-octanol from the buffer. Ce6 concentration in the buffer was 
determined by HPLC according to the set of parameters stated in section 3.B.1.1. Ce6 
concentration in the n-octanol was determined by subtracting the amount present in the 
buffer from the original amount of Ce6 used in the experiment. The partition coefficient 
was calculated as: 
                
𝐶       
𝐶      
                                                                                     
Mean values of partition coefficients at different pH conditions were reported from 
triplicate studies. 
3.B.1.3. Determination of spectroscopic characteristics of Ce6 at different pH 
A fixed concentration of Ce6 (50 μM) was selected for absorption and fluorescence 
studies at different pH conditions. A series of buffers with pH ranging from 1.2 to 10 was 
prepared according to the USP method as previously described. Ce6 was dissolved in   
0.1 % (w/v) NaOH solution to prepare a stock from which 30 μL was withdrawn and 
added to each of the buffers (pH 1.2 to 10) to produce a final Ce6 concentration of 50 μM 
in 5 mL. The absorption and fluorescence spectra of Ce6 in the buffers were then 
recorded using ultraviolet-visible spectrophotometer (Shimadzu, UVPC 2010, Kyoto, 
Japan) and spectrofluorimeter (Fluoromax-P, Jovin Yvon, Edison, NJ, USA) respectively. 
The absorption and fluorescence measurements were also conducted with increasing 
concentration of Ce6, ranging from 5 μM to 100 μM, at physiological pH 7.4 to 
investigate the effect of Ce6 concentration on aggregate formation.  
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3.B.1.4. Quantification of Ce6 species at different pH 
The quantification of different underlying species of Ce6 at various pH conditions was 
accomplished by excitation-emission matrix (EEM) spectroscopy. This method allows 
the accurate detection of various fluorophores present in a mixture on the basis of 
selective excitation and emission characteristics of the underlying constituents. EEM 
spectra of Ce6 (50 μM) at various pH conditions, from pH 1.2 to 10, were obtained using 
a  spectrofluorometer (Fluoromax-P, Jovin Yvon, Edison, NJ, USA) from 600 nm to 750 
nm, in 2 nm increments, at increasing excitation wavelengths from 390 nm to 690 nm, in 
5 nm increments with an excitation and emission slit width of 2 nm. The obtained spectra 
were analyzed using PARAFAC algorithm in the Matlab computational software, 
(version 7.10; Mathworks, MA, USA). The number of underlying Ce6 species (N) and 
their concentrations at different pH conditions were determined from the PARAFAC 
analysis.  
3.B.1.5. Determination of relative quantum yield of Ce6 at different pH 
Lipert‟s equation was used to calculate the fluorescence quantum yield of Ce6 at various 
pH conditions. The quantum yield (Φ1) at pH 10 was set at 1.0 and the relative quantum 
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where A is the absorbance, η is the refractive index and α is the area under the 
fluorescence emission spectra for standard (sample 1) and test (sample 2) respectively. 
All the measurements were carried out at room temperature (298 K), keeping Ce6 
46 
 
concentration very low in order to avoid self-absorption. For quantum yield 
determination, Ce6 concentration in each of the buffers was adjusted such that 
absorbance value was around 0.2 to ensure that roughly equal numbers of photons were 
absorbed. It was assumed that Ce6 existed primarily as monomers at pH 10 and exhibited 
the highest quantum yield. 
3.B.2. Disaggregation study using PVP and sucrose esters 
3.B.2.1. Preparation of test solutions for disaggregation study 
A fixed concentration of Ce6 (50 μM) was used for the disaggregation study with the 
afore-mentioned pharmaceutical adjuvants. For PVP-induced disaggregation study, 
different amounts of PVP were added to 50 μM Ce6 solution to give Ce6 to PVP ratios of 
1:10 to 1:1000. Similarly, sucrose ester concentrations ranging from well below to above 
critical micelle concentration (CMC) were employed to investigate the disaggregation 
effect of sucrose esters of different alkyl chain lengths. Briefly, the required amounts of 
sucrose esters were each added to 5 mL of 50 μM Ce6 solution to produce the varying 
concentrations of the sucrose ester below and above its CMC. In both set of studies, 
solutions were prepared at pH 5 to simulate the in vivo tumour physiological pH 
condition. The respective solutions were then placed in a bath sonicator for 5 min and 
absorption and fluorescence measurements were conducted immediately thereafter. 
3.B.2.2. Measurement of absorption and fluorescence 
The absorption and fluorescence spectra of the solutions consisting of Ce6 and varying 
concentrations of PVP and sucrose esters were recorded spectrophotometrically as 
described in section 3.B.1.3. 
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3.B.2.3. Determination of disaggregation efficiency of PVP and sucrose esters 
In order to determine the disaggregation efficiency of different grades of PVP and 
sucrose esters, EEM spectroscopic principles were further employed. It was speculated 
that the proportion of monomeric Ce6 species generated from its corresponding aggregate 
fraction by the action of the PVP or sucrose ester could be quantified on the basis of 
EEM spectral differences. EEM spectra of Ce6 in the presence of increasing 
concentration of each PVP and sucrose ester grade were obtained and analyzed according 
to the procedure described in section 3.B.1.4. 
3.B.2.4. Measurement of fluorescence anisotropy 
The steady-state fluorescence anisotropy (μ) measures the resistance to the rotational 
motion of a fluorescence molecule during its photochemical transformation from ground 
state to excited state. Therefore, changes in the fluorescence anisotropy value of Ce6 
were recorded for varying concentrations of each of the PVP and sucrose ester grades. 
The fluorescence anisotropy of Ce6 in varying concentrations of each PVP and sucrose 
ester grade was obtained using a fluorescence spectrophotometer (Fluoromax-P, Jovin 
Yvon, Edison, NJ, USA). It is calculated based on the following equation [166]: 
  
   −     
          
                                                                                                      
where IVV and IVH are the fluorescence intensities and the subscripts indicate the vertical 
(V) and horizontal (H) orientations of the excitation and emission polarizers and G is the 
instrumental correction factor. Fluorescence anisotropy was measured in triplicates and 
the average was reported. 
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3.B.2.5. Determination of Ce6-disaggregating agent binding constant  
3.B.2.5.1. Ce6-PVP system 
The binding of Ce6 with PVP was evaluated at physiological pH 7.4 with Ce6 
concentrations not exceeding 10 μM, where Ce6 molecules mostly existed in monomeric 
forms. Binding constants and the number of binding sites for different PVP grades were 
determined using a simple model based on drug-polymer binding [167].
 
The assumptions 
of this model are based on the fact that the drug molecule has similar affinity towards 
each of the monomer units comprising the polymeric macromolecule. Depending on the 
physicochemical factors like drug molecule size, molecular weight of polymer and length 
of monomer units, each drug molecule has binding ability with one or several monomer 
units. In the present study, Ce6 and PVP were designated as drug and polymer 
respectively. The fraction of Ce6 bound with PVP, i.e., x was determined from a set of 
Ce6 absorbances in a system with various concentrations of PVP, where on addition of 
PVP, free Ce6 molecules began to bind with PVP (partially) and virtually all the Ce6 
molecules were bound at a certain maximum PVP concentration employed. Linear 
superposition was applied by assuming that the Ce6 absorbance, D at a given PVP 
concentration, is a linear superposition of the absorbance of fully free and fully bound 
Ce6 molecules, D1 and D2, respectively: 
D =  x. D2 +  1 − x . D1 , 0 < 𝑥 < 1                                                                    (𝟔)  
Therefore, the concentration of PVP-bound Ce6 (CB) is given by: 
CB = x × CT =
D− D1
D2− D1
× CT                                                                                      (𝟕)      
Hence, free or unbound Ce6 (CF) is calculated as, CF = CT - CB, where CT is the total Ce6 
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concentration, which is a known quantity. Therefore, number of moles of Ce6 bound per 




                                                                                                                      (𝟖)                                                                                            
The binding constants and number of binding sites for different PVP grades were 










                                                                                                            (𝟗)                                                                               
where n (>1) is the number of binding sites per mole of monomer unit and Ka is the 
binding constant. When the ligand molecule is larger and the molecular weight of 
monomer unit is less, n is much smaller than 1, which introduces a new term P (1/n) that 
represents the number of monomer units required to constitute one binding site. The 




× 𝑛                                                                                                       ( 𝟎)                                                                                
where W and Wmono are the molecular weight of the PVP polymer and each monomer 
unit respectively.  
3.B.2.5.2. Ce6-sucrose ester system 
The association of Ce6 with each of the sucrose esters of different alkyl chain lengths 
was determined using the following equation [152]: 
A = Af + 
(Ab− A f  )
1
𝐾𝑏 ( 𝑆 0 − 𝐶𝑀𝐶 )
𝑀+ 1
                                                                                  (  )                                                                
where Af, A and Ab are absorbances of Ce6 in the absence of sucrose ester, at a certain 
sucrose ester concentration ([S]0) and at the maximum concentration of sucrose ester 
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employed. M is the number of micelles per Ce6 molecule, which was set at unity for 
simplicity, considering each micelle was ascribed for incorporation of single Ce6 
monomer into its core [152]. Absorbance was measured using a ultraviolet-visible 
spectrophotomer (UV 2010 PC, Shimadzu, Japan) at a constant slit width of 5 nm. 
3.B.2.6. Determination of Ce6-disaggregating agent binding mode 
3.A.2.6.1.  Fourier Transformed-Infrared (FT-IR) Spectroscopy  
The FT-IR spectra of pure Ce6, PVP, sucrose ester and the freeze-dried Ce6-PVP/sucrose 
ester complex were recorded for solid state characterization using a FT-IR 
spectrophotometer (IR Solutions, Shimadzu, Japan) over the range of 400-4000 cm
-1
. The 
spectra thus obtained were analyzed using the IR Solutions software. The above test 
samples were prepared as follows. Dry KBR (50 mg) was finely ground in a morter, and 
the respective test sample (5 mg) added and gently mixed. A manual press capable of 
delivering 8-10 MPa pressure was used to compress the mixture into thin pellets for 
spectroscopic measurements.  
3.A.2.6.2.  Temperature-dependent thermodynamic study 
The mode of binding between Ce6 and different grades of PVP and sucrose ester were 
further affirmed by a thermodynamic study. Briefly, the binding constant for each Ce6-
PVP/sucrose ester system was calculated at three specified temperature, 288 K, 297 K 
and 310 K. The thermodynamic parameters were calculated from Van‟t Hoff‟s equation:  






                                                                                                  (  )                                                                                         
 where Ka is the binding constant at a particular temperature while ΔH and ΔS are the 
changes in enthalpy and entropy of the system and  R is the gas constant. Binding 
51 
 
constant values obtained (employing Eq. 9 or Eq. 11) at different temperature points were 
plotted against 1/T and the thermodynamic parameters were calculated from the slope 
and intercept of the plot [168]. The free energy change (ΔG) was estimated from the 
following relationship: 
ΔG = −RTlnKa =  ΔH − TΔS                                                                            (  ) 
 
The mode of binding between Ce6 and PVP/sucrose ester was determined with the 
obtained values of ΔG, ΔH and ΔS in reference to thermodynamic standpoint.  
3.B.2.7. Theoretical simulation of Ce6-disaggregating agent system 
3.B.2.7.1. Molecular dynamics simulation of Ce6-PVP system 
Molecular dynamics simulation was performed using Hyperchem 8.0 (Hypercube Inc., 
Gainesville, FL, USA) to visualize the Ce6-PVP interaction at the molecular level. 
Repeating monomer unit of PVP was built using Polymer builder toolbox of Materials 
Studio (version 5.0; Accelrys Inc., San Diego, CA, USA) and a model PVP polymer with 
20 repeating units was generated. The Ce6 structure was constructed using Chemdraw 
software (Version 7.0, Perkin Elmer Informatics, Cambridge, MA, USA). Ce6 and PVP 
structures were then optimized using PM3 (modified Austin model) parameterization 
using Hyperchem software. The individual molecules were subjected to complete energy 
minimization in periodic boundary of dimensions 20-15-40 Å (x-y-z) containing 483 
water molecules. An AMBER force field and Polak-Ribiere conjugate gradient optimizer 
was used for the molecular dynamics simulation. In the present study, a run time of 0.6 ps 
was selected with an initial heat time of 0.1 ps to increase the temperature of the system 
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from 100 K to 300 K in 30 K steps. The free energy was calculated after the simulation 
run and molecular orientation of Ce6-PVP complex was demonstrated. 
3.B.2.7.2. Coarse grain modeling of Ce6 – sucrose ester system by dissipative 
particle dynamics (DPD) 
3.B.2.7.2.1. DPD theory 
DPD is a coarse-grain simulation technique often used to simulate complex fluid 
dynamical behaviour. A DPD bead represents a group of atoms or a volume of fluid that 
is large on the atomistic scale but still macroscopically small. In DPD simulations, a set 
of beads move according to Newton‟s equation of motion [156]: 
d𝐫𝑖
dt
= 𝐕𝑖 ,            m𝑖
𝑑𝐕𝑖
dt
=  𝐟𝑖 ,                                                                               ( 𝟒) 
where ri, vi, mi, fi are the position, velocity, mass and force of bead i, respectively. All 
bead masses are assumed to be the same and set to unity for simplicity. The force acting 
on each bead is the sum of conservative force (   
 ), dissipative force (   
 ), and random 
force (   
 ). 
𝐟𝑖 =    𝑖𝑗
C +  𝑖𝑗
D +   𝑖𝑗
R ,
𝑗≠𝑖
                                                                                (  ) 
The conservative force for non-bonded particles is defined by soft repulsion acting along 
the line of centers and given by: 
 𝑖𝑗
𝐶 =  
𝑎𝑖𝑗  1 −  𝑟𝑖𝑗  𝐫 𝑖𝑗 , (𝑟𝑖𝑗 < 1)
0, (𝑟𝑖𝑗  ≥ 1)
                                                              ( 𝟔) 




𝐫𝑖𝑗 = 𝐫𝑖 −  𝐫𝑗 , 𝐫𝑖𝑗  =   𝐫𝑖𝑗  , 𝐫 𝑖𝑗 =  𝐫𝑖𝑗  / 𝐫𝑖𝑗                                                    ( 𝟕) 
The dissipative force is regarded as a frictional force, which depends on the position and 
relative velocities of the beads, and given by: 
 




𝜍𝜔 𝑟𝑖𝑗  𝐫 𝑖𝑗 𝜁
 𝛿𝑡
,                                                                                                ( 𝟗) 
where vij = vi – vj, ζ is a random variable with zero mean and variance 1, δt is the time 
step used, the r-dependent weight function w(r) = 1 – r for r <1 and w(r) = 0 for r >1. 
3.B.2.7.2.2. Spring force 
In the DPD model, atoms of each molecule are grouped together into beads. According to 
Groot and Warren, the harmonic spring force acting among the different beads in a 
molecule is designated by the following relation [157]: 
 𝑖
S =  𝐶𝑟𝑖𝑗𝑗 ,                                                                                                         ( 𝟎)                                                                                  
where C is the spring constant, and the mean distance between two consecutive chain 
beads is governed by the spring force and repulsive interaction. In the present study, the 
default value C = 4 was used, resulting in a slightly smaller distance for bonded beads 
than non-bonded beads. 
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3.B.2.7.2.3. Simulation parameters used in DPD 
In order to calculate the conservative force, the repulsion parameter aij between any two 
beads should be calculated. The repulsion parameter between beads of same type, aii, is 




,          𝜌 = 3                                                                                    (  ) 
The compressibility of the pure fluid, ρ, is equal to 3 which is close to that of water [163]. 
kB is the Boltzmann constant and T is the temperature of the system. In this study, 
conservative interactive potential with kB = 1 was used. The repulsion parameter between 
different types of beads is given by [157]: 
𝑎𝑖𝑗 = 𝑎𝑖𝑖 + 3.27𝜒𝑖𝑗 ,        ρ = 3                                                                           (  ) 
where χij is the Flory-Huggins parameter, which could be calculated from the solubility 




(𝛿𝑖 −  𝛿𝑗 )
2,                                                                                        (  ) 
where V is the arithmetic average of molar volumes of beads i and j. δi and δj are the 
solubility parameters of beads i and j, which depend on the chemical nature of the species 
and can be obtained from molecular dynamics simulations.  
3.B.2.7.2.4. Assignment of DPD simulation parameters for disaggregation study 
In the DPD simulation, single beads were used to represent Ce6 and water respectively, 
while the surfactant molecules were designated as two (connected) beads, one 
representing the hydrophilic head and the other the hydrophobic tail end. All the 
structures were drawn and energy minimized in Chemdraw software (Perkin Elmer, NJ, 
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USA). The repulsion parameters were determined using Materials Studio 5.0 software 
(Accelrys Inc., CA, USA). Each Ce6 aggregate comprised an average of 5 beads, which 
were connected by non-rigid bonded interactions, so as make them labile in order to be 
disrupted by sucrose esters.  All the structures and sub-structures were energy minimized 
using COMPASS force field of Forcite energy minimizer. The Flory-Huggins interaction 
parameters (χij) between a pair of similar and dissimilar beads were then calculated using 
Blend toolbox of the software. DPD simulations were performed in a cubic box of 
dimension 20 x 20 x 20 (DPD units), implementing periodic boundary conditions in all 
three directions. The fraction of each of the components per system was determined from 
the molar concentrations of the beads present in the system. Dimensionless time step 0.05 
was employed with 20000 steps to obtain a steady phase at a constant temperature of   
298 K. 
3.C. Preparation of Ce6 formulation 
3.C.1. Dissolution enhancement of Ce6 by formulating into sucrose ester-
based nanosuspension 
3.C.1.1. Experimental design for the study of Ce6-sucrose ester nanosuspension 
production 
A 3 factor central composite design (CCD) was employed as it requires fewer runs to 
show the effects of the variables investigated. Using this statistical design, the effects of 
the process variables, such as the ratio of sucrose palmitate to sucrose laurate (X1), 
amount of Ce6 (X2) and ratio of dichloromethane to acetone in the solvent mixture (X3) 
were investigated over five levels. The circumscribed CCD model consisted of a total of 
17 runs with 3 center points and constructed using Design expert
®
 statistical software 
(version 7.1.3; Statease Inc., MN, USA). Table 3 shows the different independent 
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variables and their levels in the construction of the CCD model. Four different response 
variables, such as formulation particle size, zeta potential, encapsulation efficiency and 
time required for 90 % drug release, were designated as dependent variables. A statistical 
second-order model incorporating interactive and polynomial terms was used to fit the 
data (coded values): 
                           
        
        
                             
                                                                                                                                     𝟒  
where Y is the observed response for each of the dependent variables, b0, constant 
coefficient, bi and bij are the coefficients of effects of variables Xi and XiXj  respectively. 
The interaction term XiXj represents the interaction between Xi and Xj and shows how the 
response changes when the two variables are simultaneously changed. The polynomial 
terms   
  is used to evaluate the non-linearity effects of variable Xi.  
Table 3: Composition of central composite design model 
Factor  Levels used  
Independent variables -γ -1 0 1 + γ 
X1 = SEP:SEL ratio 0.11 1.91 4.55 7.2 9 
X2 = Ce6 (mg) 5 12.9 22.5 32.9 40 
X3 = DCM/AC ratio 4 1.01 2.13 3.24 0.25 
γ = Parameter which determines the location of points in CCD design  
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3.C.1.2. Preparation of Ce6-sucrose ester nanosuspension 
The nanosuspension was prepared according to a modified hot-melt emulsification 
process [169]. Required quantities of sucrose ester and Ce6 were first dissolved in 5 mL 
of solvent mixture consisting of a specified proportion of dichloromethane to acetone 
with the aid of heating at 60°C for 15 min. 15 mL of MilliQ water was also heated at the 
same temperature and slowly poured into the solvent mixture under controlled magnetic 
stirring at 60°C. The O/W emulsion formed was quickly added into a beaker containing 
40 mL of ice-cold water at 2-4°C to allow rapid solvent diffusion, hardening of the 
sucrose ester micelles and stabilization of the nano-droplets. The resultant 
nanosuspension was magnetically stirred overnight to allow complete evaporation of the 
organic solvents.   
3.C.2. Enhanced mucoadhesivity of nanoparticles by formulating Ce6-PVP 
complex in alginate-based carriers 
3.C.2.1. Experimental design for the study of alginate nanoparticles containing Ce6-
PVP complex 
The production of alginate nanoparticles consisting of Ce6-PVP complex was 
investigated by employing a 2 factor 3 level statistical design layout (Design Expert
®
, 
version 7.1.3; Statease Inc., MN, USA). Amounts of   PVP (x1) and Ce6 (x2) were 
designated as the independent variables and were varied in 3 levels. The levels for these 
two factors were determined based on the results of preliminary trials. All the 
experiments were carried out in duplicates. Nanoparticle size, encapsulation efficiency, in 
vitro mucoadhesivity and in vitro drug release were designated as dependent or response 
variables. The effects of the afore-mentioned factors on the formulation characteristics 
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were illustrated on the basis of statistically significant p-values and R
2
 values. The 
regression equation for this 3
2 
factorial design is given below: 
                                
        
                                 
where y is the dependent variable, b0 is constant and bi is the estimated coefficient for the 
factor xi. The main effects (x1 and x2) represent the average result of changing one 
variable at a time from its low to high values. The interaction term (x1 x2) shows how the 
response changes when the two factors were changed simultaneously. Table 4 
summarizes the independent variables with their levels. 
Table 4: Composition of 32 full factorial design model 
Factor Levels used 
Independent variables -1 0 1 
x1 = Ce6 (mg) 5 12.5 20 
x2 = PVP (mg) 10 55 100 
3.C.2.2. Method for preparing Ce6-PVP complex in alginate nanoparticles 
Alginate nanoparticles containing Ce6-PVP complex was prepared by a modified solvent 
diffusion-polymer gelation technique. Briefly, 50 mL of dilute sodium alginate solution 
(0.075 %, w/v) was prepared in MilliQ water and heated in a water bath at 70°C for 30 
min. The required amounts of Ce6 and PVP according to the factorial design lay out, 
were added in 2 mL of 1:1 ethanol-acetone mixture and heated to 70°C for 30 min and 
added into the alginate solution with brief sonication. 2 mL (0.3 %, w/v) CaCl2 was then 
immediately poured drop wise in the alginate solution containing Ce6-PVP mixture using 
a 19-gauge needle under controlled magnetic stirring. The nanoparticle suspension was 
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stirred for 8 hr for complete evaporation of solvent and the fresh nanoparticle suspension 
was transferred into a refrigerator at 4°C until use. 
3.D. Determination of various dependent variables of different Ce6 
formulations 
3.D.1. Particle size and zeta potential  
The mean particle size and particle size distribution of the nanoparticles of the two 
different Ce6 formulations were determined using a dynamic light scattering particle size 
analyzer (Horiba LB-500, Japan). The nanoparticle suspension was appropriately diluted 
and a suitable volume was placed in a quartz cuvette for measurements. The results 
obtained were derived from 100 laser scans of the nanoparticles in the sample. The mean 
particle size was then determined from the average of three replicates with the aid of a 
particle size analysis software attached to the equipment.  
The zeta potential of the corresponding Ce6 nanoparticles was measured using a zetasizer 
(Malvern Nano-ZS90, UK). The nanosuspension was appropriately diluted and a suitable 
volume was placed in a cuvette for measurement at 25°C. The zeta potential was derived 
from 6 scans of the sample and the average value obtained from three replicates was 
reported. 
3.D.2. Encapsulation efficiency 
Different procedures were employed to calculate the amount of Ce6 encapsulated in 
sucrose ester and calcium alginate nanoparticles respectively. Freshly prepared Ce6-
sucrose ester nanosuspension was centrifuged at 5000 rpm for 5 min (Beckman, CA, 
USA) to isolate undissolved materials. The supernatant consisting of encapsulated Ce6 
was collected for analysis. 0.1 mL of the supernatant was diluted to 2 mL using methanol 
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to ensure that the sucrose ester with Ce6 was fully dissolved. The Ce6 content was then 
determined by HPLC under the following conditions: column – C18 (Thermo Electron 
corporation, NJ, USA), mobile phase – 20 % PBS (acetic acid and potassium-di-
hydrogen phosphate, pH 4.0) with 80 % methanol for 15 min; 10 % PBS with 90 % 
methanol for 15-23 min; 50 % MilliQ water with 50 % methanol for 23-30 min, flow rate 
– 1 mL/min, detection wavelength – 405 nm. The encapsulation efficiency of Ce6 was 
calculated from the average of five replicates according to the following equation: 
    
     
    
                                                                                                   𝟔                                                               
where Ce6NS and Ce6T are the amount of encapsulated Ce6 present in the total volume of 
nanosuspension and total amount of Ce6 used in the preparation respectively.   
Freshly prepared suspension of alginate nanoparticles (containing Ce6-PVP complex) 
was centrifuged at 20000 rpm for 30 min. The clear supernatant was separated from the 
pellet composed of alginate nanoparticles. The Ce6 concentration of the supernatant was 
determined by HPLC according to the experimental conditions stated in section 3.B.1.1. 
The encapsulation efficiency was calculated as follows: 
     
                    −                             
                    
             
                                                                                                                                     𝟕      
The encapsulation efficiency was determined in triplicate and the average was reported. 
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3.D.3. In vitro release of Ce6 
In vitro release study of Ce6 from the sucrose ester nanosuspension and alginate 
nanoparticles was carried out in a USP paddle type II dissolution apparatus (Distek 
2100C, USA) at 37°C. Sucrose ester nanosuspension consisting of 5 mg of Ce6 was 
placed in a dialysis bag (M.W. cut off 14000, Spectrum Medical Industries Inc., 
Singapore), which was then immersed in 500 mL of dissolution medium agitated at 100 
rpm. The dissolution medium was composed of acidic buffer (pH 1.2) in the first 2 hr, 
and its pH adjusted to 6.8 thereafter using 3 M trisodium phosphate. Samples of 5 mL 
were withdrawn at regular time intervals and replaced with an equal volume of fresh 
dissolution medium. The amount of Ce6 released in the dissolution medium was 
determined by HPLC as described in section 3.D.2. For alginate nanoparticles, the 
suspension was first centrifuged at 20000 rpm for 30 min to collect the pellet composed 
of the nanoparticles.  The pellet, equivalent to 5 mg of Ce6, was diluted with 5 mL of 
MiliiQ water and introduced into a dialysis bag (M.W. cut off 14000 Da), which was then 
immersed in 400 mL of dissolution medium maintained at pH 6.2 to simulate the in vitro 
oral mucosal pH. Samples of 5 mL were withdrawn at regular time intervals and replaced 
with an equal volume of fresh dissolution medium. The amount of Ce6 released into the 
dissolution medium was assayed by HPLC equipped with the C18 column under the 
following conditions: mobile phase – 90 % methanol and 10 % PBS buffer (acetic acid 
and potassium-di-hydrogen phosphate, pH 4.0), detection wavelength – 405 nm, flow rate 
–  1 mL/min. The dissolution test was carried out in triplicate. 
Ce6 release from the polymeric alginate nanoparticles was appropriately modeled 
employing  conventional  dissolution  modeling  approaches and  the theoretical  basis of  
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drug release was discussed. 
3.D.4. In vitro mucoadhesivity of alginate nanoparticles consisting Ce6-PVP 
complex 
The method reported by Lee et al. for the determination of in vitro mucoadhesivity of a 
formulation was employed with little modification [170]. In the experiment, the t50 values 
of the various test formulations were first calculated from their in vitro release data. The 
bulk pellet obtained after centrifugation of alginate nanoparticle suspension was dried at 
room temperature, and from this approximately 10 mg of alginate nanoparticles was 
mixed with type I-S mucin solution (4 mg/mL) at pH 6.2. The mixture was then 
incubated for the corresponding t50 time period at 37˚C. This established the assumption 
that the mucoadhesivity of the formulation was attributed to the alginate polymer and the 
Ce6-PVP complex on equal weightage. The undissolved 50 % of the nanoparticles and 
the 50 % Ce6-PVP complex released would bind to the mucin in the mixture. The mucin 
bound by the alginate nanoparticles and Ce6-PVP complex were isolated by centrifuging 
the mixture at 20000 rpm for 10 min and the free mucin present in the supernatant was 
assayed by a colorimetric method using periodic acid and Schiff‟s reagent. The latter was 
prepared by diluting p-nitrosoaniline solution (40 gm/L in 2 M HCl) with water to give a 
final concentration of 1.0 %. Sodium bisulfate (80 mg) was added to 5 mL of Schiff‟s 
reagent and the resultant solution was incubated at 37°C until it became pale yellow. 
Periodic acid solution was freshly prepared by adding 10 µL of 50 % periodic acid to      
7 mL of 7 % acetic acid. 100 µL of periodic acid solution was added to the supernatant, 
which was incubated for 2 hr at 37°C. 100 µL of the pre-treated Schiff‟s reagent was then 
added and absorbance of the mixture was measured at 560 nm after 30 min. The 
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percentage of mucin adsorbed by alginate nanoparticles (Mucinad) was calculated 
according to the following equation: 
𝑀𝑢𝑐𝑖𝑛   
             
      
                                                                          𝟖                                         
where MucinS and MucinT are the amount of mucin present in the supernatant and total 
amount of mucin used in experiment, respectively. The experiment was carried out in 
triplicate.         
3.E. Response surface optimization and statistical analysis 
The Ce6 formulations were optimized with the aid of three dimensional response surface 
plots constructed from the experimental data obtained. The effect of independent 
variables on the responses was calculated by ANOVA through Fisher‟s test. The p-value 
less than 0.05 was considered to be statistically significant. To evaluate the fitness of 
second-order polynomial equation, determination coefficient (R
2
) and adjusted R
2 
were 
employed as quality indicators. All responses observed were fitted to linear, second-order 
and quadratic models, and were evaluated in terms of statistically significant coefficients, 
p-value and R
2
 values. The three dimensional surface plots were used to demonstrate the 
relationship and interaction between the coded variables and the responses. Response 
surface optimization was carried out based on the assigned values of the dependent 
variables, which were selected according to the desired characteristics of the optimized 
formulation. A few theoretical solutions along with the resultant experimental values of 
dependent variables were generated to achieve the desired optimized formulation. 
Experimental responses were then compared with that of the theoretical responses 
assigned for RSM optimization. Predicted error which is the difference between the 
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experimental value and the predicted value per predicted value was calculated for 
validation of the experimental design. Predicted error less than 5 % has generally been 
recommended for full statistical validation. 
3.F. Characterization of optimized Ce6 nanoparticles of different 
formulations 
3.F.1. Transmission electron microscopy 
The morphology of Ce6 nanoparticles was visualized by transmission electron 
microscopy (TEM). The diluted nanoparticle suspension was applied onto carbon coated 
copper grids for TEM observation. Excess liquid was blotted out and the samples on the 
grids were allowed to dry at room temperatures for 24 hr. Photomicrographs were 
obtained using a transmission electronic microscope (JEOL JEM 2010, NJ, USA) 
operated at 200 kV. 
The various solid state characteristics of the optimized Ce6 nanoparticle formulations 
were demonstrated by the following studies.  
3.F.2. FT-IR spectroscopy 
FT-IR spectra of pure Ce6, formulation components (sucrose esters/PVP and alginate) 
and the freeze-dried nanoparticle suspension of different optimized formulations were 
recorded using a FT-IR spectrophotometer (IR Solutions, Shimadzu, Japan) according to 
the method described in section 3.B.2.6. Efficient encapsulation of Ce6 and calcium 
alginate complex formation was inferred from the obtained spectra. 
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3.F.3. Differential Scanning Calorimetry 
DSC thermograms of pure Ce6, formulation components (sucrose esters/PVP and 
alginate) and the freeze-dried nanoparticle suspension of different optimized formulations 
were obtained using a DSC instrument (TA60, Waters LLC, USA). Aluminium pan was 
used as reference cell. The temperature was varied from 25-300°C with a heating rate of 
8°C per min under nitrogen atmosphere. Improved formulation characteristics such as 
efficient encapsulation or crystalline to amorphous transformation of Ce6 were deduced 
from the obtained thermograms. 
3.F.4. X-ray diffraction  
Powder x-ray diffractograms of pure Ce6, mixture of Ce6 and formulation components 
(sucrose esters) and the freeze-dried nanoparticle suspension of different optimized 
formulations were obtained using an x-ray diffractometer (X‟Pert PRO MPD, Singapore) 
under the following measurement conditions: source – nickel filter Cu anode tube, 
wavelength – 1.54 Å, voltage – 30 kV, current – 15 mA, scan speed – 2° per min. 
Improved formulation characteristics such as efficient encapsulation or crystalline to 
amorphous transformation of Ce6 were extrapolated from the obtained diffractograms. 
3.G. Evaluation of in vitro PDT efficacy of Ce6 formulations 
In vitro PDT efficacy of optimized Ce6-sucrose ester nanosuspension and alginate 
nanoparticles consisting of Ce6-PVP complex, as well as the Ce6-disaggregating agent 
mixtures, was evaluated. The different response parameters for PDT efficacy were extent 
of singlet oxygen generation, intracellular uptake and cell cytotoxicity. 
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3.G.1. Singlet oxygen generation efficiency 
The singlet oxygen generation was determined using RNO as singlet oxygen sensor and 
histidine as imidazole sensing group to trap singlet oxygen. Briefly, 100 µL of 250 µM 
RNO in distilled water and 300 µL of 30 µM histidine in distilled water were mixed 
together (Mixture A) in a quartz cuvette [171]. Free Ce6 and different Ce6-
disaggregating agent solutions containing 1 µg of Ce6 were each mixed with 700 µL of 
distilled water containing 1 % DMSO. The resultant solution was combined with Mixture 
A in the quartz cuvette and bubbled with oxygen for 10 min. It was then irradiated with 
laser light (655 nm, 30 mW/cm
2
) for 30 min. In the presence of oxygen, the labile nitroso 
group of RNO is converted to the stable nitro group, which is detected by decrease in 
RNO absorbance at a wavelength of 440 nm. Therefore, the extent of singlet oxygen 
generation was determined by monitoring the decrease in RNO absorbance every 2 min 
as a function of time up to 30 min. The singlet oxygen generation efficiency for different 
concentrations of PVP/sucrose ester was expressed in terms of proportional decrease in 
RNO absorbance over 30 min. For determination of extent of singlet oxygen production 
from the nanoparticle formulations, similar procedure was employed with little 
modification. Briefly, the nanoparticle formulations equivalent to 0.1 mg of Ce6 was 
dissolved in 10 mL of PBS (pH 6.8) and continuously stirred and then 700 μL from this 
solution was added to 300 μL of Mixture A in the quartz cuvette at different time 
intervals (30, 60, 120 min) and the afore-mentioned procedure for quantification was 




3.G.2. Uptake of Ce6 nanoparticle formulations by OSC cells  
OSC cells (100,000 cells/mL) were seeded into each well of the 12-well plate (Cellstar
®
; 
Greiner Bio-one GmbH, Frickenhaussen, Germany), which was incubated in a 
humidified atmosphere containing 5 % CO2 at 37°C for 24 hr. The cell culture medium 
was then replaced with fresh medium without fetal bovine serum, followed by the 
addition of nanoparticle formulation equivalent to 10 µg/mL Ce6. In order to investigate 
the effect of Ce6 aggregation on cellular uptake, solutions consisting of Ce6 with/without 
disaggregating agent (prepared at pH 5.0) were also tested. The cells were incubated with 
the samples for different time periods, ranging from 4 to 8, 12 and 24 hr. After the 
respective incubation period, the cells were washed thrice with cold PBS (4°C, pH 7.4, 
10 mM) and then lysed by incubating with 0.5 mL of 0.5 % Triton-X solution for 1 hr. To 
determine the level of cellular uptake of Ce6 from the various samples, 1.5 mL of 
methanol was added to the lysate sample and vortexed for 1 min. The methanol phase 
was then isolated by centrifuging the mixture at 4000 rpm for 5 min at room temperature. 
Suitable dilutions were prepared to determine the Ce6 concentration by HPLC (LC 
solutions Shimadzu, Japan) under the following conditions: Column – C18, Mobile phase 
– 80 % methanol and 20% distilled water for 15 min; 70 % methanol, 20 % distilled 
water and 10 % PBS (acetic acid and potassium-di-hydrogen phosphate, pH 4.0) for 15-
23 min; 50 % methanol and 50% distilled water for 23-30 min, Detection wavelength – 




3.G.3. In vitro phototoxicity 
OSC cells were seeded in 96-well plates at a density of 6 x 10
3
 cells per well and 
incubated in DMEM medium for 24 hr at 37°C in a 5 % CO2 humidified incubator. The 
culture medium was then removed and replaced with 100 µL of fresh medium without 
fetal serum albumin followed by the addition of nanoparticle formulation or Ce6-
PVP/sucrose ester mixture equivalent to 5 µg/mL of Ce6. Wells filled with only DMEM 
represented the blank.  After another 24 hr of incubation, 10 µL of MTT solution (5 
mg/mL in sterile PBS) was added to each well. The plate was further incubated for 4 hr. 
The mixture in each well was then removed and 100 µL of DMSO was added and shaken 
at 100 rpm for 30 min. Absorbance of the contents in each well was measured using a 
multi-plate reader (itecan M200, Mannedorf, Switzerland) at 590 nm. The percent 
proliferation (%) of the OSC cells was calculated as follows: 
 𝑒𝑟𝑐𝑒𝑛𝑡  𝑟𝑜𝑙𝑖𝑓𝑒𝑟𝑎𝑡𝑖𝑜𝑛  
𝑠𝑎𝑚𝑝𝑙𝑒 𝑟𝑒𝑎𝑑𝑖𝑛𝑔 − 𝑏𝑙𝑎𝑛𝑘 𝑟𝑒𝑎𝑑𝑖𝑛𝑔
𝑐𝑜𝑛𝑡𝑟𝑜𝑙 𝑟𝑒𝑎𝑑𝑖𝑛𝑔 − 𝑏𝑙𝑎𝑛𝑘 𝑟𝑒𝑎𝑑𝑖𝑛𝑔
               
                                                                                                               𝟗   
The percent cell inhibition was obtained by subtracting the percent proliferation from 
100. The control represents the wells, which only consisted of incubating media (DMEM) 
and MTT solution. A plot of percent cell inhibition was constructed for varying 
PVP/sucrose ester or Ce6 concentrations and the IC50 (inhibitory concentration for 50 % 
cell population) value was derived from the plot.  
3.G.4. Confocal laser scanning microscopy 
Gelatin-coated cover slip was placed in each well of a 12-well plate. OSC cells were 
introduced on to the cover slip and allowed to grow for 24 hr under normal cell culture 
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conditions as mentioned previously. 0.5 mL of optimized Ce6 formulation consisting of 2 
µg of Ce6 per mL was added to each well, followed by 0.5 mL of serum free DMEM 
medium. The cells were further incubated for predetermined time periods (1, 4, 8 hr). The 
medium was then removed and the cells washed thrice with ice cold PBS (pH 6.8). 500 
µL of 3 % paraformaldehyde (PFA) was added in each well to fix the cells. After 20 min, 
PFA was removed and the cells were washed thrice with PBS buffer (pH 6.8). 200 µL of 
500 nM DAPI solution was then added to stain the cells. After 20 min, the DAPI solution 
was washed off and the cover slip was removed from the well. It was then placed on to a 
slide with 1:1 glycerol-water mixture (40 μL) as the mounting medium for microscopic 
examination. Intracellular distribution of Ce6 was visualized using a confocal laser 
microscope (FV10i, Olympus, USA). Images were taken after selective excitation of 
DAPI and Ce6 using a DAPI (λx = 380 nm, λm = 450 nm) and Cy5.5 (λx = 400 nm, λm = 
650 nm) filter set.  
3.H. Statistical analysis of data 
Independent sample t-test was performed for comparison of two sample means. One-way 
analysis of variance (ANOVA) was performed when more than two sample means were 
required. The correlation between two different sets of data was assessed using the square 
of the Pearson correlation coefficient (R
2
). The statistical analysis of these data was 








































4. RESULTS AND DISCUSSION 
4.A.1. Elucidation of photophysical properties of aggregated Ce6 in aqueous 
media 
4.A.1.1. Overview 
Investigation of aggregate formation is an important consideration. A good understanding 
of the influence of the aggregation mechanism on the photophysical parameters of Ce6 
allows the use of these parameters in characterizing the extent of Ce6 aggregation in a 
system. As discussed in the introduction, extensive aggregation of Ce6 in aqueous media 
was observed and considering the importance of water as a vehicle in pharmaceutical 
preparation, the aggregation phenomenon of Ce6 in water needed to be investigated.  
This section discusses the investigations by spectroscopic studies of aqueous solutions of 
Ce6 as a function of pH and concentration.  
4.A.1.2. Effect of pH on Ce6 solubility and partition coefficient 
Ce6 solubility at different pH was investigated by equilibrating the respective buffers 
with excess Ce6 in a shaker water bath at 37°C for 24 hr. Figure 6 shows the relationship 
between Ce6 solubility and pH of the medium. Clearly, solubility of Ce6 was relatively 
low in the acidic to near-neutral pH conditions, as observed from pH 2 to pH 6. However, 
a more than 8-fold increase in solubility was observed in the alkaline pH region. It has 
been reported that the strong hydrophobic manifestations in the acidic pH conditions 
provide the main driving force for self-association of porphyrin photosensitizers to form 
aggregates [135]. Significant increment in solubility in the alkaline pH suggests possible 
reduction in extent of aggregate formation. NMR spectroscopic findings from earlier 
work showed that the ionization of peripheral carboxylic groups was initiated above     
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pH 8, which accounted for the increased solubility when the pH was increased [172]. 
Therefore, in order to examine if hydrophobicity is the major contributor to aggregation, 
partition coefficients of Ce6 at the different pH conditions were determined. A 4-fold 
decrease in partition coefficient was found when pH was increased from pH 2 to pH 10. 
The decrease in partition coefficient in the alkaline pH suggests that as pH increased, 
much higher amount of Ce6 partitioned into PBS than into the octanol phase. The 
reduction in affinity of Ce6 for the lipophilic octanol phase ascertains the increase in 
hydrophilicity of the Ce6 microenvironment, which leads to the disruption of aggregates 
and predominance of Ce6 monomers in the alkaline pH conditions. The ionization and 
hydrophilicity  of  Ce6  is  important  as  it aids  in  the  solubility  and  promotion  of  
 
Figure 6: Effect of pH on solubility and octanol/buffer partition coefficient of Ce6 (n = 3). 





















































aggregate-free monomerized form of Ce6. The steep reduction in partition coefficient 
which tends to level off from about pH 8 suggests that almost complete ionization and 
monomerization of Ce6 occurred at around this pH condition. 
4.A.1.3. Effect of pH on absorption and fluorescence spectra of Ce6 
The influence of pH on Ce6 aggregation was investigated over a pH range of 1.2 to 10 
with 50 μM Ce6, which was reported to be a moderate concentration in previous studies 
[135, 173]. This concentration was also within the range above which self-absorption or 
scattering was observed in the absorption and fluorescence spectra, respectively. The 
absorbance spectra of Ce6 under the specified pH conditions are shown in Figure 7. 
Preliminary studies suggested that a strong Soret band (at about 400 nm) and less intense 
Q band (in the visible region of 650-700 nm) were characteristic absorption peaks of Ce6. 
These features are similar to those observed for analogues of porphyrins. As the 
ionization of three peripheral carboxylic acid groups took place in the alkaline pH 
conditions, it was hypothesized that the unionized carboxylic groups formed 
intermolecular H-bonds and facilitated aggregate formation in the acidic to near-neutral 
pH conditions. Figure 7 shows the spectral shifts in Soret and Q bands over the pH range 
of 1.2 to 10. The wavelengths of the absorption maxima (λmax) for the Soret and Q bands 
in water (pH 6.8) were found to be 404 nm and 653 nm respectively, (Figure 7a and 7c). 
On increasing the pH from 6.8 to 10, the λmax for both the Soret and Q bands were 
unaffected but their absorbance values significantly increased. Interestingly, significant 
spectral changes were observed for both Soret and Q bands when the pH was varied from 
6.8 to about 1.2. Soret band exhibited a red shift from 404 nm to 409 nm while the Q 




Figure 7: Absorbance of (a) Soret band (pH, a to l = 1.2 to 10) and Q band in (b) acidic and (c) 






 (peak 2). The intensity also generally decreased on decreasing the pH of the solution 
(Figure 7a and 7b). Interestingly, a less broadened Q band devoid of any hump at pH 1.2 
was observed, which implied reduced aggregation state of Ce6. At very low pH, the 
imino nitrogens in the pyrrole ring of porphyrin nucleus were protonated, which could 
result in repulsion of adjacent Ce6 molecule, thereby dispersing the Ce6 aggregates 
[174].
 
From the corresponding fluorescence spectrum, the wavelength of maximum 
emission (λem) was obtained at 656 nm with an excitation wavelength of 405 nm      
(Figure 8a). On increasing the pH from 6.8 to 10, λem remained the same at 656 nm but 
the fluorescence intensity increased significantly. The fluorescence emission peak 
maxima exhibited a blue shift from 656 nm to 644 nm when the pH was decreased from 
6.8 to 3.0. Further decrease in pH to 1.2 shifted the λem to 651 nm. Nonetheless, 
fluorescence intensity gradually decreased with decreasing pH in the pH range 6 to 2. A 
blue shift implies a hydrophobic environment, thus concluding that the aggregates 
preferentially existed in the acidic pH condition. 
In order to determine how the fractions of aggregate and monomers of Ce6 varied under 
different pH conditions, EEM spectroscopic principles were applied. This trilinear model 
had facilitated the accurate determination of various fluorophores present in a mixture of 
sample. This was achieved by collecting the emission spectra at a number of excitation 
wavelengths, followed by the use of advanced multivariate deconvolution technique. The 
PARAFAC algorithm is typically used for deconvolution purpose. The technique 




Figure 8: (a) effect of pH on fluorescence emission spectra of Ce6 (pH, a to g = 1.2 to 6.0, h to l 
= 6.8 to 10.0); (b) fraction of different species of Ce6 present in the pH range 1.2 to 10 (n = 3). 
































































 where ri,j,k represents the measured response of the kth sample at the ith excitation and jth 
emission wavelengths. In this study, each kth slice of the trilinear data cube R represents 
one EEM fluorescence spectrum in a series of samples and has the dimensions of I, J, 
where I is the number of excitation wavelengths and J is the number of emission 
wavelengths. The number of factors, N, chosen to model the system, is defined by the 
user [175, 176]. Generally, the predicted N value meets the actual number of species 
when the correlation coefficient is close to unity.  
In the present study, when the N value was taken as 2 in the PARAFAC analysis, the 
highest correlation coefficient (98.2 %) was attained, suggesting aggregate and monomer 
fractions could be the only possible species present from pH 1.2 to 10. As can be seen 
from Figure 8(b), the corresponding aggregate and monomer fractions of Ce6 followed a 
reversible trend. Aggregate fraction predominated in the acidic to neutral pH range, while 
monomer fraction significantly increased in the alkaline pH range. Closer examination 
revealed that the decrease in aggregate fraction and the corresponding increase in 
monomer fraction from pH 6.8 to 10 was statistically significant (p = 0.02). This further 
confirmed the preferential existence of aggregates under acidic pH conditions.  
Thus, from the above findings, the aggregation of Ce6 could be rationalized to occur in 
the pH range of 2 to 6, which showed characteristic changes in the uv-vis and 
fluorescence spectra. From the fluorescence emission spectra, the Ce6 species in the 
acidic pH (pH 2 to 6) differed from those found in the near neutral to alkaline pH. The 
fluorescence spectra of Ce6 aggregates in the acidic pH region showed a blue shift with 
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reduced fluorescence emission intensity as pH decreased. The corresponding absorption 
spectra of Ce6 exhibited a blue shift with broadened Q band, illustrating specific features 
of aggregation. The quantification of aggregate and monomer fractions using EEM 
spectroscopy further confirmed the evidence of aggregate formation in the afore-
mentioned pH range. These observations corroborated earlier findings that Ce6 existed in 
two different forms, predominantly as aggregates in acidic pH and monomeric form in 
alkaline pH [177]. 
4.A.1.4. Effect of pH on Ce6 quantum yield 
Studies conducted by Isakau et al. showed that Ce6-PVP complexes had higher quantum 
yield than Ce6 aggregates [135]. Thus, it would be interesting to investigate if pH had 
any influence on the quantum yield of Ce6. In present study, relative quantum yield 
measurements were determined as it is a simple approach that did not require any 
standard dye. The quantum yield of Ce6 in pH 10 was assumed to be the highest possible 
and therefore assigned a value of unity. The relative quantum yields of Ce6 in other pH 
solutions were subsequently calculated using Eq. (4). Figure 9 shows the relative 
quantum yields of Ce6 in media of different pH conditions. The quantum yield increased 
significantly from pH 2 to 6, followed by a steep increase above pH 6.  It has been 
reported that a reduction in quantum yield could be caused by a nonspontaneous excited 
state transformation resulting from decrease in singlet oxygen generation [178]. Hence, it 
could be inferred that the aggregated Ce6 molecules drastically reduced the quantum 
yield values with a subsequent decrease in the sensitizing efficacy. The influence of pH 




Figure 9: Effect of pH on relative quantum yield of Ce6 (n = 3). 
4.A.1.5. Effect of Ce6 concentration on aggregate formation 
In addition to the above, it is important to investigate whether aggregation was dependent 
on the concentration of Ce6. If aggregation is concentration-dependent, this concentration 
effect has to be considered in the estimation of Ce6 needed for generation of the desired 
photodynamic activity. Figure 10 shows the absorption and fluorescence spectra of Ce6 
at concentrations ranging from 5 µM to 100 µM in buffer of pH 7.4. It was rationalized 
that pH 7.4 did not promote aggregation and a larger proportion of the Ce6 existed as 
monomers. Therefore, any effect of Ce6 concentration on aggregation would be more 
clearly seen. Besides, Ce6 will be exposed to the physiological pH of 7.4 when 
administered in vivo.  The absorption spectra showed a narrow Q band at 673 nm, 
suggesting the existence of monomer-rich Ce6 at pH 7.4. Figure 10(b) shows the 
corresponding fluorescence spectra with λem at 656 nm. The emission wavelength did not 

























Standard:Ce6 solution at pH 10
Test: Ce6 solutions at other pH
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exhibit any spectral shift on gradual increase of Ce6 concentration. In order to determine 
whether the  proportion  of  aggregate  species  increased  with increase in  concentration,  
 
Figure 10: (a) absorption and corresponding (b) fluorescence spectra of Ce6 at pH 7.4 ( a to e = 
5 μM to 100 μM). 























































PARAFAC analysis was conducted by collecting the EEM spectra at various Ce6 
concentrations from 5 µM to 100 µM. Figure 11 shows that the monomeric form 
predominated over the concentration range with insignificant increase in aggregate 
proportion (p value = 0.18). The concentration of aggregates slightly increased with 
increasing concentration of Ce6 used but the monomer to aggregate fraction ratio was 
fairly constant (ratio = 8.8-12.1).  Thus, with the set of concentration range and pH, it 
was concluded that aggregation was independent of concentration. Instead, aggregation 
was largely affected by pH through its effect on the extent of ionization of the peripheral 
carboxylic acid groups.  
 
Figure 11: Fraction of different species present in varying Ce6 concentrations from 5 μM to 100 

























The studies in this section showed the important aspects of aggregation of Ce6 and the 
effects of aggregation on the photophysical properties of Ce6. Solubility and partition 
coefficient measurements showed that Ce6 had remained in highly hydrophobic state in 
acidic pH conditions; however, its hydrophobicity decreased significantly in alkaline pH, 
which could be ascribed to ionization of the hydrophilic carboxylic moieties. Aggregation 
was not affected by Ce6 concentration in the range of 5 μM to 100 μM, studied at 
physiological pH. The spectroscopic findings suggested that the aggregation was a 
largely pH-dependent phenomenon, where ionization in the alkaline pH aided in 














4.A.2. Utilization of PVP for disaggregation of Ce6 aggregates 
4.A.2.1. Overview 
This section demonstrates the useful application of PVP in solubilizing the Ce6 
aggregates. PVP is a common excipient used in formulations to enhance solubility [179]. 
PVP has been reported to induce disaggregation of Ce6 aggregates. However, the effects 
of PVP of different molecular weights on the photophysical properties of disaggregated 
Ce6 species has been lacking. In this study, different grades of PVP were used to 
investigate the changes in photophysical properties of Ce6 in relation to disaggregation 
by the use of simple spectroscopic techniques. The relative disaggregation potentials of 
different grades of PVP were then determined by EEM spectroscopic methods. The 
interactive mechanism of complex formation was demonstrated using thermodynamic 
studies and theoretical molecular dynamic simulation. 
4.A.2.2. Effect of PVP on absorption and fluorescence spectra of Ce6 
Three different PVP grades, K17, K25 and K30, were used for the disaggregation studies. 
From the earlier study on media pH, the extent of aggregation was mainly observed for 
pH below 6. Hence, the effect of PVP K25 on the Ce6 aggregates was first investigated in 
the acidic pH range. The changes in both fluorescence intensity and fluorescence 
anisotropy over pH 2 to 6 followed similar trends, suggesting that the use of any pH 
condition within pH 2 to 6 for comparison of disaggregation effects of different PVP 
grades would be acceptable. This led to the investigation of the other two grades of PVP 
at pH 5 only. This pH value was chosen for study based on the consideration that the pH 
of the tumour microenvironment generally lies between pH 5-6. Figure 12(a) shows the 
absorption spectra of Ce6 with increasing concentrations of PVP. The absorbance values 
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of both Soret and Q bands increased with the concentration of PVP, which suggested 
increasing hydrophilicity  of  the  Ce6-PVP  complex. Close examination of Q  band  
 
Figure 12: (a) absorption spectra of Ce6 and (b) close view of Q band with increasing PVP 
concentrations at pH 5.0 (a to h = PVP:Ce6 ratio, 10:1 to 1000:1). 






















































revealed 2 peaks: peak 1 (λmax at 642 nm) and peak 2 (λmax at 673 nm). Interestingly, peak 
2 became more prominent with the addition of PVP K25 (Figure 12b). The absorbance of 
peak 1 remained relatively constant, whereas the absorbance of peak 2 gradually 
increased as the PVP to Ce6 ratio changed from 10:1 to 1000:1. The evolution of 
characteristic peak 2 in the presence of PVP indicated its disaggregation effect on Ce6. 
Isosbestic point, the intersection point of one upward and another downward curve of two 
species where one species is converted to another, was also clearly observed in Ce6 
spectra in presence of PVP. The isosbestic points observed in Q band on addition of PVP 
clearly demonstrated an aggregate-to-monomer equilibrium in the Ce6-PVP system. The 
concomitant increase in A673/A642 ratio intensity with increasing PVP:Ce6 ratio from 0 to 
100 is consistent throughout the pH range of 2 to 6. Figure 13(b) shows the variation of 
A673/A642 with PVP:Ce6 ratio for all the PVP grades at pH 5. A sharp increase in 
A673/A642 was observed when PVP:Ce6 ratio was increased from 0 to about 100. Further 
increase in PVP:Ce6 ratio resulted in more gradual rise in A673/A642. Since the absorbance 
of A642 was constant and A673 kept increasing with increasing PVP concentrations, the 
gradual rise in A673/A642 up to PVP:Ce6 ratio of about 100 translated to the fact that 
significant monomerization of Ce6 aggregates was mostly achieved at that PVP 
concentration. Further increase in PVP concentration resulted in complete 
monomerization of the remaining aggregates at a PVP to Ce6 ratio of 1000 as indicated 
by no further increase in absorbance values. This is an important observation and it could 





Figure 13: Effect of (a) pH and (b) PVP molecular weights on the ratio of absorbance between 
673 nm and 642 nm. 
The fluorescence emission spectra of Ce6 for various Ce6:PVP K25 ratios at pH 5 are 
shown in Figure14(a). Two interesting observations were noted here. Firstly, on addition 

















































































































































































































































































































of PVP, fluorescence intensity decreased and the emission spectrum exhibited a 
bathochromic shift. At a moderate PVP:Ce6 ratio (100:1), two emission peaks were 
observed, with one peak at 645 nm and another at 665 nm when excitation wavelength 
was set at 405 nm. On further addition of PVP, the peak at 645 nm gradually diminished 
and at a very high PVP concentration (PVP:Ce6 ratio of 500:1), only one intense peak 
was observed at 672 nm. No further change in peak position occurred when PVP:Ce6 
 
Figure 14: (a) Emission spectra of Ce6 for varying Ce6:PVP K25 ratios (b to h, = 1:10 to 
1:1000), (b) to (d) amounts of different Ce6 species present at varying Ce6:PVP ratios for 










































































































ratio was further increased to 1000, implying all the Ce6 molecules were eventually 
converted to monomers. Similar spectral changes were also observed with PVP K17 and 
K30 (figure not shown). A quenching-like effect was observed as the fluorescence 
intensity of Ce6 was found to decrease in the presence of PVP. However, PVP was found 
to be non-fluorescent when excited in the range 250-600 nm, suggesting the triplet state 
attainment of Ce6 was increased in the presence of PVP, instead of returning to singlet 
state following high fluorescence. Collectively, the results indicate monomerization of 
Ce6 aggregates by complex formation between Ce6 and PVP. Ce6 would bind to certain 
sites of the PVP molecule, thereby overcoming Ce6 aggregation. At very high PVP 
concentration, all the Ce6 molecules were bound to PVP and no further shift in emission 
spectra was observed. The fluorescence emission spectra of Ce6 were collected for all the 
PVP grades and PARAFAC algorithm was applied.  Figure 14(b) to (d) shows the 
proportions of varying species of Ce6 evolved by the action of each of the grades of PVP.  
The determining Factor, N, for calculating the number of different species present was 
found to vary between 2 and 3. When N was taken as 3, the average correlation 
coefficient for all the grades increased from 0.932 to 0.987. The presence of these three 
species could be identified as pure Ce6 aggregate, Ce6 partially bound with PVP and 
fully PVP-bound Ce6 monomers. Such proposition can be rationalized based on the fact 
that Ce6 emission spectra shifted from 644 nm to 665 nm at moderate PVP 
concentrations, suggesting that pure Ce6 aggregates were converted to Ce6 partially 
bound with PVP. Further shift from 665 nm to 672 nm indicated complete disaggregation 
of Ce6 at sufficiently high concentrations of PVP. Interestingly, the proportions of these 
species also varied significantly for different grades of PVP. As can be seen from         
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Figure 14(b) to 14(d), PVP K17 showed highest disaggregation efficiency than its 
counterparts as the fraction of PVP-bound Ce6 monomer was found to be highest for the 
minimum concentration of PVP employed (Ce6:PVP ratio = 1:10). Thus, the rank order 
of disaggregation efficiency was K17 > K25 > K30. The detailed explanation of varying 
disaggregation efficiency of different PVP grades is discussed in section describing Ce6-
PVP binding constant study.  
4.A.2.3. Effect of PVP on fluorescence anisotropy 
The fluorescence anisotropy (μ) values were calculated to assess the extent of complex 
formation between Ce6 and PVP. Fluorescence anisotropy measurements are often used 
to estimate the rotational movement during the photochemical transformation of a 
fluorophore from singlet to excited state [165]. Figure 15  shows  the plot of fluorescence  
 
Figure 15: Effect of PVP molecular weight on fluorescence anisotropy of Ce6. 




























































anisotropy values against PVP concentration for all the three PVP grades at pH 5. A 
sharp increase in fluorescence anisotropy was observed when the PVP:Ce6 ratio was 
increased up to 100:1, beyond which the fluorescence anisotropy gradually leveled off. 
Increase in anisotropy values with PVP concentration confirmed the association of Ce6 
with bulky PVP molecules, which restricted their rotational movement.  
4.A.2.4. Binding constant of Ce6-PVP complex  
As mentioned earlier, Ce6 molecules tend to aggregate in aqueous media especially under 
acidic conditions. In order to avoid complications of Ce6 aggregation and to simulate 
physiological pH, binding of Ce6 to PVP was studied at pH 7.4. One of the efficient ways 
to determine the binding constant of a fluorophore involves quenching studies [180]. The 
fluorescence emission of Ce6 was found to decrease in the presence of PVP, suggesting a 
quenching-like phenomenon. However, when the decrease in fluorescence intensity was 
plotted against PVP concentration using the Stern-Volmer equation, it did not exhibit a 
linear relationship. Moreover, PVP was found to be non-fluorescent in the range of 250-
600 nm. Consequently, the binding parameters were determined using the Klotz plot, a 
model used to study the interaction between polymers and drug molecules. From the 
characteristic spectral features it was found that all the Ce6 aggregates were bound to 
PVP at high PVP concentration (PVP:Ce6 ratio greater than 500:1). Therefore, the 
absorption spectrum of Ce6 at PVP:Ce6 ratio of 1000:1 was used to calculate the 
concentration of fully PVP-bound Ce6 (CB) molecules (employing Eq. 6). Figure 16(a) 
shows the bound fraction of Ce6 (x) (calculated from Eq. 6 and 7) with increasing       
PVP:Ce6 ratio for different PVP grades. The fraction of bound Ce6 (x) was observed to 
increase with increasing PVP:Ce6  ratio in a  logarithmic manner  (r
2




Figure 16: (a) Effect of PVP molecular weights on the fraction of PVP-bound Ce6 and (b) 
Fitting to Klotz reciprocal plot for different grades of PVP (n = 3). 























































PVP:Ce6 ratio, the fraction of PVP-bound Ce6 increased with decrease in molecular 
weight of PVP. All the Ce6 monomers were complexed with PVP at PVP:Ce6 ratio of 
1000. As can be seen, PVP of lower molecular weight grade facilitated improved binding 
efficacy and followed the order: K17 > K25 > K30. Based on the fraction of PVP-bound 
Ce6, the number of moles of Ce6 per mole of PVP monomer unit was calculated and 
used in the construction of the Klotz plot. All the three PVP grades generally showed 
good linearity in the Klotz plot (Figure 16b).  The binding parameters, Ka and n were then 
calculated from the slope and intercept of the Klotz plot for each of the PVP grades. The 
values of n was found to be smaller than 1 for the PVP macromolecule, indicating that 
more than one PVP monomer unit was involved in the binding with one Ce6 molecule. 
The P values (1/n) were calculated from the reciprocal of n. The number of probable 
binding sites in PVP molecule (N0) was calculated using Eq. (10). The binding 
parameters, such as Ka, P and N0 are shown in Table 5. PVP of lower molecular weight 
would produce a larger number of PVP molecules per unit weight of polymer. The results 
showed that the efficiency of binding to Ce6 was promoted by the availability of a larger 
number of PVP molecules, albeit shorter in chain length. PVP with a higher molecular 
weight will have a longer polymer chain and thus more binding sites. This aptly 
accounted for the high N0 value for PVP of higher molecular weight. The increase in N0 
value was however inconsistent, probably due to polydispersity of the polymer. The 
number of PVP monomers per binding site, P consistently decreased with increasing 
molecular weight of PVP. Increase in the p value implies association of a greater number 
of PVP monomers to each Ce6 molecule, resulting in strong interaction between them. In 
addition to binding efficiency, PVP K17 also exhibited the highest binding strength, 
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leading to the formation of the most stable Ce6-PVP complex. According to the 





. Based on the results obtained, K17 grade will make a favorable choice for Ce6-
PVP formulation. 
Table 5: Binding parameters of Ce6 with PVP of different molecular weights 
a
 average molecular weight of the PVP grade 
4.A.2.5. Binding mode of Ce6-PVP complex  
The interactive forces behind the Ce6-PVP complex formation was investigated by FT-IR 
spectroscopy and thermodynamic studies. The interaction between a drug and a 
macromolecule may involve hydrogen bonds, van der Waals forces, electrostatic forces 
and hydrophobic interactions [168].
 
Thermodynamic parameters, such as enthalpy 
changes (ΔH) and entropy changes (ΔS), are the main evidence to confirm binding 
modes. From the thermodynamic standpoint, ΔH > 0 and ΔS > 0 imply a hydrophobic 
interaction; ΔH < 0 and ΔS < 0 reflect interaction via van der Waals forces or hydrogen 
bonds; and ΔH ≈ 0 and ΔS > 0 suggest an electrostatic force of attraction [181]. From the 
spectroscopic standpoint, FT-IR has been widely used over the years in the analysis of 







) P N0 
K17 10,000 3.66 ± 0.8 61 ± 4 1.62 ± 0.2 
K25 24,000 3.51 ± 0.6 53 ± 4 4.23 ± 0.3 
K30 41,000 3.34 ± 0.6 37 ± 7 8.07 ± 0.8 
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and freeze-dried Ce6-PVP complex (at PVP:Ce6 ratio of 10:1). It was observed that the 
FTIR spectrum of Ce6-PVP complex was merely the superposition of Ce6 and PVP 
spectrum without any noticeable shifts. This was reflected by the individual stretching 
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), which were also present in the spectrum of 
Ce6-PVP  complex. The finding suggested that Ce6 was probably shielded by the 
macromolecular PVP structure indicating the absence of any electrostatic or covalent 
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Figure 17: FT-IR spectra of Ce6, PVP K25 and their resultant complex at PVP:Ce6 ratio of 
10:1. 
The binding mode was further investigated by thermodynamic studies at 288 K, 297 K 
and 310 K.  Two temperature points, one above (310 K) and the other below (288 K) the 
room temperature (297 K) were selected to study the effect of temperature difference on 
the binding mechanism. The binding constant at each temperature point was calculated 
using Eq. (9) and the values were then fitted into Van‟t Hoff‟s equation. The changes in 
entropy and enthalpy were obtained from the slope and intercept of the plot. The various 
thermodynamic parameters, such as changes in free energy (ΔG), enthalpy (ΔH) and 
entropy (ΔS), were calculated using Eq. (12) and (13) and presented in Table 6. The 
negative values of ΔG indicate that the binding processes were spontaneous for all three 
grades of PVP. The positive values of ΔH and ΔS suggest hydrophobic interaction 
between PVP and Ce6. This suggests that the Ce6 molecules were possibly entangled 
with the long polymeric chains of PVP where hydrophobic forces predominated, resulting 
in the formation of Ce6-PVP complex. 
Table 6: Thermodynamic parameters for binding of Ce6 with different PVP grades 
PVP 
Grade 






















 K17 -8543 -8822 -9225 385.5 31.9 
        K25 -8352 -8626 -9311 290.2 30.5 
 K30 -8368 -8638 -9024 272.1 30.1 
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4.A.2.6. Molecular dynamics simulation of Ce6-PVP complex 
The interaction between Ce6 and PVP was further investigated by geometry optimization 
of Ce6-PVP system using Hyperchem software with in-built molecular dynamics 
simulation [183]. The energy-minimized structures of Ce6 and PVP were used for 
simulation within a periodic box including water molecules to simulate the experimental 
condition. The optimized structure of the Ce6-PVP complex at the end of the simulation 
is shown in Figure 18(a). In the solvated condition, the porphyrin ring of Ce6 was found  
 
Figure 18: Molecular dynamics simulation of Ce6-PVP system: (a) conformation of Ce6-PVP 
complex and (b) energy vs. time profile of the simulation period. 
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to be widened, which could  be attributed to the increased  mobility of the pyrrolic N-ring 
in the presence of the polar solvent. This facilitated the passage of PVP through the 
widened porphyrin macrocycle of Ce6. In the presence of the polar solvent, PVP also 
showed increased mobility of the pyrrolidone moieties, resulting in entanglement of the 
Ce6 molecule with the PVP structure. Particularly, the pyrrolidone moieties were found 
to be closely associated with a mean approximate distance of 6 Å from the Ce6 molecule, 
suggesting the possibility of hydrophobic interaction. It was possible for the PVP 
molecule to pass through more than one Ce6 molecule, as long as the PVP molecule 
involved was linear. As a consequence, the PVP molecule would present a number of 
PVP-binding sites for Ce6.  Hence, for PVP K25 molecule with more than 100 monomer 
units, it could be extrapolated that more than one Ce6 molecule would be entangled with 
the PVP polymer. The free energy (ΔG) obtained at the end of the simulation run was 
found to be negative (-7403 kJ/mol) as similar to that obtained from thermodynamics 
study (Table 6), indicating that the conformation of Ce6 and PVP determined by the MD 
simulation study was nearly accurate. The Ce6-PVP complex was thermodynamically 
stable, as indicated by an asymptote in the energy vs. time plot (Figure 18b), thus 
confirming the formation of stable Ce6-PVP complex through hydrophobic interaction. 
4.A.2.7. Summary 
The studies in this section showed that PVP facilitated the conversion of Ce6 aggregates 
into monomeric form by forming Ce6-PVP molecular complexes. The PVP with lowest 
molecular weight (K17) exhibited the highest disaggregation efficiency as shown by the 
PARAFAC analysis and binding constants. Thermodynamic parameters calculated from 
temperature-dependent binding studies suggested that complex formation mainly 
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occurred by hydrophobic interaction between PVP and Ce6.  A molecular dynamics 
simulation from theoretical perspective was also in good agreement with the 
experimental findings. Furthermore, the spectral changes of Ce6 brought about by 
different grades of PVP have been adequately explained on the basis of absorption and 
fluorescence spectroscopic principles. Therefore, the various photophysical 
characteristics pertaining to disaggregation of Ce6 could effectively be used as a tool in 















4.A.3. Utilization of sucrose esters for disaggregation of Ce6 aggregates 
4.A.3.1. Overview 
In this section, the effect of sucrose ester-based surfactants on Ce6 aggregates was 
elucidated using spectroscopic and coarse grain simulation techniques. Surfactants have 
previously been used in the disaggregation of porphyrin and other photosensitizers. 
Recently, Dutta et al. demonstrated the usefulness of charged surfactants like SDS and 
CTAB, which formed electrostatic complexes with chlorin p6, a structural analog of Ce6 
[152]. Considering the toxicities arising from charged surfactants in the in vivo system, 
the utilization of non-ionic and biocompatible surfactants is highly recommended for 
disaggregation of Ce6. Sucrose esters are examples of novel non-ionic and biocompatible 
surfactants. Till date, these surfactants have not been explored for the disaggregation of 
Ce6 or any other fluorescence dyes. Hence, studies were carried out to investigate the 
disaggregation efficacy of three sucrose ester surfactants having lauryl (C12), myristyl 
(C14) and palmityl (C16) groups respectively as alkyl chains. The relative disaggregation 
efficacy of each of the surfactants was determined employing EEM spectroscopic 
methods. The Ce6-sucrose ester interaction was macroscopically simulated using 
dissipative particle dynamics (DPD) as a visualization tool. In addition, the response 
parameters of DPD model were correlated with the experimental findings to elucidate the 
disaggregation phenomenon. 
4.A.3.2. Absorption and fluorescence spectra of Ce6 in the presence of sucrose esters 
In order to investigate the disaggregation potential of the different sucrose ester, 
absorption and fluorescence spectra of Ce6 were obtained with varying sucrose ester 
concentrations. All the spectroscopic measurements were conducted at pH 5.0 to 
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emphasize its relevance to tumour physiological environment. The concentration of 
sucrose esters were varied from below CMC to above CMC and the concentrations of 
sucrose esters were designated in terms of their corresponding CMCs in the present 
study. It was rationalized that disruption of photosensitizer aggregates was accentuated 
near the CMC of the surfactants, whereby the monomers were incorporated into the 
resultant micelles. The CMC values of the different sucrose esters used were obtained 
from the literature (Table 7). Figure 19 shows the absorption spectra of Ce6 in the 
presence of sucrose ester monolaurate (SEL) from below CMC to 20-times of its CMC.  
 
Figure 19: uv-vis spectra of Ce6 for varying concentrations of SEL [a to h = 0.5 x CMC to 20 x 
CMC] (inset: Q band characteristics). 




































The absorbance of both Soret and Q bands were found to increase, indicating increased 
polarity in the Ce6 microenvironment. One possible reason could be association of 
disrupted aggregates with the surfactant micelles, thereby diminishing hydrophobicity in 
the microenvironment. As observed in the case of PVP, Q band similarly showed a sharp 
peak at 673 nm, suggesting disaggregation effect of SEL. Furthermore, isosbestic points 
were clearly observed on increasing concentrations of SEL, which suggests the existence 
of aggregate-monomer equilibrium in the system. Similar observations were also made 
for sucrose ester monomyristate (SEM) and sucrose ester monopalmitate (SEP) (figure 
not shown).  
Figure 20 shows the corresponding fluorescence spectra of all the three sucrose esters at 
different concentrations. Collectively for all the spectra, a bathochromic shift was 
observed. The emission maxima shifted from 644 nm to 673 nm, implying the conversion 
of Ce6 aggregates into monomeric form. The disruption of Ce6 aggregates as evidenced 
by a new emission peak at 670 nm was first observed at twice the CMC (2 x CMC) 
concentration of SEL. Further increase in SEL concentration resulted in complete 
disappearance of the aggregation peak (at 644 nm) and presence of only one sharp peak 
(at 673 nm), indicating the existence of monomer-rich Ce6 in the system. Unlike PVP, 
where it caused reduction in the fluorescence intensity of Ce6, the fluorescence intensity 
of Ce6 increased in presence of sucrose esters. This could be attributed to incorporation 
of Ce6 into the highly electron rich hydrophobic micellar core. Interestingly, the 
concentration of sucrose ester needed to induce aggregate to monomer varied 
significantly with the type of sucrose ester: 2 x CMC for SEL, 5 x CMC for SEM and   




Figure 20: Fluorescence emission spectra of (a) SEL, (b) SEM and (c) SEP [concentrations are 
represented as a function of CMC]. 
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Aggregation number refers to average number of surfactant molecules required to form a 
micelle. From Table 7, it was evident that aggregation number did not vary significantly 
for different sucrose esters [184]. This apparently reflects that a much higher number of 
micelles were required for complete disaggregation of Ce6 as the alkyl chains of sucrose 
esters increased and the disaggregation rank order could be SEL > SEM > SEP. 
However, the CMC of sucrose esters were found to vary largely and followed to decrease 
steeply as the alkyl chain length increases (Table 7) [184]. The large difference in CMC 
further  reflects that  there could be marginal  concentration difference for disaggregation  
Table 7: Properties and binding constants of sucrose esters comprising different alkyl chains 
Kb = binding constant. 
Ccd = Concentration of sucrose ester required for complete disaggregation 
effect for SEM and SEP compared to SEL. Therefore, it was quite evident that the low 
concentration of particularly SEM and SEP could not produce sufficient micelles to 
incorporate all the available Ce6 monomers, suggesting the need for higher 
concentrations (above CMC) of SEM and SEP for complete disaggregation. Therefore, 
the true disaggregation rank order could be     SEP > SEM > SEL. This was found to be 
in agreement when concentration for complete disaggregation of Ce6 was quantified for 















SEL 525 0.35 96 3.7 ± 0.2 1.75 
SEM 552 0.08 122 5.1 ± 0.1 1.6 
SEP 580 0.01 160 8.5 ± 0.6 0.8 
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4.A.3.3. Effect of different alkyl chains of sucrose ester on steady-state fluorescence 
anisotropy of Ce6 
Steady-state fluorescence anisotropy values in the presence of different sucrose esters 
were determined. Figure 21 shows the increment in anisotropy value of Ce6 as the 
concentration of sucrose ester increases. Increase in anisotropy value could be ascribed to 
 
Figure 21: Variation of fluorescence anisotropy of Ce6 with varying alkyl chains of sucrose 
esters (n = 3). 
incorporation of Ce6 monomers in the micellar core, which substantially restricted the 
rotational movement of Ce6. It was noted that the increase in fluorescence anisotropy for 
varying sucrose ester concentrations exhibited close correlation at which red shifts were 
observed in the fluorescence spectra.  For all the three sucrose esters the steep increase in 
fluorescence anisotropy corresponded with the first red shift in the emission spectra. This 
indicates that the disruption of Ce6 aggregates was followed by the incorporation of the 
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4.A.3.4. Quantification of relative disaggregation efficiency of sucrose esters with 
different alkyl chain using EEM spectroscopy  
EEM spectra of Ce6 were collected for each of the sucrose esters and PARAFAC 
algorithm was applied to determine the number and fraction of underlying species present 
at various sucrose ester concentrations. The initial addition of sucrose ester resulted in a 
decrease in fluorescence emission intensity, while a steep rise in fluorescence intensity 
was observed at sufficiently higher concentration. The lowering of fluorescence intensity 
was ascribed to further aggregation of Ce6 molecules while the steep rise in fluorescence 
intensity was ascribed to the incorporation of all the Ce6 molecules into the micellar core 
of the surfactants [152]. Such deviation of fluorescence intensities led to inaccurate 
determination of underlying species concentration and subsequently affected the 
correlation coefficient (r
a
) in PARAFAC analysis for each set of data points. Therefore, 
concentrations of underlying species were only taken into consideration for r
a
 values 
greater than 0.95. As observed for different PVP grades, effect of sucrose esters also 
resulted in dissociation of Ce6 aggregates into intermediate and completely monomerized 
species. This was deduced from the higher average correlation coefficient of PARAFAC 
analysis when the number of species, N, was considered as 3  (r
a
 = 0.97) instead of 2 (r
a
 = 
0.91. The three underlying species were pure Ce6 aggregates, intermediate Ce6 which 
was partially bound with sucrose ester and pure Ce6 monomers. Figure 22 shows the 
fractions of the three different Ce6 species in different concentrations of the sucrose 
esters. These fractions collectively made up 100 % of the Ce6 concentration, i.e., 50 µM.   
The apparent concentration (Ccd) of the sucrose ester at which complete disaggregation 




Figure 22: Fraction of different species of Ce6 present with increasing concentrations of (a) 










































































































value of the sucrose esters decreased in the following order: SEL > SEM > SEP. This 
implies that a higher concentration of sucrose ester with shorter alkyl chain was required 
for complete disaggregation of Ce6. The disaggregation effect of sucrose esters could be 
rationalized based on micellization, which was thought to be the main driving force for 
disruption of Ce6 aggregates. As mentioned earlier, the CMC of sucrose esters strikingly 
decreased as their alkyl chain length increased.  Thus, the requirement of apparently large 
number of micelles for SEP (80 x CMC) for complete disaggregation could be attributed 
to the need for complete incorporation of all the Ce6 monomers. As the CMC of SEP was 
much lower than SEL and SEM, it could be deduced that insufficient amount of micelles 
were produced at the CMC of SEP, which subsequently resulted in attainment of 
concentration (80 x CMC), much higher than its CMC for complete disaggregation. This 
also translates to the fact that the Ccd of SEP (80 x CMC) does not necessarily reveal the 
presence of large number of micelles compared to SEM and SEL indicating poor 
disaggregation ability of Ce6. Hence, the true rank order of disaggregation efficiency was 
SEP > SEM > SEL. This finding also corroborates the importance of alkyl chain length 
orientation at the interphase. Alkyl chain length increased from SEL to SEP resulting in 
reduced flexibility and better packing of surfactant molecules at the interphase, thus 
probably increasing the ability to retain Ce6 into the micellar core.  
4.A.3.5. Binding constant of Ce6-sucrose ester complex 
The binding efficiency between Ce6 and the sucrose ester with different alkyl chain 
length was calculated using Eq. (11). The binding constant values (Kb) are presented in 
Table 7. It was noted that SEP had a higher Kb value than its less lipophilic counterparts. 
The Kb values for the Ce6-sucrose ester were relatively lower than those reported for 
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Cp6-surfactant ionic interactions [152]. This could be ascribed to the presence of weak 
non-covalent interactions between Ce6 and sucrose esters, in comparison with the strong 
electrostatic interaction between Cp6 and ionic surfactants (SDS, CTAB). The Kb values 
for Ce6-sucrose ester decreased in the following order: SEP > SEM > SEL, indicating 
that sucrose ester with larger alkyl chain had higher association capability with the 
photosensitizer molecules, which will enhance its disaggregation efficiency.  
4.A.3.6. Determination of binding mode between Ce6 and sucrose esters  
The mode of interaction between Ce6 and sucrose esters was investigated using FT-IR 
spectroscopy and thermodynamics study. FTIR spectra of Ce6 and sucrose ester 
monolaurate (SEL) showed characteristic stretching and bending vibrations in the range 
of 400 to 4000 cm
-1
 (Figure 23). The FT-IR spectrum of freeze-dried Ce6-SEL mixture 
was mostly similar to that of SEL spectrum without any noticeable shift, possibly 
indicating that Ce6 was incorporated into the micellar core and remained in encapsulated 
form. This suggests that the possible binding mode was established through non-covalent 
interaction. This was further verified by temperature-dependent binding studies 
conducted at 288 K, 297 K, and 310 K respectively. The mode of binding, such as 
electrostatic, covalent or hydrophobic, could be assessed from the changes in enthalpy 
and entropy of the system as mentioned in section 4.A.2.5. The binding constant values 
obtained at different temperatures using Eq. (11) were fitted into Van‟t Hoff‟s Eq. (12) 
and the variations of enthalpy (ΔH) and entropy (ΔS) in the system were estimated. The 
values of ΔG, ΔH and ΔS for Ce6-sucrose ester system at three different temperatures are 
shown in Table 8. The interaction between Ce6 and sucrose esters was spontaneous as 




Figure 23: FTIR spectra of pure Ce6, sucrose monolaurate and their freeze dried mixture. 
binding was largely favoured by non-covalent hydrophobic interaction. Similar trends 
(negative values) were observed for ΔH and ΔS values in case of SEM and SEP, 
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Hence, the findings suggest that the Ce6 monomers were predominantly present in the 
hydrophobic micellar core of the sucrose esters.  


























SEL -2120 -2422 -3025 486.2 36.1 
      SEM -2143 -2626 -3311 498.4 37.5 
 SEP -2866 -3638 -4024 537.1 42.2 
4.A.3.7. Simulation of disaggregation effect of sucrose esters on Ce6 aggregates 
using DPD model 
The disaggregation action of sucrose esters on Ce6 aggregates was further investigated by 
dissipative particle dynamics (DPD), a coarse grain simulation model [185]. In this study, 
the disaggregation potential of the different sucrose esters was evaluated on the basis of 
varying hydrophobic chain lengths using the DPD model. The model assumes that 
surfactant molecules near its critical micelle concentration disperses the Ce6 aggregates 
and eventually incorporate Ce6 monomers into the micellar core. All the components of 
each sucrose ester-Ce6 system, such as S1, L1, M1, P1, W1 and C1 were designated by 
beads (Figure 24). As mentioned in the methodology section, the distinct hydrophobic 
and hydrophilic groups of the sucrose ester were each designated by a bead, resulting in 
each surfactant molecule represented by 2 beads. The degree of interaction between 
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different beads was determined by deriving their FH parameter. These were calculated 
using  COMPASS force field and shown in  Table 9. FH parameter, also known as  DPD 
 
Figure 24: Notation of different components for DPD simulation: (a) SEL [L1 – lauric acid, S1 













































































input parameters (χij) indicates the relative affinity between two dissimilar beads.  The 
value of FH parameter is high when two beads, i and j are incompatible while aij ≤ 0 
suggests excellent compatibility between two beads. 
Table 9: DPD input parameters of different beads designating sucrose ester, Ce6 and water 
 S1 L1 M1 P1 C1 W1 
S1 0 - - - - - 
L1 24.88 0 - - - - 
M1 33.17 - 0 - - - 
P1 57.97 - - 0 - - 
C1 73.28 47.38 108.9 140.9 0 - 
W1 14.3 26.59 38.65 74.92 246.9 0 
 Figure 25 shows the snapshots of each of the sucrose ester-Ce6 system with increasing 
sucrose ester concentration at the end of 20,000 simulation steps. The water molecules 
were discarded from the simulation box to provide a better understanding of the 
underlying interaction between Ce6 and the sucrose esters. As can be seen from      
Figure 25, the Ce6 monomers were incorporated into the micelles as the surfacatant 
concentration increased. At the highest surfacatant concentration corresponding to 
complete disaggregation (Ccd), no free Ce6 aggregates (denoted by blue) were observed 
indicating that all the molecules were incorporated into the micellar core. As can be seen 
from the snapshots, a relative reduction in number of surfactant molecules (red and green 
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beads) were observed as the alkyl chain length of sucrose esters increased. This clearly 
suggests that significantly lesser amount of micelles were produced as the alkyl chain 
length of sucrose esters increased due to their low CMC values, as described earlier. The 
produced micelles therefore could not accommodate all the Ce6 present in the system,  
 
Figure 25: Snapshots of DPD simulation for various systems, (a) to (c) SEL and (d) to (f) SEM 
at 0.5, 2, 20 x CMC respectively, (g) to (i) SEP at 20, 40, 80 x CMC. [surfactant head and tail: 











which aptly explains the requirement of relatively higher concentrations of SEP (80 x 
CMC) compared to SEM (5 x CMC) and SEL (2 x CMC) for complete disaggregation. 
At this concentration of SEP, the availability of micelles significantly increased resulting 
in complete disaggregation and the proposed disaggregation rank order was valid. 
Figure 26 shows the diffusion coefficient of Ce6 in the presence of different sucrose 
esters at their maximum concentration employed. Diffusion coefficient is an important 
DPD response parameter, which could be utilized to illustrate the effect of various 
surfactants on Ce6 aggregates. The effect of diffusion coefficient on Ce6 disaggregation 
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Figure 26: Variation of diffusion coefficients of Ce6 for different sucrose esters at their 
corresponding Ccd. 
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where D is the diffusion coefficient at temperature T, rc is the radius of diffusing 
molecule, δ is the viscosity of the medium and kB is the Boltzmann constant. Assuming a 
non-significant increase in viscosity of the aqueous phase on increasing sucrose ester 
concentration in the millimolar range, diffusion coefficient is inversely related to the 
radius of the diffusing molecule. Figure 26 shows the lowest diffusion coefficient was 
that obtained for Ce6 aggregates alone. Addition of sucrose ester to Ce6 resulted in 3-5 
times increase in the diffusion coefficient at the end of the simulation run, indicating 
disaggregation of Ce6 aggregates to form entities with smaller hydrodynamic radius. 





) of the sucrose ester molecule at various stages of the simulation period. 
As the disaggregation of Ce6 aggregates was preferentially occurred at micellar 
concentration range, it could be speculated that molecular orientation of surfactants at 
and above critical micelle concentration might have affected the ordering of the alkyl 
chains at the interphase as well as the disaggregation efficiency of the surfactants. RMS 
end-to-end distance is a concept, which describes the degree of curliness of a polymer 
chain [185]. For the same polymer chain, the RMS end-to-end distance will be reduced if 




denotes the total 
linear length of the surfactant molecule, which mostly comprises the length of the 
hydrocarbon chain. Figure 27 shows the variation of end-to-end distance of the sucrose 
esters at different concentrations. The end-to-end distance for SEL at concentrations 
below CMC was fairly constant. It increased markedly at CMC and tended to level off at 
higher concentrations. The same trend was observed for SEM and SEP. The greater end-
to-end distance of the sucrose ester molecule at and above CMC suggests a tightly packed 
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and orderly arrangement of the molecules to form the micelles. In such a situation, there 
would be reduced conformational mobility of the alkyl chains [187]. As can be seen from 




 was noticed at CMC and concentrations 





was observed. Therefore, the ordering of surfactant molecules at the interphase 
was mostly completed in that concentration range. Thus, it could be rationalized that such  
 
Figure 27: Variation of end-to-end distance of different sucrose esters with their increasing 
concentrations. 
orientation facilitated the disaggregation efficiency by increasing the ability to retain Ce6 
at the core due to increased micellar volume. This was supported by the findings of 
Kawaguchi et al. (1991) on structural studies of a homologous series of sucrose ester 
micelles [188]. The study revealed that the volume of the micellar core was higher in case 
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difference in alkyl chain packing orientations, SEP micelles had prolate (ellipsoidal) 
shape where SEL and SEM micelles had oblate (spherical) shape. Considering the fact 
that being a larger molecule (7.2 Å), the retention of Ce6 monomers in the SEP micelles 
could have been more favoured than its counterparts. 
4.A.3.8. Summary 
The studies in this section demonstrated the disaggregation behaviour of sucrose esters of 
different alkyl chain length on Ce6 aggregates. Ce6-surfactant interaction was visualized 
at the molecular level using DPD coarse grain simulation, findings of which were in good 
agreement with the experimental observation. Disaggregation efficiencies of sucrose 
esters were illustrated with the use of PARAFAC algorithm employing EEM 
spectroscopic methods. The results showed that disaggregation ability was significantly 
increased on increasing alkyl chain length of sucrose esters, based on the consideration 
that lesser amount of SEP was required than SEM and SEL as their CMC value steeply 
decreased. Sucrose esters with longer alkyl chains might have better capacity to retain 
Ce6 at the core due to enhanced conformational rigidity and less leakage. The rank order 
of relative disaggregation efficiency was SEP > SEM > SEL. Overall, the study 
established the useful application of a novel multivariate technique to quantify the extent 
of disaggregation by sucrose esters of varying alkyl chains, while the DPD model served 






4.A.4.  Photodynamic efficacy of various Ce6-disaggregating agent 
formulations  
4.A.4.1. Overview 
The influences of different factors, such as pH and Ce6 concentration, and 
pharmaceutical adjuvants, such as PVP and sucrose esters, on Ce6 aggregation have been 
investigated. The present section focuses on the photodynamic efficacy of various Ce6-
disaggregating agent formulations in terms of in vitro singlet oxygen generation, 
intracellular uptake and anti-proliferative activity. Different liquid formulations 
comprising Ce6 with disaggregating agents were prepared for investigation using human 
oral squamous carcinoma (OSC) cells as tumour xenograft model.  
4.A.4.2. In vitro singlet oxygen generation 
The photodynamic efficacy of different Ce6-disaggregating agent formulations was first 
investigated in terms of in vitro singlet oxygen generation. As the optimal PDT effect is 
largely dependent on the singlet oxygen production which kills the tumour cell, this study 
was highly significant. The extent of singlet oxygen production was measured by the 
concomitant decrease in RNO absorbance, where the labile nitroso group (of RNO) is 
converted to nitro group in presence of oxygen. Thus, upon irradiation by laser, singlet 
oxygen species were generated by Ce6, which immediately converted the oxygen-
sensitive p-nitrosoaniline (RNO) to more stable p-nitroaniline. This would reduce the 
absorbance of RNO. Therefore, the latter could be used to indicate the singlet oxygen 
generation by Ce6. Based on the findings of earlier disaggregation studies, PVP K17 and 
sucrose monopalmitate (SEP) were selected for use. All the formulations were prepared 
at pH 5 to simulate the in vivo tumour physiological environment. The                        
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Ce6:disaggregating agent ratios employed in the formulations were similar to those used 
in the earlier disaggregation studies. Figure 28 shows the reduction of RNO absorbance 
by the action of singlet oxygen species generated by Ce6 in the presence of different  
 
Figure 28: Singlet oxygen generation efficiency of Ce6 in the presence of different 
concentrations of (a) PVP K17 and (b) SEP.  
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concentrations of   PVP K17 and   sucrose esters, using   pure  Ce6  as  control. As   the 
concentration of PVP K17 and SEP increased, the monomeric Ce6 fraction increased, 
which significantly enhanced the singlet oxygen generation efficiency leading to 
oxidation of the nitroso group of RNO.  
4.A.4.3. Intracellular uptake of Ce6 from various formulations 
Solutions with varying ratios of disaggregating agent to Ce6 were prepared to assess the 
cellular uptake of Ce6 by OSC cells. The formulations were designated by codes and 
their corresponding components are shown in Table 10. Figure 29 shows the trend of Ce6  
Table 10: Composition of various Ce6-disaggregating agent formulations 
Disaggregating agent (C1) Codes Amount of Ce6 (C2) 
Ce6: disaggregating 
agent (C2: C1) (w/w) 
SEP a 
SEP 1 50 μM 50 μM : [20 x CMC] 
SEP 2 50 μM 50 μM : [40 x CMC] 
SEP 3 50 μM 50 μM : [80 x CMC] 
PVP b 
PVP 1 50 μM 1:10 
PVP 2 50 μM 1:100 
PVP 3 50 μM 1:1000 
a  Molecular weight = 580 
b Molecular weight = 10000 
uptake from different formulations over a period of 24 hr. The control consisted of Ce6 
without any disaggregating agent. As can be seen, from Fig. 29, cellular uptake of both 
Ce6 formulations consisting of PVP or SEP increased gradually from 4 hr to 24 hr as that 
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of the control. However, the cellular uptake by the PVP or SEP formulations were higher  
at specific concentrations of the adjuvants employed. The highest cellular uptake (6.4 μg)  
 
Figure 29: Uptake of Ce6 by OSC cells from formulations consisting of (a) Ce6-SEP and (b) 
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was  demonstrated by  SEP at a  concentration of  [40 x CMC]. The  uptake of  Ce6  was 
almost double that of the control (3.32 μg). This could be attributed to the disaggregation 
of Ce6 and entrapment of Ce6 in the micelles. Studies showed that the lectin present in 
the cell surface aids in internalization of sugar-based derivatives, while the highly 
lipophilic plamityl chains could easily permeate through the cell membrane resulting in 
enhanced uptake capasity [189]. However, the uptake of Ce6 was slightly reduced at 
higher SEP concentration [80 x CMC], which could be due to high concentration of SEP 
affecting the cell membrane and the uptake of Ce6.  
Formulations with different PVP concentrations also showed gradual increase in cellular 
uptake, which was comparable to that of the control. However, significantly higher 
uptake (4.88 μg) was demonstrated by the formulation consisting Ce6:PVP ratio of 1:100. 
PVP has been reported to possess mucoadhesive property which may aid in drug 
attachment to cells thereby promoting drug uptake [190]. However, insignificant 
difference (p-value) in Ce6 uptake was observed between the control and the PVP 2 
formulation. Further increase in PVP concentration at a Ce6:PVP ratio of 1:1000 (PVP 3 
formulation), where all the aggregates virtually exist as PVP-bound monomerized 
species, the uptake value fall to 3.3 μg, similar to that of pure aggregates. This could be 
attributed to increasing hydrophilicity of the Ce6-PVP complex which slowed down the 
extent of uptake. Additionally, high PVP concentration would have increased the 
viscosity of the PVP 3 formulation and might have a negative impact on cellular uptake 
[191]. The substantial cellular uptake by aggregates (control) is not surprising as it could 
be ascribed to high lipophilicity of parent Ce6 molecule in the acidic pH environment of 
the OSC cells. Considering the fact that aggregates are joined together by weak 
124 
 
hydrophobic force, a substantial Ce6 uptake would have been possible in the form of 
monomers, which might had dissociated from the aggregates at the lipophilic boundary of 
the cell membrane. Considering SEP 2 and PVP 2 formulations, lesser amount of 
adjuvants was required for SEP 2 as can be seen from Table 10. Thus SEP was more 
useful than PVP in promoting Ce6 uptake.  
4.A.4.4. Anti-proliferative activity of Ce6-disaggregating agent formulations  
Various formulations consisting of different concentrations of Ce6 (1-25 μg/mL) at 
constant PVP K17:Ce6 (100:1) or constant SEP concentration (40 x CMC) were 
prepared. The anti-proliferative activity of the formulations was evaluated by MTT assay. 
The latter is a simple in vitro method for determining cell viability by photometric 
measurements. The yellow tetrazolium MTT (3-(4,5-dimethylthiazolyl-2)-2,5-
diphenyltetrazolium bromide) would be reduced by metabolically active cells, in part by 
the action of dehydrogenase enzymes,  to form purple-coloured crystals known as 
formazan. The Formazan crystals would dissolve in the solvent, DMSO, used in the 
method and the absorbance of the resultant was determined. A higher absorbance of the 
formazan solution indicates greater cell viability or lower anti-proliferative activity of the 
test formulations [192]. The anti-proliferative activity of different Ce6 formulations was 
calculated as described by Eq. (27). The IC50 values of the control, Ce6-PVP K17 and 
Ce6-SEP formulations were calculated using Graph Pad Prism (version 5; CA, USA) for 
the purpose of comparing their anti-proliferative activity.  
For all the formulations, Ce6 had little effect on the cell viability when the cells were 
kept in the dark, implying that the inactivated Ce6 was non-toxic in the dark condition. 
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After irradiation, cell viability in the different formulations decreased to varying extent. 
The anti-proliferative activities of different test formulations are shown in Figure 30. The  
 
Figure 30: Percent cell survival and corresponding anti-proliferative activity of Ce6-SEP2 
formulation (a - b), Ce6-PVP2 formulation (c - d) and control (e - f) (n = 6).  
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IC50 values were found to decrease in the following order: SEP (2.14 μg/mL) < PVP (2.4 
μg/mL) << aggregates (22.1 μg/mL). Formulations containing SEP and PVP K17 clearly 
showed potent anti-proliferative activity as indicated by their IC50 values, which were 
approximately 10 times less than that of the control. Collectively, the results confirmed 
the disaggregation action of PVP K17 and SEP, enabling the production of monomer-rich 
Ce6 which is largely responsible for the PDT activity of Ce6. The high IC50 value      
(22.1 μg/mL) of the control suggests that the Ce6 in the control was mostly aggregated 
with little anti-proliferative activity. Thus, aggregation of Ce6 reduced the generation of 
singlet oxygen species, which explains the higher concentrations of Ce6 needed to 
destroy the OSC cells. Hence, anti-proliferative activity was mostly associated with 
efficiency of singlet oxygen generation but not solely dependent on the extent of cellular 
uptake.  
4.A.4.5. Summary 
The studies in this section investigated in vitro photodynamic efficacy of Ce6 
formulations with disaggregating agents such as PVP K17 and SEP. High singlet oxygen 
generation was detected in the formulations, along with enhanced cytotoxic potentials. 
Although the intracellular uptake of these formulations differed significantly and found to 
be substantially high than the pure aggregates in certain cases. The suitable properties of 
SEP and PVP facilitated higher uptake efficiency than the aggregates. The results also 
suggested that it is not necessarily the intracellular uptake but the extent of singlet oxygen 
generation, which was the rate-limiting step for PDT-induced cell death. Therefore, it 
could be postulated that a fair balance between lipophilicity and monomer-rich Ce6 
species is highly required to produce the optimum photodynamic efficacy. The excellent 
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in vitro photodynamic efficacy of Ce6-PVP and Ce6-SEP formulation further warrants 
their suitable application as drug carrier for delivery of Ce6. The studies also reflected the 
importance of singlet oxygen generation for cytotoxic activity, however additional 
studies are required to elaborate the type of photochemical transformation (Type 1 or 
Type 2) encountered to elicit anti-proliferative action on OSC cells.  
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4.B.1.  Dissolution enhancement of Ce6 by formulating into sucrose ester-
based nanosuspension 
4.B.1.1. Overview 
The useful properties of sucrose esters have been illustrated in the earlier section, which 
could be successfully utilized in preparing a delivery system for Ce6. High 
disaggregation along with high intracellular uptake of Ce6 brought about by the sucrose 
esters rendered them an ideal choice as drug carrier for Ce6. Therefore, it was postulated 
that an optimal sucrose ester-based formulation could substantially enhance the in vitro 
dissolution of Ce6 along with substantial accumulation of Ce6 in OSC cells. In addition, 
Ce6 would be expected to exist mostly as monomeric species, thus providing high 
photodynamic activity. With this hypothesis, the production of Ce6-sucrose ester 
nanosuspension was investigated using a central composite design, where different 
formulation factors were varied to optimize the particle size, zeta potential, encapsulation 
efficiency (EE) and in vitro drug release of the nanosuspensions. The PDT activity of the 
optimized formulations in OSC cells was further investigated in terms of singlet oxygen 
generation and cytotoxic potential.  
4.B.1.2. Preparation of Ce6-sucrose ester nanosuspension 
Sucrose ester is a group of non-ionic surfactants synthesized by esterification of sucrose 
with fatty acid. Sucrose esters were found to be useful in the formulation of 
microemulsion and transdermal-based dosage forms. In addition, these glyco-conjugated 
compounds were found to aid cellular uptake owing to their cell-compatible sucrose 
moiety, while the alkyl chains of different lipophilicity also facilitated efficient cellular 
uptake [158-160, 189]. In the earlier studies, sucrose esters were found to be capable of 
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disrupting the Ce6 aggregates, followed by entrapment of the Ce6 monomers in the 
micellar core. Li et al. (2011) proposed that a combination of sucrose esters was more 
effective than a single sucrose ester in the preparation of nanosuspension, as the 
combination offers a fair balance between hydrophilicity and lipophilicity facilitating 
desirable drug release characteristics [193].  In the present study, a modified hot-melt 
emulsification process was employed to prepare a sucrose ester-based nanosuspension 
where the Ce6 was encapsulated in sucrose ester matrix. Upon contact with the 
dissolution medium, the sucrose esters would gradually dissolve. As sucrose esters are 
basically modified surfactants, their dissolution at concentrations above CMC would 
produce micelles, in which Ce6 would remain as monomeric species. Therefore, the 
modified nanosuspension approach employed would fulfill two important objectives, 
namely enhancing the dissolution and preventing the aggregation of Ce6. Sucrose 
monolaurate (SEL) was fairly water-soluble, while sucrose ester monopalmitate (SEP) 
had partial aqueous solubility at room temperature. Thus, although the presence of excess 
SEL potentiates faster dissolution of the sucrose ester matrix, it could instantaneously be 
solubilized during the formulation preparation and result in partitioning of the drug to the 
aqueous phase. Therefore, using SEL-rich sucrose ester matrix, the encapsulation 
efficiency of the formulation would be generally low. Therefore, in order to achieve 
balance between encapsulation efficiency and in vitro dissolution, a combination of SEL 
and SEP was used in the formulation. The influence of varying ratios of SEP to SEL with 
a fixed total weight (200 mg) was investigated. In the design model, a higher proportion 
of SEP with respect to SEL was used to increase the encapsulation efficiency of Ce6. A 
mixture of dichloromethane (DCM) and acetone (AC) were used as organic phase in the 
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preparation of hot-melt emulsion. Ce6 was readily soluble in DCM. Being immiscible 
with water, DCM would be dispersed as droplets in the aqueous phase. Several studies 
have suggested that a mixture of miscible and immiscible solvents often increase the 
emulsification efficiency by controlling the diffusivity of the solvent [194]. Acetone (AC) 
is an example of a volatile miscible solvent. When the drug is dissolved in a volatile 
miscible solvent dispersed in an aqueous medium, the solvent would aid in diffusion of 
the drug into the aqueous medium, where the drug would precipitate as nanoparticles. It 
was therefore postulated that a combination of miscible and immiscible solvents could be 
employed to prepare a nanosuspension with desired characteristics. This is because of the 
fact that solvent evaporation of the immiscible solvent (DCM) is a controlled procedure, 
which could generate uniform small-sized particles, while the diffusion of miscible 
solvent (AC) is generally rapid and could precipitate particles of larger size fractions 
[195]. Therefore, the proportion of DCM to AC was varied with a fixed total volume of  
5 mL in the present study. The maximum drug loading and encapsulation efficiency were 
also investigated by varying the concentration of Ce6 used. Thus, factors such as SEP to 
SEL ratio (X1), amount of Ce6 (X2) DCM to AC ratio (X3) and were designated as 
independent variables in the central composite design (CCD) model employed. These 
factors were varied over 5 levels. The CCD model was chosen over other statistical 
models, such as box behnken design, because it allows more number of levels to 
precisely investigate the effects of the above-mentioned factors on formulation 
characteristics.  Figure 31 depicts the schematic diagram for the preparation of SEP/SEL-
Ce6 NS. An O/W emulsion was initially formed by addition of DCM/AC mixture 
containing SEP/SEL and Ce6 to the aqueous phase preheated at 60˚C. This primary 
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emulsion was then immediately poured into a large volume of ice-cold water to facilitate 
the precipitation of SEP/SEL to stabilize the nanosized droplets produced. The AC in the 
nanosized droplets would diffuse rapidly into the aqueous phase, while DCM would 
gradually evaporate. The diffusion/evaporation of AC/DCM would further cause the 
precipitation of SEP/SEL and Ce6, as well as the formation of pores on the surface of the 
sucrose ester matrix. The latter effect could additionally aid to enhance the dissolution 
potential of SEP/SEL-Ce6 NS.  
 
Figure 31: Schematic diagram of modified hot-melt emulsification method for the preparation of 
SEP/SEL-Ce6 nanosuspension. 
4.B.1.3. Evaluation of central composite design results 
4.B.1.3.1. Particle size (Y1) 
The average experimental results from the joint effects of the three independent variables 
on the particle size of SEP/SEL-Ce6 NS are shown in Table 11. The mean particle size 
(Y1) of the NS formulations varied from 76 nm to 304 nm indicating that the particle size 
was affected by the different levels of independent variables. The smallest mean particle
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Table 11: Observed responses in central composite design for SEP/SEL-Ce6 NS 
Batch  Independent variables Dependent variables 
1 X1  X2 (mg) X3  Y1 (nm) ± SD Y2 (mV) ± SD Y3 (%) ± SD Y4 (%) ± SD 
1 7.20 12.09 3.24 187.4 ± 8 -21.3 ± 2.8 86 ± 6.4 132 ± 6.4 
2 1.91 12.09 3.24 107.2 ± 4 -16.5 ± 2.2 50 ± 3.1 134 ± 5.5 
3 7.20 32.91 3.24 199.4 ± 6 -20.1 ± 1.7 69 ± 4.4 106 ± 3.2 
4 0.11 22.50 2.13 76 ± 4 -11.6 ± 1.1 36 ± 3.2  94 ± 5.4 
5 1.91 12.09 1.01 118.2 ± 6 -14.6 ± 1.6 43 ± 3.6 138  ± 2.9 
6 1.91 32.91 3.24 95.5 ± 4 -12 ± 1.4 45 ± 4.2 121± 6.8 
7 1.91 32.91 1.01 107.4 ± 8 -13.2 ± 2 37 ± 5.7 111 ± 12.4 
8 4.55 22.50 2.13 232.4 ± 6 -18.1 ± 2.1 68 ± 4,1 138 ± 11 
9 4.55 22.50 4.00 184.7 ± 9 -18.7 ± 2.1 77 ± 3.1 143 ± 9.7 
10 4.55 40.00 2.13 237.5 ± 11 -17.7 ± 2.3 56± 4.9 125 ± 12.1 
11 7.20 12.09 1.01 282.3 ± 14 -19.1 ± 2 66 ± 5.1 120 ± 9.8 
12 9.00 22.50 2.13 266.7 ± 12 -22 ± 2.3 62 ± 3.4 173 ± 6.2 
13 7.20 32.91 1.01 304.3 ± 17 -20.4 ± 2.2 56 ± 3 111 ± 8.3 
14 4.55 22.50 2.13 224.2 ± 11 -19.2 ± 1.6 69 ± 4.3 146 ± 11.4 
15 4.55 22.50 0.25 262.7 ± 13 -18.7 ± 1.3 59 ± 6.3 141 ± 12.3 
16 4.55 22.50 2.13 231 ± 14 -18.2 ± 1.8 72 ± 6 152 ± 7.2 
17 4.55 5.00 2.13 240 ± 11 -18.1 ± 1.1 81 ± 5.2 130 ± 6.1 
X1 = SEP:SEL ratio, X2 = amount of Ce6, X3 = DCM:AC ratio, Y1 = mean particle size, Y2 = Zeta potential, Y3 = encapsulation efficiency, Y4 = 
time required for 90 % dissolution (t90) 
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size was obtained particularly at lower level of SEP:SEL ratio (X1) and higher level of    
DCM:AC ratio. An equation that can adequately describe the influence of the selected 
variables on the mean particle size was obtained after conducting a multiple regression 
analysis on the results along with the statistical validation of the model as shown in  
Table 12. From the coefficient values and probabilities of significance, SEP:SEL ratio 
(X1) and DCM:AC ratio (X3) were found to have significant effect on the particle size. In 
addition, there were also significant interaction effects indicating strong influence of the 
process variables on the particle size of NS. The Ce6 concentration did not have any 
substantial effect on particle size as observed from the insignificant p-value (> 0.05). 
F-test was performed to determine the significance of the regression model. The low 
probability value (p < 0.05) for mean particle size indicates that the model was 
statistically significant. The goodness of fit of the model was checked by adjusted 
determination coefficient (R
2
). This was found to be high (~ 90%) indicating a high level 
of significance for the model. The p-value of lack of fit was found insignificant 
suggesting there is a large probability (12.1%) of lack of fit due to error. The above 
analysis shows the adequacy of the regression model for particle size.   
From the values of the coefficients, it could be inferred that increasing ratio of SEP:SEL 
(X1) had a positive effect on the particle size. In contrast, the ratio of DCM:AC (X3) had 
a negative effect on the particle size. Overall, the extent of influence by the independent 
variables on the particle size was ranked as follows: SEP:SEL ratio > DCM:AC ratio > 
Ce6 concentration. The response surface plots representing the variation of particle size 
as a function of the independent variables are presented in Figure 32. As can be seen, 
increase in SEP:SEL ratio (X1) in the formulation increased the particle size, while a 
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 SD F value 
p-value  
(Lack of fit) 
p-value 
(model) 
Size (Y1) Quadratic 0.945 0.906 5.19 13.58 0.1213 0.0012 
Zeta potential (Y2) Quadratic 0.976 0.947 0.71 32.75 0.44 <0.0001 
EE (Y3) Quadratic 0.943 0.911 5.35 13.02 0.31 0.0014 
% drug release (Y4) Quadratic 0.906 0.953 11.83 0.50 0.19 0.033 
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higher DCM:AC ratio (X3) in the formulation decreased the particle size. The trends were 
in agreement with the findings of the regression analysis.  The scientific basis of the 
underlying responses from this statistical model could be accounted by the higher 
aqueous solubility of SEL in comparison with SEP. This is because SEL would produce 
micelles more readily than SEP when in contact with water. Thus, the large number of 
micelles produced by using a higher fraction of SEL as matrix material would shift the Z-
average diameter to the lower side. The existence of the micelles and the nanoparticles 
was indicated by the high polydispersity index (PDI of 0.95) of the nanosuspension 
prepared at SEP:SEL ratio (X1) of 0.11. When SEP content increased, the possibility of 
micelle formation was lowered and the average particle size increased with 
corresponding PDI < 0.5.  
When DCM:AC ratio (X3) was increased, the mean particle size of the nanosuspension 
shifted to the lower side. The presence of a larger fraction of DCM would slow down the 
solvent diffusion process, with precipitation taking place more gradually through 
evaporation of DCM. The latter led to the production of comparatively smaller sized 
particles. On the other hand, with higher AC content, solvent diffusion process would be 
faster, resulting in more rapid precipitation of the stabilized nano-droplets and a higher 
propensity for larger particle size.  
4.B.1.3.2. Zeta potential (Y2) 
The regression model for zeta potential (ZP) was also constructed. It was found to be 
statistically significant in terms of p-value, lack of fit, adjusted R
2
 and regression 
coefficients (Table 12 and Figure 32). Zeta potential was found to be negatively affected 
by SEP:SEL ratio (X1), while DCM:AC ratio (X3) and amount of Ce6 (X2) had little 
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effect. The response surface plot shows an increase in ZP from -22 mV to -11.6 mV with 
decrease in SEP:SEL ratio (X1) from 9 to 0.11.The same trend was observed for 
nanoparticle size, suggesting that the fraction of micelle content increased with an 
increase in the SEL content resulting in highly polydispersed species namely micelles and 
nanoparticles. This was reflected in the high polydispersity index (PDI of 0.95) of the 
formulation using SEP:SEL ratio (X1) of 0.11. Increase in SEP content resulted in 
production of lesser fraction of micellar species and more uniform-sized nano-
precipitated particles (PDI < 0.5). This resulted in higher ZP value indicating better 
stability of the NS formulation.  
4.B.1.3.3. Encapsulation efficiency (Y3) 
The p-value, lack of fit and adjusted R
2 
values for EE were found to be significant, 
indicating that the effects of the dependent variables conformed to a quadratic model 
(Table 11). Encapsulation efficiency was found to be positively affected by SEP:SEL 
ratio (X1) and amount of Ce6 (X2) while DCM:AC ratio (X3) exerted a negative effect. 
All the independent variables as well as their interaction parameters were found to have 
significant effect on EE, indicating that EE was highly affected by the formulation 
factors. The response surface plots show the individual as well as the combined effects of 
the factors on EE. The latter was found to vary markedly 36 % to 86 % (Figure 32). As 
can be seen from the response surface plots, increase in SEP:SEL and DCM:AC ratios 
increased the EE, while increase in Ce6 concentration had the opposite effect. Increasing 
Ce6 concentration in a constant amount of sucrose ester matrix negatively affected 
encapsulation efficiency as lesser amount of Ce6 become available for completely 
embedded in the matrix, while the rest is partitioned to the outer aqueous phase. Thus, 
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increase in Ce6 aptly accounts for the decrease in EE. Increase in SEP:SEL ratio (X1) on 
the other hand, lowered the possibility of instantaneous dissolution due to the presence of 
the lesser amount of SEL. This prevents immediate partitioning of Ce6 present in the 
fraction of a soluble matrix material. This was reflected when EE relatively decreased 
when SEP:SEL ratio (X1) was decreased, i.e. fraction of SEL was increased. The 
variation of solvent mixture was also found to have substantial impact on EE as the latter 
was found highest when the highest DCM:AC ratio (X3) employed. As explained earlier, 
AC would diffuse more readily than DCM into the aqueous phase. When AC fraction 
was higher, the Ce6 dissolved in the solvent mixture of the O/W emulsion therefore had 
higher propensity to diffuse into the external aqueous phase. In contrast, when DCM 
fraction was higher, a major fraction of Ce6 remained in immiscible DCM phase and 
would not result in significant loss of Ce6 to the aqueous phase. Thus, a higher 
proportion of DCM in the solvent mixture increased the EE for Ce6.  
4.B.1.3.4. Time required for 90 % dissolution (Y4) 
Time required for 90 % dissolution (t90) of Ce6 from the different formulations was fitted 
into the regression equation. High adjusted R
2
 and lack of fit with p-value less than 0.05 
were obtained, indicating statistical significance of the quadratic model. From the 
different values of regression coefficient, it was inferred that SEP:SEL ratio (X1) and 
amount of Ce6 (X2) had significant impact on the in vitro dissolution of Ce6. The t90 of 
different NS formulations were varied from minimum 94 min to maximum 173 min when 
X1 was lowest and highest, respectively (Table 11 and Figure 32). A lower SEP:SEL ratio 
employed would result in nanoparticles with a higher fraction of SEL in the matrix. As 
SEL was more soluble in water, it would enhance the dissolution of the matrix containing 
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the Ce6. Decrease in drug dissolution with increase in SEP fraction could be attributed to 
the increased hydrophobicity of the matrix and therefore, further time was required for 
complete dissolution/disintegration of the matrix. It was also observed that increase in 
Ce6 content had slightly positive impact on the in vitro release. This could be explained 
on the basis of Ce6 encapsulation in the sucrose ester matrix. A higher amount of Ce6 in 
constant amount of sucrose esters will probably result in inefficient encapsulation. 
Precisely, the possibility of Ce6 to remain embedded in the matrix was lesser and 
therefore, Ce6 could be remained adsorbed or loosely bound to surface of the ester 
matrix, which upon dissolution showed instantaneous dissolution in the nanoprecipitate 
form.  
4.B.1.3.5. Optimization of SEP/SEL-Ce6 nanosuspension 
In this study, the influence of 3 independent variables, such as SEP:SEL ratio (X1), 
amount of Ce6 (X2) and ratio of DCM:AC (X3), on the properties of SEP/SEL-Ce6 NS 
was investigated. It was unlikely that optimizing one response (i.e. one property) would 
lead to the best outcome for the others. For this reason, “optimization” was defined as the 
most preferred experimental conditions that fulfilled the overall desirable properties of 
the formulation, where the different responses were mostly satisfactory. Optimization can 
be performed by mathematical or graphical approaches using Design Expert
®
 software. 
The numerical optimization method involved a desirability function, di, that varied over 
the range of 0 ≤ di  ≤ 1 [196]. This function indicates that at what extent the experimental 
and predicted values are close to each other.  
The desirable particle size was set to approximately 200 nm as particles of similar size 
had provided the effective EPR effect as well as the ability for uptake by the Payer‟s 
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patches [197]. Particle size smaller than 200 nm was not chosen because it necessitates 
the need for higher SEL content, which had a negative impact on encapsulation 
efficiency. The ZP of the optimized formulation was set to lower minimum to ensure 
higher stability. The EE and t90 were set to higher maximum to ensure effective 
encapsulation and faster dissolution of Ce6. The desirability function for each of the 
responses was then combined to obtain the overall desirability function (di), which was 
calculated using the following equation: 
𝑑                 
                                                                                   
The overall desirability for the optimized formulation is shown by the optimized values 
of the independent variables in Table 13. Formulations were subsequently prepared 
according to the optimized values of independent variables and the values of dependent 
variables were experimentally determined and shown in Table 13. As can be seen, the 
responses of the dependent variables (i.e. experimental values) were found to be very 
close that with the predicted values (i.e. desired values) indicating the applicability of this 
statistical design for the optimization of the formulation. The experimental response 
values were in good agreement that with the predicted values, as shown by small 
percentage prediction errors (Table 13). The characteristic features of the optimized 
formulation are shown in Figure 33. The optimized NS showed unimodal particle size 
distribution with average diameter of 188 nm, along with high stability (ZP = − 20.8 mV) 
(Figure 33 a,b). Compared to pure Ce6 control, the formulation showed a 10-fold 
increase in drug dissolution, facilitating approximately 85 % drug release in 2.5 hr 
(Figure 33c). The dissolution rate of pure Ce6 was very low, which translated to the fact 
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that fast dissolution from NS probably occurred as micelle-bound form. The aggregation 
characteristics of the dissolved Ce6 were further analyzed in terms of shifts in 
fluorescence emission spectrum. Figure 33(d) shows the normalized emission maxima of 
Ce6 at 679 nm. It was found to match that of micelle-bound Ce6 monomers (Fig. 20 
obtained in disaggregation study). The latter exhibited an emission maximum at 673 nm. 
Such results further reinforced the assessment that dissolution of NS took place in 
micelle-rich condition and Ce6 existed as monomers in the micelles.  















X1 = 7.06 
X2 = 15.22 
X3 = 3.24 
Y1 (nm) Minimize 188 203 
0.829 
7.38 
Y2 (mV) Minimize -20.8 -21.2 1.88 
Y3 (%) Maximize 82.4 85 3.05 
Y4 (%) Maximize 171 152.3 -12.8 
4.B.1.4. Characterization of SEP/SEL-Ce6 NS 
4.B.1.4.1. FTIR analysis 
The effect of sucrose esters on enhanced dissolution of Ce6 was further investigated 
using IR spectroscopy in the light of solid-state interactions. Figure 34 shows the FTIR 
spectra of Ce6 with the following characteristic peaks: 1710 cm
-1
 (C=O vibration),    
2962 cm
-1
 (C–H vibration) with weak stretching at 3303 cm-1 (mild N–H vibration) and 
3440 cm
-1 
(mild O–H vibrations) [198].  SEP:SEL (7:1) also showed characteristic C–H,  






Figure 33: (a) Particle size distribution, (b) zeta potential, (c) in vitro drug release (n = 6) and (d) fluorescence emission characteristics of the 
optimized SEP/SEL-Ce6 nanosuspension.  
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. The FTIR spectrum of the freeze-dried nanosuspension was 
relatively similar to that of SEP/SEL, albeit of lower intensity (transmittance). This 
strongly suggested that Ce6 was efficiently incorporated in the sucrose ester matrix, 
resulting in effective encapsulation of Ce6, particularly for the SEP-rich formulation. 

































































4.B.1.4.2. DSC analysis 
The DSC thermograms of pure Ce6, SEP:SEL (7:1) and freeze-dried nanosuspension are 
shown in Figure 35. The Ce6 thermogram did not show any melting endotherm, however  
 
Figure 35: DSC thermograms of Ce6, sucrose esters and optimized SEP/SEL-Ce6 formulation. 
above 250˚C, the thermogram followed an upward curve indicating degradation of Ce6 at 
high temperature (~300˚C). The mixture of sucrose esters showed two characteristic 
endotherms, one at 46˚C and the other at 200˚C, indicating complete melting of fatty acid 
chains and sucrose respectively. Interestingly, SEP/SEL-Ce6 NS showed an additional 
endotherm at 135˚C apart from the endotherms of the sucrose esters, which could be 
assigned to the melting of incorporated Ce6 in the SEP/SEL matrix. Such finding 
possibly suggests the presence of amorphous form of Ce6 in the sucrose ester matrix.  
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4.B.1.4.3. PXRD analysis 
The X-ray diffractograms of pure Ce6, Ce6-sucrose ester physical mixtures and 
SEP/SEL-Ce6 nanosuspension are shown in Figure 36. Ce6 on its own and in the 
presence of the sucrose esters showed diffraction patterns characteristics of compounds in 
crystalline form. Complete disappearance of the diffraction patterns was observed for 
SEP/SEL-Ce6 nanosuspension, which strongly indicates that Ce6 was probably present in 
amorphous form in the sucrose ester matrix [199-201].  
 
Figure 36: X-ray diffractograms of pure Ce6, physical mixtures of sucrose esters and Ce6 and 
optimized SEP/SEL-Ce6 NS formulation. 
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4.B.1.4.4. Morphology of SEP/SEL-Ce6 nanoprecipitates 
Morphology of SEP/SEL-Ce6 in the optimized formulation was determined by taking 
TEM pictures of the freshly prepared nanosuspension. Figure 37 shows Ce6 particles in 
the nanosize range, with mean diameter of 100−150 nm.  
 
Figure 37: TEM images of optimized SEP/SEL-Ce6 nanosuspension (inset: close view of 
nanoparticles) 
4.B.1.5. PDT efficacy of SEP/SEL-Ce6 NS 
4.B.1.5.1. In vitro singlet oxygen generation  
The SEP/SEL-Ce6 NS was placed in the dissolution medium and aliquot samples were 
collected at different time intervals for assay of singlet oxygen generation. The extent of 
in vitro singlet oxygen generation, which is inversely proportional with the absorbance of 
RNO, is shown in Figure 38. As can be seen, singlet generation was increased by 2-4 
folds in comparison with the control (pure Ce6). The proportionate increase in singlet 
oxygen generation than the control suggested that the photophysical properties of Ce6  
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were not changed after being incorporated in the sucrose ester matrix as NS form [202]. 
The increase in singlet oxygen generation with time could be attributed to the increased  
 
Figure 38: (a) Singlet oxygen generation at different time intervals and (b) typical uv-vis 
spectrum of optimized SEP/SEL-Ce6 NS, collected from the dissolution medium. 
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availability of Ce6 through gradual degradation of the sucrose ester matrix. In order to 
substantiate the basis of improved singlet oxygen generation efficiency, the absorption 
spectra of the corresponding SEP/SEL-Ce6 NS samples were obtained. A typical 
absorption spectrum of the nanosuspension sample collected from the dissolution 
medium is shown in Figure 38(b). As can be seen, both Soret and Q bands were sharp, 
indicating the presence of monomeric Ce6 in the solution. This is because the dissolution 
of the sucrose ester matrix resulted in soluble micelle in which Ce6 was largely present as 
monomers. Therefore, it was evident that monomer-rich Ce6 enhanced singlet oxygen 
generation in vitro.   
4.B.1.5.2. Cellular uptake and intracellular distribution 
The uptake and intracellular localization of Ce6 from SEP/SEL-Ce6 NS in OSC cells was 
investigated by confocal laser scanning microscopy in dark conditions. As can be seen 
from Figure 39(a) more than 65 % of the Ce6 content SEP/SEL-Ce6 NS was taken up by 
the cells within 4 hr. The results showed a rapid intracellular passage across the cell 
membrane for SEP/SEL-Ce6 NS, which was almost twice faster than that for the Ce6 
solution (control).The significant increase in cellular uptake compared to the control 
could be ascribed to the lipophilicity of SEP, which facilitated the passage of Ce6 across 
the lipophilic cell membrane. Furthermore, from the dissolution study, it was shown that 
Ce6 was present not as the free form but as micelle-bound form. Therefore, it could be 
argued that the Ce6 containing NS droplets had facilitated rapid intracellular 
accumulation through cell-mediated endocytosis pathways. The intracellular distribution 
of Ce6 from SEP/SEL-Ce6 NS was imaged by fluorescence microscopic technique using 
DAPI as the nucleus staining dye. The chlorin ring structure of Ce6 would generate a 
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strong fluorescence signal, thus enabling confirmation of the uptake and intracellular 
localization of the photosensitizer by deep red fluorescence emission. Figure 39 (b,c) 
shows the intracellular accumulation of Ce6 from NS after 1 and 4 hr respectively. The 
OSC  cells were  pretreated with  DAPI, which  was located  in the  nucleus and produced  
 
Figure 39: (a) cellular uptake of optimized SEP/SEL-Ce6 NS (n = 6) and confocal laser 
scanning microscopy images of OSC cells incubated with SEP/SEL-Ce6 NS for (b) 1 hr and (c) 4 
hr [i= DAPI filter; ii = Cy5.5 filter and iii = phase contrast mode].  
blue fluorescence. After incubation with SEP/SEL-Ce6 NS, the cells exhibited a strong 







































and Ce6 filters (phase contrast mode) were active, the cells were found to retain mostly 
the blue fluorescence of the nucleus while the rest showed by red colour, indicating Ce6 
was not localized in the nucleus. Thus, Ce6 was preferentially accumulated in the 
cytoplasm and exhibited cytotoxic effects on lysosomes. Interestingly, no nuclear 
fragmentation, a marker of cell-apoptosis, was observed after DAPI staining, confirming 
the absence of cell toxicity in the absence of light exposure [203-204]. 
4.B.1.5.3. Cytotoxic effect on OSC cell-line 
The in vitro cytotoxicity of Ce6 to OSC cells was evaluated by determining the cell 
survival after 4 hr of incubation under either dark or laser-irradiated conditions. The cell 
viability was determined for different concentrations of Ce6 in either free or NS form by 
MTT assay. In the absence of irradiation, no cytotoxicity was observed for both pure Ce6 
(control) and SEP/SEL-Ce6 NS (Figure 40a). This indicates that Ce6 exhibited toxicity 
only when it was subjected to laser irradiation, i.e. it exhibited selective phototoxicity. 
The cell survival continued to decrease to different extents and leveled off at higher 
concentration of Ce6 for the NS formulation and control. Interestingly, the decrease was 
steep in the case of NS than compared to the control at equivalent Ce6 concentrations. 
The efficacy of the SEP/SEL-Ce6 NS was determined by its cytotoxic potential in terms 
of IC50 value and compared with that of the control. As can be seen from Figure 40(b), 
Ce6 in NS exhibited potent cytotoxic effect, which was found to be approximately 15 
times greater than that of the control. The much greater effectiveness of SEP/SEL-Ce6 
NS could be due to several possible reasons. The most likely reason is that Ce6 in NS 
was preferentially present as monomers, which facilitated singlet oxygen generation and 
accounted for the high cell death. In contrast, pure Ce6 existed mostly in the aggregated 
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form, which markedly reduced the singlet oxygen generation and therefore exhibited 
comparable cytotoxicity at a much higher concentration. Additionally, it could be argued 
that the uptake of Ce6 was higher when delivered by the NS vehicle than free Ce6 
solution form, particularly when  mediated by endocytosis  pathway. The above findings 
are  in  agreement  with  other  studies  that  showed  different  nanoparticle-based  
 
Figure 40: (a) Phototoxicity and (b) inhibitory concentration (50%) of (a) optimized SEP/SEL-
Ce6 NS and (c) control (n = 6).  
IC50 = 1.7 μg/mL



























IC50 = 22.1 μg/mL
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photosensitizer formulations were more effective than equivalent free photosensitizer in 
solution [205].  Another possible reason could be that Ce6 in nanoparticulate form led to 
its localization in more sensitive sub-cellular sites, indicating a possible explanation of 
the increased effectiveness of SEP/SEL-Ce6 NS formulation [206].  
It is noteworthy that the IC50 of the SEP/SEL-Ce6 NS was 19 % lower than that of the 
Ce6-SEP(2) solution (p = 0.02). In addition, the SEP/SEL-Ce6 NS (Fig. 39a) showed 
higher intracellular uptake within first 4 hours of incubation compared to Ce6-SEP(2) 
solution (Fig. 29a), clearly indicating the usefulness of the nanoparticulate carriers. The 
enhanced uptake of Ce6 from the nanosuspension by the OSC cells could be ascribed to 
the greater amount of sucrose ester in the nanosuspension compared to the solution. 
Being surfactants, the sucrose esters probably increase the fluidity of the intracellular 
junctions, therby aiding permeation of components into the cells. Additionally, due to 
EPR effect of the nanoparticulate dosage forms, SEP/SEL-Ce6 NS would be more 
effectively accumulated in the carcinoma cells than the solution form, when administered 
into the subjects. This would result in significantly higher PDT efficacy of SEP/SEL-Ce6 
NS when used in vivo.  
As PDT is an effective treatment modality for superficial carcinoma, a topical application 
of the optimized SEP/SEL-Ce6 NS would be more suitable for oral carcinoma condition. 
The SEP/SEL-Ce6 NS could be freeze-dried and the resultant fine powder could be 
incorporated into an actuated device. These powdered formulations would be then 
dispensed from the device on to the affected oral mucosa. The flowability of the freeze-




The study clearly showed the usefulness of sucrose esters as matrix material for 
nanosuspension formulation. The combination of the different sucrose ester grades 
resulted in improved formulation characteristics.  Improved encapsulation efficiency was 
facilitated by SEP, while SEL augmented the drug dissolution. Overall, this work 
establishes the suitability of sucrose esters as drug carriers in PDT, which has not been 
reported in the literature.  
4.B.1.6. Summary 
A modified hot-melt emulsification-solvent diffusion method was employed in the 
preparation of Ce6-sucrose ester nanosuspension. The Ce6 in the nanosuspension was 
encapsulated as monomers within nanoparticulate sucrose ester matrix. The properties of 
the nanosuspension were affected by the hydrophobicity of the sucrose esters, diffusivity 
of the solvent mixtures and Ce6 loading in accordance with a quadratic regression model. 
The optimized nanosuspension exhibited high encapsulation efficiency, high stability and 
rapid release of Ce6. In the optimized formulation, more than 80 % of Ce6 was loaded in 
the sucrose ester matrix and approximately 85 % Ce6 was available in the dissolution 
medium within 2.5 hr. The enhanced dissolution was ascribed to amorphous form of Ce6, 
supported by DSC and XRD studies. The optimized nanosuspension reduced the 
proliferation of OSC cells to a much greater extent than free Ce6, as indicated by a 15-
fold decrease in IC50 value than the control.  In addition, efficient cellular uptake was also 
demonstrated with selective accumulation in the cytoplasm. A concomitant high singlet 
oxygen was observed, implying Ce6 was predominantly present as monomers in the 
nanoparticulate sucrose ester carrier.  
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4.B.2. Improved mucoadhesivity of alginate nanoparticles containing Ce6-
PVP complex 
4.B.2.1. Overview 
In this section, the efficacy of nanoparticulate alginate carrier for mucosal delivery of 
Ce6 was investigated. Sodium alginate is a mucoadhesive biopolymer, which facilitates 
drug release from its hydrophilic matrix in the mucosal pH condition. To increase the 
PDT efficacy and permeation of Ce6 to the oral mucosal carcinoma cells, PVP was 
incorporated into the Ce6 formulation. It was hypothesized that the encapsulation of 
monomer-rich PVP-bound Ce6 would enhance photodynamic activity by largely 
increasing the singlet oxygen generation. In this study Ce6 formulations were prepared 
by a modified solvent diffusion-polymer gelation method with a view to achieve high 
encapsulation efficiency, high mucoadhesive property and rapid in vitro drug dissolution. 
This was achieved by using various concentrations of Ce6 and PVP in three levels by 
employing design of experiments. The photodynamic efficacy of the optimized 
formulation was evaluated using OSC cells as tumor xenograft model. 
4.B.2.2. Preparation of alginate nanoparticles containing Ce6-PVP complex 
Sodium alginate (Alg) is a biopolymer of interest in nanoparticulate drug delivery owing 
to its good biocompatibility, biodegradability, mucoadhesion, gelation and film forming 
properties [207-211]. Alg exists as alginic acid below pH 4.0 where it is insoluble. 
Disintegration of the alg matrix occurs in phosphate buffer at near neutral to alkaline pH 
conditions, enabling rapid drug release from the matrix. Alg-based nanoparticulate 
systems were produced for the delivery of various hydrophilic drugs by ionotropic 
gelation of very low concentrations of Alg polymer [212-215]. Studies on the 
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encapsulation of hydrophobic drugs using Alg nanoparticles are limited due to 
insolubility of the drug in the aqueous medium. In this study, a modified solvent 
diffusion-polymer gelation method was developed to encapsulate the hydrophobic 
photosensitizer, Ce6. The effectiveness of this nano-formulation was further improved by 
incorporating PVP with Ce6 within the Alg matrix. It was postulated that the presence of 
PVP would allow Ce6 to remain in monomeric form, thus enhancing singlet oxygen 
generation, while the increased hydrophilicity of the Ce6-PVP complex would aid in 
rapid drug dissolution. Increase in mucoadhesion was also expected due to the presence 
of PVP. In the present context, it was anticipated that the degradation of the alginate 
matrix in the mucosal pH conditions would release the Ce6-PVP complex and therefore, 
high PDT activity of Ce6 could be obtained.  
In this study, a 1:1 mixture of ethanol and acetone was used to solubilize Ce6 and PVP. 
In order to speed up the solvent evaporation of the solvent mixture (boiling point              
~ 68°C), both the solvent mixture and aqueous alginate solution were preheated to 70°C. 
The solvent mixture was then dispersed in the aqueous solution, where the alginate 
polymer was attracted to the surface of the dispersed droplets. The use of 
ultrasonication/homogenization was critical for producing nanosized droplets.  The 
solvent mixture would be lost from the droplets by diffusion or evaporation into the 
aqueous medium, resulting in precipitation of PVP-Ce6, surrounded by Alg adhered to 
the surface of the droplet. Upon addition of calcium chloride, the Alg would be cross-
linked to form an insoluble matrix with entrapped Ce6-PVP complex.  
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4.B.2.3. Evaluation of 3
2
 factorial design results 
As mentioned earlier, design of experiment (DoE) has been widely used in the 
pharmaceutical field to study the effects of formulation variables on the response 
parameters [213-214]. In this study, a 3
2 
full factorial design was used where the 
concentrations of Ce6 (x1) and PVP (x2) were varied over 3 levels to determine its effects 
on particle size (y1), percent encapsulation efficiency (y2), percent mucoadhesivity (y3) 
and in vitro drug release (y4). The various targeted response parameters were statistically 
analyzed by applying one-way ANOVA (analysis of variance), at 5 % significance level 
and the significance of the model was estimated using the statistical package, Design-
Expert
®
. The results are shown in Table 14 while the response surface plots for each of 
the dependent variables are shown in Figure 41.  
4.B.2.3.1. Particle size (y1) 
As can be seen from Table 14, the mean particle size of the different formulations varied 
from 312 nm to 544 nm. Table 15 shows the quadratic model of the effects of Ce6 (x1) 
and PVP (x2) concentrations on particle size.  The model was found to be statistically 
significant in terms of its p-value, lack of fit and adjusted R
2
, indicating that particle size 
was significantly affected by the concentrations of Ce6 (x1) and PVP (x2). The regression 
coefficients presented in Table 15 suggest that particle size was mostly affected by PVP 
concentration, while Ce6 concentration had limited effect on it. The variation of particle 
size could be explained by reviewing the process of Ce6-PVP encapsulation in alginate 
matrix. As PVP concentration increased, the viscosity of the organic solvent phase also 
gradually increased. Considering the shear force exerted by sonicator and the magnetic 
stirrer to be almost constant, the constant shear force that was available for dispersing the 
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organic solvent phase became less effective as viscosity increased with gradual increment 
in the PVP concentration. Consequently, larger droplets were produced, resulting in the 
formation of larger particles. 
Table 14: Observed responses of the various Ce6-PVP-Alg NP formulations prepared according 
to the 32 factorial design 







(nm) ± SD 
y2  
(%) ± SD 
y3  
(%) ± SD 
y4  
(%) ± SD 
1 12.50 10.00 323.3 ± 14 75.4 ± 6.6 11.17 ±  1.2 81.23 ± 6.6 
2 20.00 55.00 389.2 ± 23 59.43 ±  4.3 15.06 ± 0.8 92.12 ± 5.1 
3 12.50 100.00 522.2 ± 21 54.92 ± 5.9 41.08 ± 1.8 99.67 ±  5 
4 12.50 55.00 348.4 ± 16 60.32 ±  5.1 36.2 ± 2.1 90.08 ± 5.8 
5 5.00 10.00 312.3 ± 11 84.22 ± 7.2 16.41 ± 2.2 80.66 ± 7.2 
6 20.00 10.00 330.2 ± 8 68.31 ± 5.8 8.23 ± 1.1 78.34 ± 5.3 
7 12.50 55.00 366.4 ± 12 61.6 ± 4.8 31.06 ± 2.6 90.59 ± 4.9 
8 5.00 100.00 544.2 ± 14 60.16 ± 5.6 47.11 ± 3.4 95.04 ± 4.6 
9 5.00 55.00 390.2 ± 11 72.22 ± 4.8 34.23 ± 2.8 93.02 ± 6.8 
10 12.50 55.00 378.1 ± 14 59.49 ± 5.1 34.59 ± 3.2 89.7 ± 7 
11 20.00 100.00 531.7 ± 18 47.08 ± 3.8 34.87 ± 3 96.54 ± 4.2 
12 12.50 55.00 388.3 ± 11 57.32 ± 4.5 35.66 ± 3.8 87.23 ± 6.2 
x1 = amount of Ce6  
x2 = amount of PVP 
y1 = mean particle size  
y2 = encapsulation efficiency  
y3 = mucoadhesivity (%)  
y4 = in vitro release (%) 
4.B.2.3.2. Encapsulation efficiency (y2) 
The effects of the independent variables on encapsulation efficiency (EE) of the different 
Ce6-PVP-Alg NP formulations were also investigated. From Table 14 and Figure 41, EE 










































































































































The regression model for encapsulation efficiency (EE) was constructed and found to be 
statistically significant in terms of p-value, lack of fit, adjusted R
2
 and regression 
coefficients. As can be seen from the values of regression coefficients in Table 15, both 
Ce6 and PVP were found to have significant effect on EE. Increase in Ce6 concentration 
(x1) was observed to decrease EE. In the polymer gelation-solvent diffusion method, the 
Ce6-PVP complex was dissolved in ethanol and acetone, and lost from the dispersed 
phase via diffusion/evaporation of the organic solvents into the aqueous medium 
containing Alg. Keeping Alg concentration constant, increase in Ce6 concentration would 
increase the drug to polymer ratio. The alginate matrix formed would therefore be less 
effective in retaining Ce6 when the concentration of Ce6 was increased. This aptly 
explains why the EE was highest when the Ce6 concentration was at the lowest. It was 
also found that EE tended to decrease with increased PVP concentration (x2). Increase in 
PVP concentration would increase the viscosity of the solvent phase, which consequently 
reduced the rate of solvent diffusion into the aqueous phase. This might had led to poor 
precipitation of the Ce6-PVP mixture in Alg-bound aqueous phase, leading to leakage of 
the drug with less effective encapsulation.  It was evident from the results that optimum 
encapsulation could be achieved through a balance of amounts of Ce6 and PVP used.  
4.B.2.3.3. In vitro mucoadhesivity (y3) 
The mucoadhesivity of Ce6-PVP-Alg NP was determined by an in vitro mucin-based 
assay. The mucoadhesivity was found to vary from 8 % to 47 % (Table 14 and Figure 
41). As can be seen from the values of regression coefficients in Table 15, the effect of x1 
on the mucoadhesivity was little, while x2 had positive impact on it. A quadratic model 
was found to be statistically significant for this response variable as indicated by the 
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Size (y1) Quadratic 0.979 0.979 6.52 95.68 0.72 <0.0001 
EE (y2) Quadratic 0.874 0.948 2.48 37.59 0.09 0.0006 
% mucoadhesivity (y3) Quadratic 0.936 0.873 4.72 14.79 0.16 0.0051 
% drug release (y4) 
Quadratic 0.906 0.953 2.18 20.44 0.14 0.0024 
   
Regression equations of the fitted models  
 
  
             𝑥        𝑥         𝑥 




         −    𝑥 −      𝑥        𝑥 
       𝑥 
   
 
  
         −     𝑥       𝑥  −      𝑥 












p-values, lack of fit and adjusted R
2
 values. As the PVP concentration increased, the 
possibility of complex formation between Ce6 and PVP also increased. The 
mucoadhesivity was attributed to the mucoadhesive Alg and PVP. As the degradation of 
polymeric Alg chains occurred with time, the Ce6-bound PVP played a greater role in 
facilitating mucoadhesion. The mucoadhesivity of Ce6-PVP-Alg NP was compared with 
that of other formulations [215, 216]. It was noted that Ce6-PVP-Alg NP possessed 
substantially lower mucoadhesivity on a weight-by-weight basis when compared to 
nanoparticles prepared by ionotropic complexation between chitosan (CS) and Alg 
polymers. The high mucoadhesivity of Alg-CS matrix could be ascribed to direct 
electrostatic interaction between cationic CS and negatively-charged sialic present in 
mucin. In the case of Ce6-PVP-Alg NP, electrostatic interaction was not present and the 
only effective interaction was contributed by weak van der Waals force, which accounted 
for the low mucoadhesivity. Notably, presence of PVP increased mucoadhesivity and 
therefore, incorporation of PVP in the Alg matrix could be advantageous in the 
preparation of mucoadhesive formulation.  
4.B.2.3.4. In vitro drug release (y4) 
The effects of the independent variables on amount of Ce6 released in 5 hr were 
investigated. The lowest drug release was observed when concentration of PVP (x2) was 
in lower level, while higher level of x2 resulted in 100 % release within the stipulated 
time. The p-value, lack of fit and adjusted R
2 
values for in vitro drug release were found 
to be significant and the data fitted a quadratic model. As can be seen from the regression 
coefficient values in Table 15, PVP concentration had pronounced positive effect on the 
in vitro drug release profile, while Ce6 had little effect. An increase in PVP concentration 
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increased the possibility of Ce6-PVP complex formation and ensured the presence of a 
higher fraction of PVP-bound monomeric Ce6. The latter was more hydrophilic than pure 
Ce6. During in vitro dissolution, once the degradation of alginate polymeric shell began, 
the highly hydrophilic Ce6-PVP complex rapidly dissolved in the dissolution medium. 
When the PVP concentration was on the lower side, all the Ce6 molecules present could 
not form complex with the available PVP molecules and therefore, a fraction of Ce6 
would remain unbound to PVP. Thus, it could be inferred that during in vitro dissolution, 
a longer time would be required for complete dissolution of the unbound Ce6 fraction, 
which consequently prolonged the overall drug release from Ce6-PVP-Alg NPs.  
4. B.2.3.5. Optimization of Ce6-PVP-Alg nanoparticles 
The optimal amounts of Ce6 (x1) and PVP (x2) were determined by employing the 
numerical optimization technique on the measured dependent variables, namely mean 
particle size (y1), encapsulation efficiency (y2), percent mucoadhesivity (y3) and in vitro 
drug release (y4). It was evident from the previous discussion on the effects of the 
independent variables on the formulation parameters that a low PVP content in the 
formulation would have a negative effect on mucoadhesivity and in vitro drug dissolution 
with mean particle size on the lower range. For this reason, no constraint over particle 
size was set but the EE, percent mucoadhesivity and drug release were set to maximum. 
The nanoparticle formulation was prepared using the optimal amounts of Ce6 and PVP 
derived based on the constraints set. The afore-mentioned properties of the formulation 
were then evaluated. The desirability coefficient and the predicted values of these 
properties (i.e. dependent variables) are shown in Table 16. As can be seen, all the 
predicted values were found to  be close to  the experimental values. The relatively low 
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percentage prediction errors suggested high effectiveness of the regression model 
employed for each of the dependent variables. As shown in Figure 42, the optimized Ce6-
PVP-Alg NP formulation showed a normal size distribution, with mean particle size of 
466 nm. The EE and percent mucoadhesivity achieved were acceptable. In addition, more 
than 80 % drug release in pH condition of oral mucosal fluid was achieved in 5 hr. The 
drug release rate was higher for the first hr, followed by a more gradual release for the 
remaining of the time span. The overall curve fitting (Table 17) showed that the drug 
release followed the zero order model in the first hour. Korsemeyer-Peppas model best 
described the drug release in the later phase, with an n value of 0.44, suggesting that the 
drug transport was mainly mediated by Fickian diffusion. The more rapid initial release 
could be attributed to extremely small nanoparticles, which had large specific surface 
area, as well as, to the Ce6 found on the particle surface. In the later phase, drug release 
was mainly governed by the sequential processes of polymer hydration, solvent 
penetration, drug dissolution and matrix erosion/disintegration [217]. 
Table 16: Comparative values of predicted and experimental responses for optimized Ce6-PVP-














x1 =  11 mg 
x2 = 78 mg 
y1 (nm) in range 466.2 499.8 
0.742 
6.61 
y2 (%) maximize 73.66 72.98 -0.93 
y3 (%) maximize 37.82 44.51 15.03 





Figure 42: (a) particle size distribution and (b) in vitro drug release of optimized Ce6-PVP-Alg 
NP (n = 6).
















































 (0- 1 hr) r
a
 (1-5 hr) 
Zero order 𝑚 −  𝑚  𝐾 𝑡 0.994 0.971 
First order   𝑚  𝐾 𝑡 0.975 0.981 
Higuchian 𝑚 −  𝑚  𝐾 𝑡
    0.982 0.984 
Korsemeyer-Peppas     𝑚 −  𝑚     𝐾  𝑞    𝑡 0.984 0.998 
Hixon-Crowell 𝑚 
   
− 𝑚    𝐾 𝑡 0.972 0.974 
m0 = amount of drug release at time, 0 
m = amount of drug release at time, t 
Ki = dissolution constant (i = 1 to 5) 
q = Korsemeyer-Peppas coefficient 
ra = correlation coefficient 
4.B.2.4. Characterization of Ce6-PVP-Alg nanoparticles 
4.B.2.4.1. FTIR analysis 
FT-IR spectra confirmed the Ca
2+
 induced cross-linking of sodium alginate as matrix 
material for Ce6-PVP complex (Figure 43). In the case of Alg, broad bands were 
observed at 3423 cm
-1
, which is ascribed to O−H stretching vibrations [218]. The peak at 
1400 cm
-1
 corresponded to symmetric COO− stretching of free carboxylic acid ends 
[219]. The peaks in the region 1300-1000 cm
-1
 corresponded to C−O stretchings arising 
from the oxygen linkages between the mannuronic and guluronic acid blocks [218]. In 









observed due to for O-H, C-H, N-H and C=O stretching respectively. PVP also showed 
the characteristic C-H, N-H and C=O stretching in the afore-mentioned regions. For the 
Ce6-PVP-Alg NP  formulation, the peak  at 1400 cm
−1 




Figure 43: FTIR spectra of Ce6, alginate, PVP and the optimized Ce6-PVP-Alg NP formulation. 
complexation of alginate with divalent calcium ions [219]. In addition, no prominent 
characteristic peaks of Ce6 and PVP were observed in the spectrum for Ce6-PVP-Alg 
NP, suggesting efficient complexation of Ce6-PVP in the Alg matrix by the divalent 
calcium ions.   






































































4.B.2.4.2. DSC analysis 
The DSC thermograms of sodium alginate, PVP, Ce6, Ca-Alg NP and the optimized Ce6-
PVP-Alg NP formulations are shown in Figure 44. As can be seen, the crystalline Ce6 
did not show any melting endotherm and showed slightly upward degradation curve at 
around 300°C. PVP and Alg exhibited melting endotherms in the range of 80-100°C. The 
thermogram of the optimized Ce6-PVP-Alg NP formulation showed a characteristic shift 
in melting point at around 125°C without any observable degradation pattern of Ce6. To 
affirm that the peak at around 125°C is the melting endotherm of calcium alginate, DSC 
endotherm of blank Ca-Alg NP was also recorded. It showed an endothermic peak at  
 
Figure 44: DSC thermograms of Ce6, alginate, PVP and the optimized Ce6-PVP-Alg NP 
formulation. 


























similar temperature, indicating that the melting point had shifted to a higher temperature 
for the cross-linked alginate polymer. Collectively, the findings suggested that Ce6-PVP 
was molecularly dispersed in the Ca-Alg matrix.   
4.B.2.4.3. PXRD analysis 
The X-ray diffractograms of Ce6 and the optimized Ce6-PVP-Alg NP formulation are 
shown in Figure 45. As can be seen, Ce6 showed several intense peaks, indicating its 
crystalline nature. However, these peaks were absent in the diffractogram of the NP  
 
Figure 45: XRD patterns of pure Ce6 and the optimized Ce6-PVP-Alg NP formulation.  




















































formulation, further confirming that Ce6 was effectively entrapped in the Ca-Alg matrix, 
possibly in molecularly dispersed form. 
4.B.2.4.4. Morphology of Ce6-PVP-Alg NP 
The TEM photomicrographs showed that the nanoparticles appeared to be spherically 
distinct particles (Figure 46). Under TEM, the nanoparticles appeared considerably 
smaller (200-250 nm) than the average particle size (~ 466 nm) detected by DLS 
measurements. Such discrepancy between the two results could be explained on the basis 
that dehydration of the hydrogel Ce6-PVP-Alg NP during sample preparation for TEM 
imaging, which led to the apparent decrease of hydrodynamic radius than that obtained 
from DLS measurements under hydrated conditions. 
 





4.B.2.5. PDT efficacy of Ce6-PVP loaded alginate nanoparticles 
4.B.2.5.1. in vitro singlet oxygen generation  
Singlet oxygen generation efficiency was determined in accordance with the procedure 
employed for SEP/SEL-Ce6 NS (section 4.B.1.5.1). The extent of in vitro singlet oxygen 
generation by the optimized Ce6-PVP-Alg NP is shown in Figure 47(a). As can be seen,  
 
Figure 47: (a) Singlet oxygen generation and (b) cellular uptake of the optimized Ce6-PVP-Alg 
NP formulation (n = 6). 
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singlet generation efficiency was found to increase with time that was evidenced by 2-4 
folds higher than compared to the control. The proportionate increase in singlet oxygen 
generation suggested that Ce6 did not undergo any photophysical changes after being 
incorporated in the Alg matrix in NS form. Such increase in singlet oxygen generation 
with time could be attributed to increased availability of Ce6 through gradual degradation 
of the calcium alginate complex. The better singlet oxygen generation capacity of Ce6-
PVP-Alg NP than the control could be ascribed to Ce6 monomers, which remained bound 
to PVP. Therefore, it could be argued that the efficiency of alginate nanoparticles 
containing Ce6 was notably increased by the introduction of PVP in the system.  
4.B.2.5.2. Cellular uptake and intracellular distribution 
The uptake and intracellular localization of optimized Ce6-PVP-Alg NP formulation in 
OSC cells was confirmed by confocal laser scanning microscopy under dark conditions. 
The extent of intracellular uptake over 24 hr is shown in Figure 47(b). As can be seen, a 
comparable intracellular accumulation of both formulation and the control was observed 
in the first 4 hr. Interestingly, 80 % of the uptake was completed within 8 hr of 
incubation, suggesting that the uptake could be proportionately correlated with the in 
vitro drug dissolution. Finally, the uptake efficiency was found to increase 1.6 times over 
the control by the end of 12 hr.  The cellular uptake of Ce6 was further compared 
between the optimized Ce6-PVP-Alg NP formulation and a corresponding NP 
formulation without PVP. The cellular uptake of Ce6 from the latter was found to be 
lower over the period of 24 hr. This observation indicates the significant role of PVP 
besides alginate. As the OSC cellular environment has pH of around 5, degradation of 
Alg matrix could not be ruled out as this would result in the liberation of Ce6-PVP 
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complex. This further suggests the synergistic effect of both PVP and alginate for 
improved mucosal permeability of the Ce6. The intracellular distribution of the optimized 
Ce6-PVP-Alg NP was imaged by fluorescence microscopic technique using DAPI as 
nucleus staining dye. Figure 48 shows the intracellular accumulation of Ce6 from the 
optimized Ce6-PVP-Alg NP formulation after 4 and 8 hr respectively. The OSC cells  
 
Figure 48: Confocal laser scanning microscopy images of OSC cells incubated with Ce6-PVP-
Alg NP optimized formulation for (a) 4 hrs (b) 8 hrs [i = DAPI filter; ii = Cy5.5 filter and iii = 
phase contrast mode]. 
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exhibited a strong red colour in the cytoplasm, indicating accumulation of Ce6 into the 
cells. The phase contrast mode showed a blue fluorescence at the centre of the cells, 
indicating the nucleus was unaffected by Ce6 and retained the stain of DAPI. Such 
finding corroborated the fact that Ce6-PVP-Alg NPs were preferentially accumulated in 
the cellular organelles like lysosomes, thus exerting their cytotoxic potential [203-204]. 
4.B.2.5.3. Cytotoxic effect on OSC cell-line 
The in vitro cytotoxicity of Ce6-PVP-Alg NP formulation to OSC cells was evaluated by 
determining the cell survival after 8 hr of incubation under either dark or laser-irradiated 
conditions, as discussed in section 4.B.1.5.3. As observed in case of SEP/SEL-Ce6 NS, 
no cytotoxicity was observed for both pure Ce6 (control) and SEP/SEL-Ce6 NS (Figure 
49 a) in dark conditions, indicating selective phototoxicity of the chlorin photosensitizer. 
As can be seen, the cell viability gradually decreased with increase in Ce6 concentration 
in both free and NP-bound form suggesting phototoxic effect on OSC cell-lines. 
Although Ce6 in NP-bound form exhibited enhanced cytotoxicity compared to the 
control as observed by steep decrease in cell viability at equivalent concentrations of Ce6. 
This was supported by approximately 10-times lower IC50 value of the Ce6-PVP-Alg NP 
formulation than that of the control. This clearly suggested the better effectiveness of 
Ce6-PVP complex in the nanoparticulate form compared to the solution form of free Ce6. 
The potent cytotoxicity could be attributed to the presence of PVP-bound Ce6 monomers 
facilitating the enhanced singlet oxygen generation. These monomeric species became 
gradually available through degradation of the alginate matrix and exerted their cytotoxic 
activity. In case of free Ce6 solution, albeit of substantial cellular uptake, Ce6 was mostly 




Figure 49: (a) Phototoxicity and (b) inhibitory concentration (50%) of the optimized Ce6-PVP-
Alg NP formulation and (c) control (n = 6). 
much higher concentration of Ce6 was required to elicit the similar cytotoxic action as 
that of Ce6-PVP-Alg NPs. Another plausible explanation could be the localization of the 
photosensitizer was more efficient, when delivered in the nanoparticulates form than in 
the free form [220-221].  
The optimized hydrogel nanoparticulate formulation would be suitable for topical 
application to the carcinoma in buccal mucosa. The nanoparticulate formulation could be 


























IC50 = 2.38 μg/mL
Control 
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centrifuged and the concentrated pellet applied to the affected buccal mucosa. The 
mucoadhesive property of the drug carriers (PVP and alginate) would facilitate improved 
mucosal absorption at the affected site.   
The efficacy of Ce6 in superficial cancers such as carcinoma of  the buccal mucosa has 
not yet been established. This study clearly demonstrated the improved mucosal 
absoption of the nanoparticulate form of Ce6 with PVP and alginate as drug carriers. 
These formulations were found to be mucoadhesive. Their mucoadhesivity can probably 
be further improved by the incorporation of other additives, such as chitosan, poly-lysine 
or poly-ethylenemine. However, these additives may  prolong drug release and therefore 
not suitable for PDT modality.  
4.B.2.6. Summary 
In this section, the potential of alginate polymer as a hydrophilic nanoparticulate matrix 
for mucosal delivery was investigated. The effectiveness of the formulation was further 
studied by incorporating PVP in the system. PVP was found to form a complex with Ce6. 
The complex was encapsulated by the alginate matrix cross-linked by calcium. PVP 
rendered Ce6 in disaggregated state (monomer form) and also enhanced percent 
mucoadhesivity and drug dissolution, thus aptly increasing the PDT efficacy of the 
formulation. The formulations were optimized by statistical screening design with the 
concentrations of Ce6 and PVP as independent variables. Results showed that the 
independent variables had greatly influenced the formulation characteristics, which 
revealed statistical significance when fitted in quadratic regression models. The 
optimized formulation showed a manifold increase in photodynamic potential compared 
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to the free Ce6 solution and hence, establishing the rationale of oral mucosal delivery of 

























PART 5: CONCLUSION 










5. CONCLUSION  
Ce6 is a photosensitizer currently used in photodynamic therapy (PDT) to treat cancer. 
The usefulness of Ce6 is limited by its hydrophobicity and tendency to aggregate. The 
objectives of this study were to elucidate the factors affecting aggregate formation of Ce6 
and explore the use of non-toxic pharmaceutical excipients as disaggregating agents. The 
suitability of the selected disaggregating agents as drug carriers for Ce6 was also 
investigated.  
Chlorin e6 existed predominantly as aggregates in acidic to near neutral pH conditions as 
exhibited by broadened absorption spectra, reduced fluorescence intensity and lower 
quantum yield in the afore-mentioned pH conditions. Under such comditions, the 
carboxylic acid moieties of Ce6 were unionized and formed H-bonding resulting in 
aggregation of Ce6 molecules. In alkaline pH conditions, ionization of the carboxylic 
acid moieties took place, which simultaneously increased Ce6 solubility with reduced 
aggregate formation propensity resulting in the predominance of Ce6 monomers. 
Multivariate chemometric approach, PARAFAC algorithm was employed to quantify the 
extent of aggregate and monomer fraction for varying pH and Ce6 concentrations. It 
revealed that aggregation was mostly a pH-dependent phenomenon and was not affected 
by varying Ce6 concentration.  
Polyvinylpyrrolidone (PVP) and sucrose ester (SE) were able to reduce the aggregation 
of Ce6. The disaggregation efficiency varied with the grades of PVP and SE employed. 
Both the disaggregating agents favoured a hydrophobic binding affinity with Ce6 as 
reflected from the thermodynamic study and FT-IR spectroscopy. Ce6 monomers formed 
complex by entangling with PVP macromolecules, while micellization of the Ce6 
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monomers in the hydrophobic core of SE prompted the disaggregation. The PARAFAC 
analysis showed that PVP K17 and sucrose monopalmitate (SEP) exhibited highest 
disaggregation potential on the basis of minimum amount of PVP/SE required for 
complete disaggregation among the different grades of disaggregating agents employed. 
It was found that, PVP of lower molecular weight had higher number of molecules per 
constant PVP weight and therefore had a better probability of complex formation with 
Ce6, while very low CMC value of SEP facilitated the use of minimal quantity for the 
study. Henceforth, these were later used as drug carrier for Ce6. Compared to pure 
(crude) Ce6, the complex composed of Ce6 and disaggregating agents exhibited higher 
singlet oxygen generation, cellular uptake and anti-proliferative activity against oral 
mucosal carcinoma cells. This aptly suggested that the monomer rich form of Ce6 
predominated in the mixture by the action of PVP/SE, which had better photodynamic 
efficacy than the aggregate-rich (crude) Ce6.  
In the next stage, dissolution enhancement of Ce6 was successfully achieved by 
formulating into nanosuspension using sucrose ester as matrix by a modified hot-melt 
emulsification technique. Monomeric Ce6-PVP complex was also encapsulated in 
alginate nanoparticles, thus providing enhanced mucoadhesivity for improved 
photodynamic efficacy against oral mucosal carcinoma cells. Sucrose ester facilitated 
enhanced dissolution of Ce6 by micellization and subsequently retained Ce6 in 
disaggregated form, thus facilitating improved PDT activity. In addition, the process 
modification resulted in amorphous form of Ce6 in the resultant nanosuspension. The 
optimized formulation showed an acceptable size and zeta potential value with 80 % Ce6 
encapsulated in SE matrix, which exhibited approximately 85 % release within 2.5 hr. 
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Alginate nanoparticles consisting of PVP-Ce6 complex exhibited high affinity for mucin 
and cellular uptake than corresponding nanoparticles without PVP. This was attributed to 
synergistic effect of alginate and PVP, which facilitated increased mucin absorption and 
cellular uptake.  Both the optimized Ce6-SE nanosuspension and alginate nanoparticles 
consisting Ce6-PVP complex showed enhanced PDT efficacy. This clearly showed the 
suitability of PVP or SE as drug carriers as well as disaggregating agent for Ce6.  
In summary, this study showed a deep understanding of chlorin e6 photophysics in 
different pH conditions and in the presence of disaggregating agents, namely PVP and 
SE. This study is the first of its kind to quantify aggregate-to-monomer conversion by 
application of novel chemometric approach. Based on the findings, formulation of Ce6 
with enhanced PDT activity could be achieved using PVP or SE as drug carriers. These 
formulations were found to be highly effective against oral mucosal carcinoma cells 
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 Shubhajit Paul, Chan Lai Wah and Paul Heng Wan Sia, Formulation optimization 
and in vitro characterization of surfactant-lipid nanoparticles of chlorin e6 for 
enhanced photodynamic activity. Poster presented in 26th AAPS Annual meeting 
and exposition 2012, Chicago, United States. 
 
 Shubhajit Paul, Chan Lai Wah and Paul Heng Wan Sia, Elucidating surfactant-
chlorin e6 aggregates interaction using coarse grain modeling and fluorescence 
spectroscopic technique. Poster presented in 26th AAPS Annual meeting and 
exposition 2012, Chicago, United States. 
 
 Shubhajit Paul, Chan Lai Wah and Paul Heng Wan Sia, Optimization of solvent 
selection for photodynamic therapy. Poster presented in 25th AAPS Annual 




 Shubhajit Paul, Chan Lai Wah and Paul Heng Wan Sia, Use of excitation-emission 
matrix fluorescence spectroscopy for characterization of aggregation-disaggregation 
phenomena of chlorin e6 as a function of pH and disaggregating agents. Poster 
presented in 25th AAPS Annual meeting and exposition 2011, Washington DC, 
United States. 
 
 Shubhajit Paul, Susithra Selvam, Chan Lai Wah and Paul Heng Wan Sia, A 
photophysical study on the disaggregation of Chlorin e6 by PVP using fluorescence 
spectroscopy. Poster presented in 5th Asian Association for Schools of Pharmacy 
2011, (Bandung) Indonesia. 
 
 Shubhajit Paul, Chan Lai Wah and Paul Heng Wan Sia, Nanoparticle formulations 
for the delivery of poorly water soluble drugs, poster presented in 6th ANSC 
Symposium on Drug Delivery, Singapore 2010.  
